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Preamble
1.1 Résumé de la thèse
L’expansion, au cours de l’évolution des vertébrés, de familles de gènes impliqués dans le
développement de cancers ou d’autres maladies génétiques chez l’homme, pose question. En
effet, alors que ces gènes subissent une forte pression de sélection négative, on constate que
leur famille s’est considérablement élargie par le biais de duplications. Dans ce travail, nous
avons montré que les copies de ces gènes chez les vertébrés n’ont pas été retenues suite à
une duplication locale, mais une duplication globale de génome. En fait, l’expansion de ces
familles de gènes est la conséquence de deux duplications globales du génome, chacune couplée
à un phénomène de spéciation, qu’a connu l’ancêtre des vertébrés il y a environ 500 millions
d’années. Nous avons également montré que la rétention de ces gènes dupliqués par duplica-
tion globale de génome — aussi appelé ’ohnologues’ — est favorisée par leur susceptibilité aux
mutations délétères ayant un phénotype dominant. Par ailleurs, cette rétention se révèle être
plus fortement associée à leur susceptibilité aux mutations délétères dominantes, c’est-à-dire
à leur “dangerosité”, plutôt qu’à leur nature essentielle vis-à-vis de l’organisme.
De nombreuses hypothèses ont été proposées pour expliquer la rétention de copies de gènes
après des événements de duplications locales ou globales telles que le niveau d’expression des
gènes ou la conservation des séquences. En particulier, la nécessité de maintenir un équilibre
entre les différents niveaux d’expression de gènes, ou hypothèse d’équilibre de dosage, a sou-
vent été invoquée comme cause principale de rétention des ohnologues. Afin de distinguer les
effets directs et indirects des différents hypothèses proposées, nous avons effectué des analyses
statistiques d’inférence bayésienne, ou analyse de médiation. Ces analyses nous ont permis de
démontrer que la susceptibilité aux mutations délétères dominantes est en fait la cause di-
recte de rétention des ohnologues dans le génome humain, les autres propriétés ayant un effet
indirect sur leur rétention.
Nos résultats nous ont permis d’établir le mécanisme de rétention des copies de gènes après
duplication globale de génome. Ce mécanisme repose sur le phénomène de spéciation se pro-
duisant après une duplication globale et sur la susceptibilité de certains gènes aux mutations
délétères dominantes. Notre équipe a par ailleurs confirmé ce mécanisme grâce à des simula-
tions de ce nouveau modèle de rétention.
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De nombreux organismes sont aujourd’hui reconnus comme descendants d’ancêtres poly-
ploïdes ayant survécus à des événements de duplications globales. Ces phénomènes de du-
plications globales ont joué un rôle majeur dans l’histoire évolutive de ces organismes en
offrant d’innombrables possibilité d’innovations. Toutefois, les réarrangements génomiques,
la perte de certains gènes et la divergence des séquences rendent difficile l’identification des
ohnologues, notamment dans les lignées pour lesquelles les duplications globales sont très
anciennes. Dans ce travail, nous avons développé une approche permettant d’identifier effi-
cacement les ohnologues issus de duplications globales. Plus particulièrement, cette approche
nous a permis de déterminer les ohnologues issus des deux duplications de génome ayant eu
lieu chez l’ancêtre commun à tous les vertébrés, ainsi que les ohnologues provenant des dupli-
cations globales chez les poissons. Notre approche exploite les données de génomes complets
aujourd’hui disponibles pour certains vertébrés et invertébrés. Une point important de notre
algorithme est qu’il nous permet d’établir un indice de confiance (p-value) pour chaque paire
d’ohnologues identifiée, basés sur la distribution des homologues dans les génomes comparés.
Nos résultats mettent en avant le rôle important de la sélection négative couplée aux du-
plications globales de génome dans l’émergence de la complexité des vertébrés, tout en expli-
quant la surprenante expansion au cours de l’évolution des familles de gènes impliqués dans
les maladies génétiques chez l’homme. Par ailleurs, notre algorithme, en permettant une iden-
tification des ohnologues avec un indice de confiance, fournit une meilleure compréhension de
l’histoire évolutive des génomes, et permet la mise en évidence de régions du génome poten-
tiellement dangereuses à l’échelle de l’individu.
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1.2 Thesis summary
The emergence and evolutionary expansion of gene families implicated in cancers and other
severe genetic diseases is an evolutionary oddity from a natural selection perspective. Disease
genes have been shown to be under strong purifying selection in the human genome. Yet, these
gene families have been greatly expanded by duplications in the course of vertebrate evolution,
compared to other vertebrate genes without known deleterious mutations. In this work, we
have shown that the majority of these genes have not been duplicated through small scale
duplications (SSD). Instead, the expansion of these gene families can be traced back to two
rounds of whole-genome duplication (WGD), that occurred at the onset of jawed vertebrates,
some 500 MY ago. We also observed that the retention of these WGD-duplicated genes — so-
called ohnologs — is most enhanced for the genes prone to dominant deleterious mutations
and not recessive mutations. This retention was also found to be more strongly associated
with their susceptibility to deleterious mutations, than their functional importance in terms of
essentiality.
It has been well established that different duplication mechanisms (SSD or WGD) lead to
the biased expansion of different categories of genes. Constraint to maintain balanced expres-
sion levels or the so called dosage balance hypothesis has been argued to be the major underly-
ing mechanism behind the enhanced retention of ohnologs. To unravel the causal mechanism
beyond statistical correlations we used a Mediation analysis in the context of ohnolog reten-
tion. Using Mediation analysis, we have shown that the susceptibility to deleterious mutations
is a likely direct cause of the retention of ohnologs in the human genome. Furthermore the ob-
served effect of dosage balance constraints, and many other functional properties known to
be associated with ohnolog retention, are in fact indirectly mediated by the susceptibility to
dominant deleterious mutations.
We have also developed a population genetic model to explain our observations. According
to our model, this enhanced retention of ohnologs prone to autosomal-dominant deleterious
mutations is a consequence of WGD-induced speciation and the ensuing purifying selection in
post-WGD species.
Diverse organisms are now known to descend from polyploid ancestors, often with multiple
rounds of WGDs. These ancient polyploidy events are of immense significance in the evolu-
tionary history of organisms, as they are known to facilitate unique evolutionary innovations.
However, genome rearrangements, high gene loss, sequence divergence and discrepancies in
genome annotation make identification of ohnologs in the extant genomes difficult, especially
for old genome duplications. In the present work, we have developed an efficient algorithmic
approach to identify ohnologs from the vertebrate ancestral WGD and the fish specific WGD
with high confidence. Our approach takes advantage of the availability of multiple complete
genome sequences for vertebrates and invertebrates to overcome these challenges. More im-
portantly, we have developed an approach to calculate a confidence index (P-value) associated
with individual ohnolog pairs based on the conservation of synteny in multiple genomes.
Our findings highlight the importance of WGD-induced non-adaptive selection for the emer-
gence of vertebrate complexity, while rationalizing, from an evolutionary perspective, the ex-
pansion of gene families frequently implicated in genetic disorders and cancers. The high con-
fidence ohnologs identified by our approach will pave the way for further analyses in a variety
of vertebrate genomes.
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1.3 Organization of the thesis
This manuscript has been organized in 4 parts and 14 chapters. Part-I having the first five
chapters, including the current one, concerns the introduction of the subject matter of this the-
sis. In chapter 2 and 3, I attempt to introduce the mechanisms that give rise to duplication of
genes and entire genomes, followed by the evolutionary constraints that underlie the retention
of only a subset of duplicated genes.
Chapter 4 is focussed on the two round of whole genome duplications in the vertebrate
ancestor and the overall impact of these events on the evolution of vertebrates. I will also
discuss here, the evolution after whole genome duplications and the approaches used to identify
genome duplication in vertebrates, and the challenges in identification of ohnologs. In the last
chapter of introduction, I will summarize the questions and problems addressed in this thesis.
Part-II contains the methods used in this work. In chapter 6, I will detail our approach
to identify ohnologs from the vertebrate and fish specific WGD. Chapter 7 contains details of
collection of data on disease and cancer mutations, and other functional/sequence properties
studied in this work. The last chapter summarizes the approach to perform causal inference
analysis.
The third part contains the results acquired. In chapter 9, the results of our approach to
identify ohnologs have been summarized. Followed by the analysis of these ohnologs in the
context of disease mutations and other associated properties in chapter 10 and 11. Chapter 12
explains the results of causal inference analysis, followed by the population genetic model to
explain the retention of ohnologs in chapter 13.
Part-IV consists of the last chapter containing general discussion and perspectives followed
by lists of table/figure and bibliography.
1.4 Publications resulted/forthcoming from this thesis
(1) Singh PP*, Affeldt S*, Cascone I, Selimoglu R, Camonis J, Isambert H. (2012) On the ex-
pansion of "dangerous" gene repertoires by whole-genome duplications in early vertebrates.
Cell Reports Nov. 29;2(5):1387-98.
(2) Affeldt S*, Singh PP*, Cascone I, Selimoglu R, Camonis J, Isambert H. (2013) Évolu-
tion et cancer: Expansion des familles de gènes dangereux par duplication du génome.
Médecine/Science 4(29): 358-361.
(3) Singh PP, Affeldt S & Isambert S. Human dominant disease genes are enriched in par-
alogs originating from whole genome duplication, a comment on Chen et al. PLoS Comput
Biol. (2013). 9(5):e1003073. [Submitted to PLoS Computational Biology]
(4) Malaguti G Singh PP & Isambert S. (2013) On the Retention of Gene Duplicates Prone to
Dominant Deleterious Mutations. [Submitted to Theoretical Population Biology]
(5) Singh PP, Arora J & Isambert H. Improved ohnolog detection using combined synteny
information from multiple outgroups [Under Preparation]
Natural selection merely modified, while redundancy created.
– Susumu Ohno
2
Evolution by Gene Duplication
ALTHOUGH duplication of genomic segments has been documented by early geneticists [Sturte-vant, 1925; Haldane, 1932; Bridges, 1936], it was not until late 1960’s that the potential of
gene duplication as an important evolutionary mechanism has been fully appreciated. Genome
sequences and sophisticated analysis methods were not available. Yet, based on early exper-
imental observations and limited genomic information Susumu Ohno [Ohno et al., 1968] and
Masatoshi Nei [Nei, 1969] highlighted the importance of gene duplication as the primary evo-
lutionary force to create new genes. Some of the initial concepts and theoretical framework
of the evolution after gene duplication was laid down by Susumu Ohno in his seminal book,
Evolution by gene duplication [Ohno, 1970]. We have come a long way since then, and gene
duplication has now been firmly established as the primary mechanism of the formation of
new genes. In the introduction of this thesis, I will discuss the mechanisms of formation of new
genes, evolutionary constraints underlying their retention (or loss), and the overall impact of
gene duplications on the evolution of organisms, in particular vertebrates.
2.1 Mechanisms of gene duplication
The widespread occurrence of gene duplication has become apparent with the advent of genome
sequencing. A large number of genes in every sequenced eukaryotic genome have considerable
sequence similarity and are clearly the products of gene duplication. An additional copy of a
gene can be generated by several mechanisms.
2.1.1 Unequal crossing over
The first observation of duplication by unequal crossing over was made by Taylor et al. study-
ing the replication of DNA on individual chromosomes [Taylor et al., 1957]. Crossing over
is the exchange of DNA between the two homologous chromosomes e.g. the maternal and
paternal chromosome during meiosis. During this process, the homologous regions on the two
aligned chromosomes break and then reconnect to create variations by double stranded breaks.
However, if the chromosomes are misaligned, this may result in a duplication of the genomic
segment on one chromosome and a deletion in the other (Figure 2.1), also called as non-allelic
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Figure 3 | change in copy number by homologous recombination. Each line represents a single DNA strand, polarity 
is indicated by half arrows on 3′ ends, and specific sequences are identified by letters w–z. a | Non-allelic homologous 
recombination (NAHR) will occur by unequal crossing over if a recombination repair event uses a direct repeat (x) as 
homology (upper panel). In this situation, a crossover outcome leads to products that are reciprocally duplicated and 
deleted for the sequence between the repeats (y). These might segregate from each other at the next cell division, thus 
changing the copy number in both daughter cells. NAHR can also occur by BIR when the broken molecule uses ectopic 
homology to restart the replication fork (lower panel). BIR will form duplications and deletions in separate events.  
b | Single-strand annealing. When 5′-end resection on either side of a double-stranded break (DSB) does not lead to 
invasion of homologous sequence, resection continues. If this resection reveals complementary single-stranded 
sequence (x) shown by the filled regions, these can anneal. Removal of flaps, gap filling and ligation complete repair of 
the DSB with deletion of the sequence between the repeats (y) and of one of the repeats.
Loss of heterozygosity
Loss of an allelic difference 
between two chromosomes in 
a diploid cell.
Helicase
An enzyme that separates the 
two nucleic acid strands of a 
double helix, resulting in the 
formation of regions of ssDNA 
or ssrNA.
Topoisomerase
An enzyme that can remove  
(or create) supercoiling and 
concatenation (interlocking)  
in duplex DNA by creating 
transitory breaks in one  
(type I topoisomerase) or  
both (type II topoisomerase) 
strands of the sugar–phosphate 
backbone.
generate crossovers. SDSA seems to be a mechanism for 
avoiding crossing over and loss of heterozygosity (loH), 
although it is still capable of producing changes in copy 
number when the DNA template contains direct repeats 
(reviewed in ref. 41).
Crossing over between homologous chromosomes 
can lead to loH if the chromatids carrying the same 
alleles segregate together at mitosis. If a crossover forms 
when the interacting homologies are in non-allelic 
positions on the same chromosome (NAHr) this will 
result in duplication and deletion of sequence between 
the repeats owing to unequal crossing over (fIG. 3a). 
Crossing over during intrachromosomal recombination 
between direct or inverted repeats leads to deletion or 
inversion, respectively. In all organisms tested, includ-
ing humans, there is a bias in vegetative cells towards the 
non-crossover outcome (for example, see refs 42,43). 
The differences in crossing over frequency can be 
explained if Hr often occurs by the double Holliday 
junction model in meiotic cells and by the SDSA model 
in mitotic cells (fIG. 2a). Several different DNA helicases 
and topoisomerases can channel DSB repair into a non-
crossover pathway either by unwinding the D loop after 
DNA synthesis44–47 (which has been primed by an invad-
ing strand) or by resolving a double Holliday junction 
into a non-crossover event48 (fIG. 2a). Another factor 
that restricts crossing over is repeat length — cross-
overs are unlikely to form during Hr between short 
repeats, probably owing to the decreased ability to form 
an intermediate of crossing over, that is, the double 
Holliday junction49.
Hr is used not only to repair two-ended DSBs 
(fIG. 2a), but also to repair collapsed or broken replica-
tion forks (fIG. 2b). This process is called break-induced 
replication (BIr). BIr is normally faithful and leaves 
no trace, except that it can lead to loH if the broken 
end invades a homologue instead of a sister molecule. 
If the repair process involves homologous sequence in 
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Figure 2.1: Molecular mechanisms of ge e duplication by unequal crossing over, or break induced
repair (adapted from [Hastings et al., 2009])
homologous recombination. Such a recombi atio ca also occur by br ak induced repair (BIR).
In BIR, broken molecules use ectopic homology to restart the replication fork, which may result
in duplication or deletion in distinct events [Hastings et al., 2009].
The gamet with the duplicated segment, when transferred to the next generation results in
an organism with the duplicated segment. The duplication (or deletion) of DNA can also occur
in the cells during mitotic recombination [LaFave and Sekelsky, 2009]. An unequal exchange
of genomic DNA leading to a d plication c n also occur between non-homologous chromosomes
if there are highly similar sequ nc s on the non-homologous chromos mes.
In the human genome the unequal crossing over can be facilitated by transposable elements
such as Alu elements [Hurles, 2004]. Alu element a e 300-b se pair dispersed repeti ive el-
ements, with approximately 1 million copies in the human genome. Alu element constitute
approximately 10% of the entire human genome. Due to their highly similar sequences and
high frequency of occurrenc they are implicated i unequal crossing over in most of the rec nt
duplications in the human genome [Bailey et al., 2003]. In fact, the rate of unequal cross-
ing over is expected to increase with the amount of repetitive elements in the genomes. The
repetitive elements therefore, in part underlie the higher duplicates observed in the metazoan
genomes.
A duplication resulted from unequal crossing over can encompass a single gene to a large
segment of the genome. If the exchange occur ed between the two homologous chromo omes,
the duplicated segments would be arranged in tandem. However, in the cases of non-homologous
recombination, they may reside on separate unlinked genomic loci. Furthermore, such dupli-
cates tend to preserve the structure of the original gene e.g. exons, introns and regulatory
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elements.
The exact contribution of unequal crossing over in generation of small scale and segmen-
tal duplication is unclear, however, the analysis of pseudogenes in the human genome have
estimated that 20 to 28% of all the identifiable pseudogenes were generated by segmental du-
plications through unequal crossing over [Torrents et al., 2003; Pei et al., 2012].
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Figure 1 | Mechanism of gene retroposition. a | Gene retroposition is initiated with the transcription of a parental 
gene by RNA polymerase II. b | Further processing of the resulting RNA (by splicing and polyadenylation) produc s  
a mature mRNA. c | Gene retroposition is mediated by the L1 endonuclease domain (pink rectangle), which creates a 
first nick (yellow star) at the genomic site of insertion at the TTAAAA target sequence. d | This nick enables the mRNA 
to be primed for reverse transcription by the L1 reverse transcriptase domain (pink oval), which uses the parental 
mRNA as a template. e | Second-strand nick generation (precise mechanism not known). f | Second DNA-strand 
synthesis (precise mechanism not known). g | cDNA synthesis in the overhang regions created by the two nicks.  
This process creates a duplication of the sequence flanking the target sequence, which is one of the molecular 
signatures of gene retroposition; other signatures include the lack of introns and the presence of a poly(A) tail.  
The direct repeats and the poly(A) tail degenerate over time, and are therefore usually only detectable in recent 
retrocopies. The illustration is based on findings described in Refs 26–28.
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Figure 2.2: Gene duplicati n by retroposition. Retroposition is initiate with the regular transcription
producing a mature mRNA (a-b). At the site of insertion, the endonuclease domain (pink rectangle),
creates a first nick (yellow star) (c), this enables the mRNA to be primed for reverse transcription (d-e).
A second-strand nick then is generated, leading the cDNA to be inserted at the site flanked by the target
sequence (f-g). (adapted from [Kae smann et al., 2009])
2.1.2 Retroposition
Duplicated copies of genes can also be generated by transposable elements, particularly by
retrotransposons. Retrotransposons encode a reveres transcriptase with the endonuclease ac-
tivity. These reverse transcriptases recognize polyadenylated mRNAs and can reverse tran-
scribe it to DNA. The endonuclease activity leads to the insertion of this reverse transcribed
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DNA at a random location in the genome (Figure 2.2). In mammals, LINE-1 or L1 elements
(Long Interspersed Elements) are responsible for gene duplication by retroposition [Moran
et al., 1999]. Since the retroposition process requires the expression of mRNA, the genes that
are expressed in germline are the most likely candidates of retroposition [Kaessmann et al.,
2009].
The DNA that is inserted in the genome by this process comes from the processed mRNAs,
therefore, such genes lack regulatory elements, introns and have long poly-A tails. For these
genes to be functional they must recruit a promoter or other regulatory elements at their new
location from the nearby genes. It has been thought earlier that retroposition only leads to
non-functional processed cDNA copies, however, recent genome wide studies have shown that
these genes are often functional [Kaessmann et al., 2009]. Yet, since their success depends on
the recruitment of regulatory elements, a large number of pseudogenes in the human genome
(> 80%) correspond to ‘processed’ pseudogenes generated by retroposition[Pei et al., 2012].
2.1.3 Non-homologous mechanisms
Apart from homologous mechanisms, many non-homologous mechanisms can also lead to du-
plication of genomic DNA during replication. One such mechanism is the slipping of replication
fork [Levinson and Gutman, 1987]. During DNA replication on the lagging strand, if the repli-
cation machinery is displaced and subsequently misplaced on another location, it may lead to
a duplication or deletion of DNA segment in the genome. Typically, the lengths of such dupli-
cated segments are short (tens to hundred base pairs), however, it can also lead to spontaneous
duplication of large genomic regions spanning many genes [Koszul et al., 2003].
In some cases, the lagging strand stalls and subsequently exchanges the template with an-
other replication fork which has a sequence with micro-homology. This may lead to duplication
of a part of misaligned segment, and is referred to as Fork Stalling and Template Switch-
ing (FoSTeS) [Hastings et al., 2009]. A variation of FoSTeS, called microhomology-mediated
break-induced replication (MMBIR) is also known to underlie many structural variations and
duplications in the human genome [Zhang et al., 2009; Hastings et al., 2009].
2.1.4 Whole genome duplication
All the above mechanisms generate duplicated regions ranging from a few base pairs to a large
genomic segment, typically arranged in tandem. Throughout this thesis, we will refer them
as small scale duplicates (SSD). Whole genome duplication (WGD) or polyploidy, however, can
give rise to duplication of the entire genome. Such a genome duplication can be achieved by two
mechanisms, auto- and allo-polyploidy. Autopolyploidy, can occur by incomplete chromosome
segregation, cytokinesis defects or fusion of two cells of the same organism during early devel-
opment, leading to a polyploid embryo. In case of allopolyploidy, two cells from different but
closely related organisms can fuse and give rise to an organism with whole genome duplication.
Traditionally, polyploidy had been considered to be an evolutionary dead end [Mayrose
et al., 2011]. Many polyploid plant species were known to early geneticists and it was believed
that once an organism becomes polyploid, due to the very nature of the event, the odds of
further ‘evolution’ diminish. It was also believed that animals, unlike plants should not tolerate
polyploidy due to the mode of sexual reproduction [Muller, 1925; Mable, 2004]. Susumu Ohno,
however proposed that genome duplications are a significant mechanism of evolution even in
the animal genomes [Ohno et al., 1968; Ohno, 1970].
Growing genome sequences and state-of-the-art analysis approaches have now established
2.1. MECHANISMS OF GENE DUPLICATION 11
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Box 1. Whole genome duplication in the evolution of eukaryotes
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Whole genome duplications (WGDs) have now been firmly established in all major eukaryote kingdoms [8–18]. WGDs
have been particularly frequent in plants [11,12,24–27] due to their widespread polyploidy and might have helped them
survive the Cretaceous-Tertiary extinction event 65MY ago [27]. But successive WGDs have also occurred in animal
genomes, even though most extant species are diploids. In particular, most vertebrates are now known to descend
from a single lineage that experienced two consecutive WGDs soon after the divergence of chordates about 500MY
ago (this is the long debated “2R hypothesis” [7, 9, 16, 18]). Similarly, all bony fish, which make up about 90% of
extant fish, are now known to derive from a single species that doubled its genome about 300MY ago (i.e. the “3R
hypothesis” [15]). In addition, the common carp (Cyprinus carpio) and the salmonidae fish (salmon, trout) have also
experienced another recent WGD [28]. Hence, there are, for instance, 4 consecutive WGDs between the cephalochordate
amphioxus (or lancelet Branchiostoma floridae) [18] and the common carp, with most tetrapods (including mammals)
in between at +2WGDs from amphioxus and −2WGDs from carp and most bony fish at +3WGDs from amphioxus
and −1WGDs from carp [15, 16, 28, 29]. In fact, the carp, salmon, trout, as well as the amphibian Xenopus laevis and
the mammal Tympanoctomys barrerae (red vizcacha rat from Argentina [30]) are all pseudotetraploid vertebrates with
about twice as many gene loci as their close relatives lacking this recent WGD. Likewise, polyploid species are also
suspected or confirmed in most invertebrate phyla, as in annelids (e.g., leeches [31]), flatworms (e.g., Stenostomum [32]),
mollusks (e.g., Pacific oyster, Crassostrea gigas [33]) and in the major classes of arthropods, including insects (e.g., Nabis
pallidus [34]), maxillopods (e.g., copepods [32]) and branchiopods (e.g., brine shrimp [35]).
All these species are living examples demonstrating that accidental doublings of genomes occur ubiquitously in all
eukaryote kingdoms, presumably due to cell-cell fusion or mitosis/cytokinesis defect at early developmental stage. In fact,
constitutive tetraploidy is even occasionally observed in humans where it is responsible for 1 to 2% of early miscarriages
but may lead, in rare cases, to liveborn infants reaching the age of two [36]. Hence, although most WGDs are unlikely
to bring much fitness benefit on short evolutionary time scales, they open up unmatched combinatorial possibilities to
vary gene expression over long evolutionary time scales. In addition, WGDs are believed to favor both genetic drift
through population bottleneck effect and species radiation through the emergence of recombination barriers between
pseudotetraploid subpopulations (this is caused by the accumulation of differences in ohnologue deletion patterns across
duplicated chromosomes) [37,38]. Together, these unique properties likely account for the profound impact left by WGD
transitions on the long-term evolution of eukaryotes.
Figure 2.3: hole genome duplication in th evolution of eukaryotes
polyploidy as a major evolutionary mechanism in all major eukaryotes — from unicellular eu-
karyo es, fungi plants and animals (Figur 2.3). Polypl idy is especially common in plants (Fig-
ure 2.4)1. The common ancestor of all the extant angiosperms have undergone a tetraploidy
event [Jiao et al., 2011], and almost all major plant lineages have undergone multiple poly-
ploidy events subsequently.
Successive WGDs have also occurred in many animal genomes. Even though most extant
species are diploids, polyploid species are also suspected or confirmed in most invertebrate
phyla, as in annelids (e.g., leeches [Gambi et al., 1997]), flatworms (e.g., Stenostomum [Gregory
et a ., 2000]), mollusks (e.g., Pacific oyster, Crassostrea gigas [Eudeline et al., 2000]) and in the
major classes of arthropods, including insects (e.g., Nabis pallidus [Grozeva et al., 2004]), max-
illopods (e.g., copepods [Gregory et al., 2000]) and branchiopods (e.g., brine shrimp [Dufresne
and Hebert, 1995]) (Figure 2.3). Polyploidy in the animal kingdom is specially common in the
amphibians e.g. Xenopus laevis [Hughes and Hughes, 1993].
Most importantly, most ve t bra es are now known to desce d from a si gle lineage that
experie ced two consecutive WGDs soon after the divergence of other chordates about 500MY
ago (this is the long debated “2R hypothesis” [Ohno et al., 1968; Ohno, 1970], Chapter 4).
Similarly, all bony fishes, which make up about 90% of the extant fishes, are now known to
derive from a single species that doubled its genome about 300MY ago (i.e. the “3R hypothesis”
[Amores et al., 1998; Jaillon et al., 2004], Chapter 4). In addition, the common carp (Cyprinus
carpio) and the salmonidae fish (salmon, trout) have also experienced another recent WGD
[David et al., 2003]. Hence, there are, for instance, 4 consecutive WGDs between the cephalo-
chordate ((or lancelet) Amphioxus (Branchiostoma floridae) and the common carp, with most
tetrapods (including mammals) in between at +2WGDs from Amphioxus and –2WGDs from
1http://genomevolution.org/wiki/index.php/Plant_paleopolyploidy
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Figure 2.4: Whole genome duplications in the plant kingdom. Figure adapted from CoGEPEdia.
carp and most bony fish at +3WGDs from amphioxus and –1WGD from carp.
Many plant species and animals such as carp, salmon, trout, as well as the amphibian
Xenopus laevis and the mammal Tympanoctomys barrerae (red vizcacha rat from Argentina
[Gallardo et al., 2006]) are in fact pseudotetraploid organisms with about twice as many gene
loci as their close relatives lacking this recent WGD. Such ‘neopolyploid’ organisms still carry
clear evidence of polyploidy in their genomes.
However, in case of most of the other WGDs, such as the 2R-WGD in vertebrates or the
3R-WGD in bony fishes, the evidence in the genome is not direct. In fact, the genome of these
organisms are genetically diploid, yet the evidence that their ancestors underwent WGDs can
be sought in the structure of their genomes (Discussed in Chapter 4). Such genetically diploid
but structurally polyploid genomes are referred to as paleopolyploid genomes. Before the ad-
vent of genome analysis techniques, polyploidy could only be recognized by counting number of
chromosomes, or by analyzing the distribution of a handful of sequences on genomes. Hence,
many of these paleopolyploidy events have been debated for very long time.
Although in the short term, polyploidy leads to population bottleneck and possible compe-
tition with their diploid ancestors, the success of paleopolyploid organisms and the frequent
occurrence of a number of neopolyploids strongly suggests that whole genome duplication has
been central to the evolution of a vast number of organisms.
3
Evolutionary Constraints & Retention of
Duplicated Genes
GENOME wide analyses have estimated the rate of occurrence of gene duplications to beclose to nucleotide substitutions, on the order of 0.01 per gene per million years [Lynch
and Conery, 2000]. Although the fact that many of the genes are retained by the ancestral
WGDs in the studied organisms was not taken into account, the knowledge of the frequent
occurrence of gene duplicates has also led to the realizations that not all the duplicates are
retained in the genome. Immediately after duplication, both the copies (called paralogs) are
expected to perform identical functions. If this redundancy is not advantageous, during subse-
quent evolution one of the two paralogs becomes typically a non-functional pseudogene by ac-
cumulating degenerating mutations and the traces of the duplication are lost from the genome
as it continues to harbour mutations without any selective pressure. This stochastic silencing
of one of the copy is called as pseudogenization, and is considered to be the most likely fate of
a duplicated gene. However, in some cases, both duplicated copies are retained in the genome,
diverge and become eventually fixed in the population. What evolutionary constraints under-
lie the retention of only a small fraction of genes? Many mechanisms have been proposed to
explain the retention of genes after duplication.
3.1 Neofunctionalization
The idea of neofunctionalization had been proposed very early by Haldane and Fisher [Dittmar
and Liberles, 2011], and was followed by Susumu Ohno [Ohno, 1970]. Ohno argued that in the
absence of a redundant copy, the function performed by any gene would be under strong selec-
tive constraint. However, if an additional copy is available by gene duplication, this purifying
selection would be relaxed. While one of the two paralogs provides the ancestral function,
the other one would be free to accumulate mutations, and on occasions would evolve a new
beneficial function. Both copies would now be retained through positive selection.
However, clear and well studied examples of neofunctionalization are difficult to find [Dittmar
and Liberles, 2011; Gibson and Goldberg, 2009]. Under the light that most mutations are ei-
ther neutral and deleterious, the neofunctionalization concept has been under scrutiny since
13
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its inception. Most claims supporting neofunctionalization have been indirect. For example,
on the genome-wide scale the asymmetric divergence pattern of the duplicate copies has been
taken to be the evidence of neofunctionalization [Kellis et al., 2004; Byrne and Wolfe, 2007].
Neofunctionalization at the regulatory level has been assessed and supported by the overlap-
ping expression profiles of the duplicated genes [Tirosh and Barkai, 2007; Assis and Bachtrog,
2013]. Acquisition of new domains by the duplicated genes have also been taken to be the
evidence for neofunctionalization [Drea et al., 2006; Casewell et al., 2011; Jin et al., 2009]. In
most reported instances of neofunctionalization, the neofunctionalized gene performs a func-
tion not performed by the ancestral gene, yet the function would exist in some other gene in
the genome. Therefore, many instances of proposed neofunctionalization can be accounted for
by domain shuffling coupled to fixed duplicates. Evolution of truly ‘new’ functions, non-existent
in the genome before duplication is expected to be very rare.
3.2 Subfunctionalization
Another mechanism that can leads to the fixation of duplicated genes was initially proposed by
[Hughes, 1994], and studied extensively by [Force et al., 1999; Lynch and Force, 2000a], known
as subfunctionalization. According to this model, both copies continue to accumulate muta-
tions after duplication, and degenerate to a level where none of the paralogs alone can provide
old ancestral functions. Hence, the duplicated copies can be preserved for longer times, as
the loss of any of the paralog is expected to become deleterious after subfunctionalization. In
general, such a subfunctionalization mechanism (also called Duplication Degeneration Com-
plementation or DDC) is neutral and because the duplicates can no longer be lost, population
genetic processes ultimately lead to the eventual fixation of the duplicated copies [Lynch and
Force, 2000a]. However, several variants of the subfunctionalization model exist and some of
the mechanisms are also proposed to be adaptive.
For example, in cases where a single gene performs multiple functions, subfunctionaliza-
tion may lead to uplifting of such pleotropic constraints, and hence can be beneficial [Hughes,
1994]. The duplicated copies can now escape from the adaptive conflict (the EAC model) of
the ancestor and can now become specialized, which was not possible with a single ancestral
copy [Des Marais and Rausher, 2008]. A similar model referred to as Adaptive Radiation or
Innovation Amplification Divergence (IAD) provides another mechanism of subfunctionaliza-
tion based on an initial advantageous dosage increase [Francino, 2005; Näsvall et al., 2012].
The boundary between all these mechanisms is not clearly defined and specific evidences in
support of each of these models are available. Yet, on a genome wide scale, subfunctional-
ization appears to be a common mechanism with vast number of gene duplicates with high
sequence similarity, related functions and non-overlapping expression profiles [Duarte et al.,
2006; de Souza et al., 2005].
3.3 Buffering against deleterious mutations
Several studies have argued that gene duplicates can compensate each other’s function and
hence, may lead to robustness against deleterious mutations. It had been noticed that gene
duplicates confer robustness against null mutations in yeast [Gu et al., 2003; Gu, 2003] and
Caenorhabditis elegans [Conant and Wagner, 2004]. Such a buffering mechanism requires,
however, that the functions of the duplicated copies do not diverge too much.
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Functional compensation against deleterious mutations have been also argued by the ob-
servations that the disease genes in the human genome have more duplicates as compared to
non disease genes. Furthermore, these duplicated genes tend to have higher sequence similar-
ity and co-expression than the duplicates of non-disease genes [Chen et al., 2013b; Dickerson
and Robertson, 2011].
Another line of evidence for buffering against deleterious mutations comes from the anal-
ysis of essential genes, i.e. genes in which silencing or knock-out mutations lead to lethality
or sterility. However, the results have been equivocal. If the buffering against deletion for
essential genes is indeed beneficial, on a genome wide scale essential genes should have more
duplicates than non-essential genes. While some studies indeed observed an enrichment of
essential genes in gene duplicates [Gu et al., 2003; Kamath et al., 2003; Makino et al., 2009],
many others however have failed to observe any such bias [Liang and Li, 2007; Liao and Zhang,
2007; Guan et al., 2007]. The relationship between gene duplication and functional compensa-
tion has remained enigmatic.
3.4 Dosage balance hypothesis
The concept of neo- and subfunctionalization to explain retention of duplicated genes were
developed before the distinct properties of the genes retained from small scale duplication
(SSD) and whole genome duplication (WGD) became apparent. Therefore, these models do not
account for the fact that the genes retained from SSD or WGD have very distinct functional
properties. As more genome sequences of paleopolyploid genomes became available it was
realized that SSD and WGD-duplicated genes have very distinct functional properties [Davis
and Petrov, 2005; Hakes et al., 2007; Fares et al., 2013].
Indeed, WGD-duplicated genes, have been preferentially retained in specific gene classes
associated with organismal complexity, such as signal transduction pathways, transcription
networks, and developmental genes [Maere et al., 2005; Blomme et al., 2006; Freeling and
Thomas, 2006; Sémon and Wolfe, 2007; Makino and McLysaght, 2010; Huminiecki and Heldin,
2010]. By contrast, gene duplicates coming from SSD are strongly biased toward different func-
tional categories, such as antigen processing, immune response, and metabolism [Huminiecki
and Heldin, 2010]. SSD and WGD duplicated genes also differ in their gene expression and pro-
tein network properties [Hakes et al., 2007; Guan et al., 2007]. Furthermore, recent genome-
wide analysis have shown that WGD genes in the human genome have experienced fewer
SSD than non-WGD genes and tend to be refractory to copy number variation (CNV) caused by
polymorphism of small segmental duplications in human populations [Makino and McLysaght,
2010].
Dosage balance hypothesis has been proposed to explain these antagonist retention pat-
terns of WGD and SSD/CNV gene duplicates. The dosage of a gene i.e. the amount of protein
expressed has been proposed to play an important role for proper formation or functioning of
cellular assemblies such as transcription factors and protein complexes [Birchler et al., 2001;
Veitia, 2002, 2003]. Although the early studies focussed on the stoichiometric imbalance of reg-
ulatory complexes, [Papp et al., 2003] associated all protein complexes with the dosage balance
hypothesis. Studying the yeast duplicates, they observed that only WGD-retained genes are
enriched in protein complexes and interpreted that an imbalance in the components of protein
complexes leads to lower fitness. [Papp et al., 2003] also set the precedent to seek enrichment
of protein complexes in the WGD-retained genes in the support of dosage balance hypothesis.
In general, the dosage balance hypothesis posits that the relative amount of interacting
gene products e.g. subunits of protein complexes is crucial for its proper formation and func-
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1988; Sabl & Birchler, 1993; Guo & Birchler, 1994) to
produce direct or inverse dosage effects. Many fewer
changes were observed with changes in ploidy (Guo et al.,
1996). Similar types of effects were observed at the RNA
level for selected genes analysed (Guo & Birchler, 1994). It
was postulated that alterations of the stoichiometry of regu-
latory genes might be responsible for this spectrum of
effects (Birchler & Newton, 1981).
Whenever a regulatory gene producing an inverse dosage
effect and a subset of its target loci are varied on the same
chromosomal segment, dosage compensation is observed.
In other words, increasing the dosage of a structural gene
increases its expression in proportion to copy number.
However, increasing the dosage of an inverse regulator at
the same time would restore the original diploid expression
level (Birchler, 1979, 1981; Devlin et al., 1982; Birchler
et al., 1990) because the two opposing effects cancel each
other. The first described example involved the alcohol
dehydrogenase (adh1) gene on the long arm of chromosome
1 in maize (Birchler, 1981). Indeed, varying the dosage of
the gene itself produced a gene dosage effect for the amount
of product observed. Conversely, varying another portion
of 1L produced an inverse dosage effect on the levels of
alcohol dehydrogenase (ADH). When both regions are var-
ied together in the whole of chromosome arm 1L, dosage
compensation of ADH concentrations was observed. Com-
pensation also operates on the RNA level (Birchler et al.,
1990; Guo & Birchler, 1994).
The inverse and direct effects on gene expression
observed in aneuploids could be mimicked by the recovery
of single gene mutations that would increase in the twofold
range or reduce in the range of one-half the expression of a
reporter gene in Drosophila (Rabinow et al., 1991). A leaky
allele of the white eye color gene was used to find modifier
mutations that would reduce or increase its expression as a
heterozygote. A collection of 47 such mutations in indepen-
dent genes was recovered over two decades of screening
(Birchler et al., 2001). These genes show a dosage effect on
the white eye color reporter gene and thus are reasonable
candidates for being responsible for the aneuploid effects.
The majority showed an increased effect on white while
others reduced the expression (Fig. 2).
The connection between dosage effects and QTL
It is an interesting question of how there can be such a large
number of modifiers of the white eye color gene. The
answer likely resides in the fact that gene regulatory systems
operate in a hierarchy with one regulator controlling
some downstream effectors, which in turn control other
regulators (Birchler et al., 2001). Moreover, regulators are
often multisubunit complexes and thus each subunit-encod-
ing gene can be a modifier of the phenotype. The develop-
mental progression of the Drosophila embryo has been
studied in great detail and illustrates the cascade of dosage-
dependent regulatory molecules that trigger each subse-
quent step in development (Driever & Nusslein-Volhard,
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Fig. 2 Heuristic example for the explanation of inverse dosage
effects produced by a regulatory trimer ABC with variation of
subunit B. Consider that trimer assembly is random and irreversible
(the reactions are represented within the frame of the graph and are
the same as in Fig. 1). The reaction conditions that can lead to the
observed inverse dosage effects mentioned in the text are consid-
ered. For each mole of monomer of A and C, the trimerization reac-
tion involves three moles of monomer B and all kinetic constants are
the same (unitary for simplicity). This scenario will yield 0.33 moles
of ABC (and incomplete subcomplexes). This reaction will produce
100% of ABC in the diploid. For the same (unitary) amounts of A
and C, halving the amount of B (1.5 moles of B) leads to 200% of
trimer yield and increasing the relative amount of B (to 4.5 moles)
leads to 67% of trimer. Thus, if the trimer acts positively on target
genes and B is varied in an aneuploid series, the inverse effect on
target loci would result. Note that A, B and C can also be multi-
subunit subcomplexes. Such an example does not exclude the
possibility that an inverse dosage effect is produced by negatively
acting regulators.
A + B + C = A – B – C(a) 
A + B + C = A – B – C + AB + BC(b) 
+      +       = 
+          +      =             +  
Nonproductive
subcomplexes 
Fig. 1 Effects of over-expression of a dosage-sensitive subunit
involved in a macromolecular complex. (a) Irreversible assembly of
trimer A–B–C allowing intermediate dimers AB and BC. Although not
represented in the figure the reactions involved are A + B = AB,
B + C = BC, AB + C = ABC and BC + A = ABC. (b) An excess of the
molecular bridge B (1.5 X) leads to a decrease in yield of ABC because
of the production of intermediates that cannot be completed because
of the lack of enough A and C monomers (notice how incomplete
dimeric complexes outnumber the normal expected trimers).
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Figure 3.1: Dosage imbalance in macromolecular complexes. (a) A trimer A-B-C is assembled irre-
versibly from three subu its: A, B and C. A 1:1:1 ratio of each of the subunit leads to proper formation
of the trimer. (b) An imbalance in this stoicheometry is caused by the over-expression of one subunit B,
that significantly reduces the yield of the functional trimer A-B-C (adapted from [Birchler and Veitia,
2010])
tioning. Duplication of nly ne of the interacting partner by SSD leads to dosage imbalance
such as a stoichiometric imbalance d ring formation of protein complexes (Figure 3.1). This not
only leads to a decreased yield of functional complex, but might also lead to dominant negative
or toxic effects by partially assembled non-productive subcomplexes [Papp et al., 2003]. How-
ever, in WGD since all the genes are duplicated simultaneously, the relative amount of all the
interacting partners is pres rved. Yet, just as the duplication of individual genes, the deletion
after WGD will also lead to dosage imbalance and hence would be opposed by selection. The
dosage balance hypothesis has been frequently invoked to explain the biased retention of SSD
and WGD genes in a variety of organisms such as yeast [Papp et al., 2003], Paramecium [Aury
et al., 2006], Arabidopsis [Maere et al., 2005] and humans [Makino and McLysaght, 2010], by
seeking enrichment of pro in complexes in WGD duplicates.
4
Whole Genome Duplications & Evolution of
Vertebrates
Duplication of genes and their subsequent divergence has now been established as the major
evolutionary mechanism to generate new genes and rewire cellular pathways and networks.
While small scale duplications (SSD) provides a continuous flux of genetic material, large scale
sporadic duplications of entire genomes are now known to play very important role in the evo-
lution of many organisms. Such whole genome duplication (WGD) events have now been firmly
established in almost all major eukaryotic lineages [Van de Peer et al., 2009]. Organisms as di-
verse as Saccharomyces cerevisiae, paramecium, vertebrates and flowering plants are known to
be descended from polyploid ancestors, often with multiple rounds of WGDs (Figures 2.3, 2.4).
These organisms are referred to as paleopolyploids, as this polyploidy can only be observed at
a structural and not at the genetic level in their extant genomes.
In vertebrates in particular, genome duplications were first proposed by Susumu Ohno
[Ohno et al., 1968] (the 2R-hypothesis) who argued that the huge leap in complexity in ver-
tebrates was facilitated by sudden burst of increase in genetic material by WGDs, which was
tinkered by millions of years of subsequent evolution. The compelling evidence in support of
2R hypothesis remained elusive for a long time, but recent genome wide studies strongly advo-
cate these vertebrate ancestral WGD events [McLysaght et al., 2002; Dehal and Boore, 2005;
Putnam et al., 2008]. Due to pioneering works of Susumu Ohno in this area, the genes retained
from whole genome duplications are now referred to as “ohnologs” [Wolfe, 2000].
These ancient polyploidy events are of immense significance, as they are known to facili-
tate unique evolutionary innovations. It is now known that ohnologs and SSD contribute an-
tagonistically to different functional categories consistently across diverse taxa, with ohnologs
primarily associated with signaling pathways and developmental genes. Although a basic set
of developmental genes was already present in chordates, the selective expansion of these gene
families in vertebrates by WGDs led to evolution of complex developmental processes [Hol-
land et al., 1994] including neural creast, [Holland et al., 2008] vertebrate skeleton [Wada,
2010], brain [Holland and Short, 2008] and adaptive immune system [Okada and Asai, 2008].
HOX gene clusters involved in patterning of the body plan have also been duplicated primarily
by WGD in both vertebrates and teleost fishes [Soshnikova et al., 2013; Kuraku and Meyer,
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2009]. Furthermore, gene families involved in many key cellular processes and pathways
have retained an excess of ohnologs as compared to SSDs e.g. haemoglobins [Opazo et al.,
2012; Storz et al., 2012], ligand-receptor interactions [Braasch et al., 2009], ABC [Annilo et al.,
2006], glycolytic pathway [Steinke et al., 2006], GPCRs [Semyonov et al., 2008], GATA tran-
scription factor [Gillis et al., 2009], tetraspanins [Huang et al., 2010], 14-3-3 binding proteins
family [Tinti et al., 2012]. These observations have strengthened the hypothesis that WGDs
have indeed played a major role in the evolution of vertebrate complexity. Therefore analyz-
ing ancient WGD events, and identification and characterization of ohnologs is central to the
understanding of the evolutionary history of paleopolyploid organisms.
Accurate identification of ohnologs from ancient WGD events however, is not straightfor-
ward. A typical evolutionary scenario after WGD is presented in Figure 4.1 A-D. Each gene has
been labelled by a number and orthologous/paralogous relationships (genes of same color) are
depicted by lines. Immediately after WGD all the genes exist in twice as many identical copies
preserving their order on chromosomes (Figure 4.1 B). However, this pattern will be faded pro-
gressively during the course of evolution primarily by random gene loss from one of the sister
regions (Figure 4.1 C). As the polyploid genome eventually becomes genetically diploid again,
typically only 10-15% of the genes retain their ohnologs [Brunet et al., 2006]. Furthermore,
a combination of inter and intra-chromosomal rearrangements, small scale duplications (not
depicted in Figure 4.1 B for simplicity) and sequence divergence of retained paralogs lead to
the fractionation of large duplicated regions into smaller degenerated segments with only a
few duplicated genes (Figure 4.1 B). This process is termed as rediploidization after WGD.
Such structurally degenerated duplicated regions covering a large proportion of genome are
the signals of an ancient polyploidy event and can be identified when the extant paleoployloid
genome is compared to itself. If a genome has experienced an ancient WGD event, large blocks
of conserved synteny would be detected where all the paralogs duplicated at the suspected time
of duplication. For example, using a criteria that at least two consecutive genes duplicated by
WGD occur in a window size of three, paralogous synteny blocks can be identified in Figure 4.1
I, highlighted in boxes. The genes on such blocks, if they have been duplicated at the time of
WGD event can be characterized as ohnologs.
Another, more convincing evidence of an ancient WGD event can be sought in the com-
parisons between genome of paleopolyploid organism with an organism diverged before the
WGD event, called as an outgroup organism (Figure 4.1 E & G). The outgroup genomes would
also undergo independent lineage specific rearrangements (depicted by shuffled location of the
genes in Figure 4.1 F & H). Yet each region in the outgroup genome should ideally be paral-
ogous to two regions in the WGD genome, a pattern called doubly conserved synteny (Figure
4.1 J & K). The number of degenerate synteny blocks sharing the same outgroup block can
vary depending on the number of WGD experienced by paleopolyploid organism. Such signals
covering the majority of the genomes have provided compelling evidence of a WGD in a variety
of organisms [Kellis et al., 2004; Jaillon et al., 2004, 2007; Putnam et al., 2008].
However, accurate identification of ohnologs in paleopolyploid genomes poses many chal-
lenges, especially in case of old whole genome duplication events such as vertebrate ancestral
WGDs. First, only a small fraction of genes retain their ohnolog partners. Second, inter- and
intra-chromosomal rearrangements in both outgroup and WGD genome lead to the weakening
of synteny conservation making the identification of the synteny blocks difficult. Third, even in
the case of retained duplicate partners, sequence divergence and the criteria to identify them
(e.g. E-value in BLAST or gene family construction) can lead to spurious orthologs/paralogs
assignment, and may also lead to discrepancies in the estimation of their duplication time.
Fourth, the levels of genome annotation vary also vastly for different genomes, such as the
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Figure 4.1: Evolution after WGD and identification of ohnologs using self and outgroup synteny com-
parison
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predicted number of genes, their location and the quality of the genome assembly, affecting
ohnolog detection. Lastly, window based approaches are typically used to detect such signals;
however, in most studies arbitrary window sizes and arbitrary numbers of orthologs/paralogs
are used to make synteny calls. Moreover, a quantitative measure to identify the quality of
ohnologs has been lacking. Many studies identified human ohnologs by detecting such block
within the human genome using a sliding window based approach [Dehal and Boore, 2005;
Makino and McLysaght, 2010], yet surprisingly only a few studies have attempted a compar-
ison with a single chordate outgroup genome — Amphioxus — with the human genome to
identify regions descended from WGDs [Abi-Rached et al., 2002; Putnam et al., 2008].
Due to lineage specific rearrangements it is highly likely that many of the ‘true’ ohnologs
would be missed if the same window size and only a single synteny comparison is performed.
For example, note that using a criteria of 2 consecutive candidates in a window of size 3, (Figure
4.1 I-K) many of the ohnologs would not be identified by either self comparison or the outgroup
comparison alone e.g. ohnolog pairs V1 −V ′1, V5 −V
′
5 are missed as ohnologs by self synteny
comparison, but are covered by outgroup-1 and 2 respectively Figure 4.1 I-K. Therefore, it is
really important to perform synteny comparisons with multiple outgroups in addition to the
genomic regions in the same vertebrate genome. More importantly, as only 10-15% genes are
typically retained in synteny after any typical WGD, in outgroup comparison more power in
synteny identification can be generated by the orthologs.
5
Objectives of This Thesis
DOMINANT deleterious mutations, that are lethal or drastically reduce fitness over the lifes-pan of organisms, must also impact their long term evolution on timescales relevant for
genome evolution (e.g., >10–100 MY). In fact, dominant disease genes in humans have been
shown to be under strong purifying selection. Yet, disease gene families implicated in cancer
and severe genetic diseases have also been greatly expanded by duplication in the course of ver-
tebrate evolution. Indeed, considering that many vertebrate disease genes are phylogenetically
ancient [Domazet-Lošo and Tautz, 2008; Cai et al., 2009; Dickerson and Robertson, 2011], and
that their orthologs also cause severe genetic disorders in extant invertebrates [Berry et al.,
1997; Ciocan et al., 2006; Robert, 2010], it is surprising that dangerous gene families have
been duplicated more than other vertebrate genes without known dominant deleterious muta-
tions. Furthermore, in invertebrates and vertebrates, very different classes of genes has been
expanded by duplications [Putnam et al., 2008]. While gene duplicates might confer muta-
tional robustness against loss-of-function mutations, multiple copies of genes prone to gain-of-
function mutations are expected to lead to an overall aggravation of a species’ susceptibility to
genetic diseases and thus be opposed by purifying selection.
Two alternative hypotheses can be put forward to account for the surprising expansion of
dangerous gene families. Either, the propensity of certain genes to acquire dominant deleteri-
ous mutations could be a mere by-product of their presumed advantageous functions. In that
case, only the overall benefit of gene family expansion should matter, irrespective of the mecha-
nism of gene duplication. Alternatively, gene susceptibility to dominant deleterious mutations
could have played a driving role in the striking expansion of dangerous gene families. But
what could have been the selection mechanism?
The first aim of this study was to characterize the mechanism of the duplication of cancer
and disease genes. Unlike many previous studies, we aimed to generate a comprehensive
dataset of Mendelian disease genes and cancer genes, including many other classes of genes
known to be susceptible to deleterious mutations. We wanted to investigate the retention
pattern of these disease genes after SSD and WGD with the most comprehensive and a high
confidence subset of disease genes.
To discriminate between Ohnologs and SSDs, our next aim was to develop an improved
method to detect ohnologs in the human genome. In particular, we aimed to use the power of
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multiple genome comparisons to overcome many limitations associated with the identification
of ohnologs. More importantly, our objective was to calculate a confidence measure to quantify
the quality of the identified ohnologs.
We hypothesized, that the susceptibility of these genes must play the central role in their
biased retention after duplication in the human genome. A similar proposition had been made
in an article comment by Gibson and Spring [Gibson and Spring, 1998]. In fact, multiple
genomic properties have been reported to correlate with the retention of genes after WGD or
SSD. Therefore, we aimed to go beyond statistical correlations and to use advanced statistical
approaches to disentangle the relative effects of mutation susceptibility and other properties,
such as dosage balance in particular.
Ultimately, we wanted to put forward a comprehensive model to explain our observations
from statistical and advanced inference analysis from a population genetic perspectives.
Part II
Materials & Methods
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6
Identification of Ohnologs
THE identification of the genes retained from whole genome duplication is not straightfor-ward. During millions of years of evolution following WGD, as the paleopolyploid genome
is reduced to normal ploidy levels, sister regions created by WGD are redistributed across the
genome by rearrangements and degenerated by the loss of the majority of ohnologs (Figure
4.1). We used a window based approach to detect such regions, called synteny blocks, between
a pair of outgroup (invertebrates) and paleopolyploid (vertebrates) genomes. We compared each
vertebrate genome to outgroup genomes (outgroup comparison) and to itself (self-comparison).
A summary of our overall approach is detailed in Figure 6.1.
6.1 Input genomes, orthologs and paralogs (6.1A)
To identify ohnologs retained from the 2R-WGD, we used six invertebrate genomes, one lancelet
(cephalochordate): Amphioxus (Branchiostoma floridae), two tunicates (urochordates): Ciona
intestinalis and Ciona savignyi, an echinoderm: sea urchin (Strongylocentrus purpuratus), and
two basal bilaterians: fly (Drosophila melanogaster) and worm (Caenorhabditis elegans) as out-
groups. Using these outgroups we identified ohnologs in six completely sequenced vertebrate
(tetrapod) genomes: human (Homo sapiens), chicken (Gallus gallus), dog (Canis lupus famil-
iaris), pig (Sus scrofa), mouse (Mus musculus) and rat (Rattus norvegicus) (Figure 6.2).
6.1.1 Protein coding genes and their genomic coordinates
We limited ourselves to protein coding genes. Except for sea urchin and Amphioxus, the protein
coding genes and their genome positions were obtained from Ensembl version 70 [Flicek et al.,
2013] using BioMart. Sea urchin and Amphioxus genes and their genome coordinates were
downloaded from Ensembl Metazoa [Kersey et al., 2012] and DOE Joint Genome Institute
(JGI) [Putnam et al., 2008] respectively. We further excluded genes belonging to unassem-
bled scaffolds or haplotype regions in the vertebrate genomes. Each outgroup and vertebrate
genome was then represented by a list of gene identifiers sorted on the basis of their start
positions on their respective chromosome.
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Figure 6.1: Flowchart of the algorithm to identify ohnolog pairs and construct ohnolog families for
a single vertebrate genome by synteny comparison with multiple outgroup genomes (left panel) and
self-comparison (right panel).
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Figure 6.2: Schematic tree for the organisms analyzed in this study. The duplication nodes are from
Ensembl Compara. Gray nodes are not the part of Ensembl. Paleopolyploid genomes are marked in red
boxes and outgroups (for 2R-WGD) are in green box.
6.1.2 Orthologs and paralogs
We then identified vertebrate genes sharing the same outgroup ortholog using pairwise BLASTp
(E-value < 10−5) and selected the best outgroup match for each vertebrate gene. The vertebrate
genes that share the same invertebrate ortholog are the only candidate gene duplicates con-
sidered in the vertebrate genomes.
Duplicated genes within vertebrate genomes (paralogs) and their relative node of duplica-
tion were obtained from Ensembl compara [Vilella et al., 2009] using BioMart. We noticed
ambiguities in the relative duplication timing of genes in different Ensembl versions. This is
because Ensembl compara assesses duplication times by constructing gene families through
clustering, and then reconciles gene trees for each family with the species tree. Therefore, as
new organisms are added in recent versions the duplication node of a gene can change. For
example the paralog pairs RalGDS – RGL4 has been annotated to Eutheria in Ensembl v66,
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Bilateria in v67, again to Eutheria in v68-69 and to Euteleostomi in v70.
Therefore, rather than using just one node at the base of vertebrates, we considered par-
alogs from four duplication nodes at the base of vertebrates: Chordata, Vertebrata, Euteleostomi
and Sarcopterygii, as candidate ohnologs if they also fulfil our synteny criteria. For the human
genome, we further took the consensus of 6 Ensembl releases (v65 – v70) and collected paralogs
whose relative duplication time were annotated to one of these four nodes in the majority of
the recent releases, taking the most recent version (v70) in the case of ambiguities. Table 6.1
lists the number of genes, orthologs and paralogs for all the analyzed genomes.
Table 6.1: Number of protein coding genes, orthologs and paralogs for analyzed vertebrate (A)
and invertebrate (B) genomes
A. Vertebrates
Organism
Total
genes
*Total
paralogs
*Candidate
paralogs
Ortholog pairs
B. floridae C. intestinalis C. savignyi S. purpuratus D. melanogaster C. elegans
Homo sapiens 20415 127981 36775 16462 14746 13955 15807 14165 13135
Canis lupus
19574 103380 31402 16424 14731 13857 15756 14051 13011
familiaris
Gallus gallus 15310 48334 16688 12006 10841 10201 11522 10359 9590
Mus musculus 22571 273095 48737 17707 15693 14795 16927 15053 13998
Rattus norvegicus 22865 218224 48678 18750 16635 15593 17998 16004 14832
Sus scrofa 19429 121315 29930 16414 14413 13544 15715 13744 12626
B. Invertebrate (Outgroup)
Protein coding genes 50817 16658 11604 28525 13924 20505
* The numbers correspond to number of pairs
6.2 Identification of synteny blocks and anchors (6.1B)
A synteny block is defined as a region between an outgroup and a vertebrate genome (Figure
6.3 A), or two regions within the same vertebrate genome (Figure 6.3 B) having multiple homol-
ogous gene pairs. Between the genomes of two species such blocks represent conserved genomic
regions descended from their last common ancestor. Within the genome of the same organism,
synteny blocks represent duplicated sister regions, provided the duplication time of the genes
residing on such blocks is the same. Vertebrate WGDs are among the oldest known genome
duplications and the conservation of gene order or collinearity is limited [Putnam et al., 2008].
However, conservation of macro- or content-based synteny can be observed between genomic
regions, where there is a statistical enrichment of orthologs, even after more than 500 million
years of independent evolution since the divergence between vertebrates and invertebrates.
We used a window based approach to detect such regions between outgroup and verte-
brate genomes extending earlier similar approaches [Dehal and Boore, 2005; Makino and
McLysaght, 2010]. Any two regions between an outgroup and a vertebrate genome were consid-
ered to be candidate syntenic regions if there were at least m orthologous gene pairs between
them, within a window of size W , where 2 ≤ m ≤ W . We scanned the genomes of inverte-
brate and vertebrate organisms by placing a symmetric window around the ortholog genes in
each genome in such a way that there are W /2 genes upstream and downstream (Figure 6.3
A). Hence, the ortholog partner under consideration was at the center of the windows in each
genome. If there were at least 2 ortholog pairs in this window W , including the central pair,
it was considered to be a synteny candidate (necessary but not sufficient condition). All such
blocks were identified genome-wide and were labelled by the ortholog pair at the center of the
blocks, referred to as the anchors (O7–V7,O7–V
′
7, (Figure 6.3 A). At the chromosome bound-
aries, we kept the window size fixed by extending it in the opposite direction and making the
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window asymmetric around the anchor gene to avoid biasing the calculation of synteny P-value
as described in the next section.
The procedure was repeated between regions in the same genome to perform the self com-
parison of vertebrate genomes and to identify all vertebrate-vertebrate anchors (e.g. V7–V
′
7,
(Figure 6.3 B). While comparing two regions within the same vertebrate genome, we only
considered paralogs duplicated at the base of vertebrates for each of the vertebrate genome
according to Ensembl compara as detailed in Section 6.1.2.
Vertebrate 
Region 1
Anchor
Outgroup
Vertebrate 
Region 2
W = 8, k = 4
Anchor
V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11 V12 V13
W = 8, k = 5
O1 O2 O3 O4 O5 O6 O7 O8 O9 O10 O11 O12 O13
V1’ V2’ V3’ V4’ V5’ V6’ V7’ V8’ V9’ V10’ V11’ V12’ V13’
Vertebrate 
Region 1
W = 8, k = 5
Vertebrate 
Region 2
Anchor
V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11 V12 V13
V1’ V2’ V3’ V4’ V5’ V6’ V7’ V8’ V9’ V10’ V11’ V12’ V13’
B
A
Figure 6.3: Comparison of genomic regions to identify anchor pairs (in red) and ohnolog candidate
pairs (dashed red). Each block represents a gene labeled by Oi on the outgroup genome and Vi on
the vertebrate genome. Duplicated regions in the vertebrate genome are marked by V
′
1 −V
′
n. Other
orthologous (A) and paralogous (B) relations are depicted by green lines.
(A) Identification of anchors between an outgroup window and two windows in the vertebrate genome.
Using a window of size 8(+1) centered around O7–V7 and O7–V
′
7 orthologous pairs, we observe 4 and 3
additional genes between the outgroup and vertebrate regions 1 and 2 respectively. Hence, O7–V7 and
O7–V
′
7 are the two anchors, and since both the vertebrate genes V7 and V
′
7 share the same outgroup
ortholog O7, they are inferred as paralogs and make a candidate ohnolog pair.
(B) Identification of ohnologs between two regions in the same vertebrate genome. The anchor V7–V
′
7
having four additional paralog pairs (k = 5) in the window can directly be taken as a candidate ohnolog
pair.
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6.3 Calculation of P-value to rule out spurious synteny
(6.1C)
Since we resort to content based synteny and there is no bound on W and m, it is important to
establish that the observed synteny is not just by chance especially for larger W and small m.
Given the ortholog (or paralog) relations and location of the homologous gene on the outgroup
and vertebrate genomes, we calculate the probability of finding at least k homologous genes
by chance in a window (P≥k ≡ P − value) for all identified anchors, where k is the number of
observed outgroup genes (excluding anchor) having orthologs in the vertebrate window under
consideration.
For any gene i in a given synteny block (e.g. i = O5 : O9; Figure 6.4),we first calculate the
probability Pi of finding at least one ortholog of gene Oi by-chance in a given window of size
Wp in the vertebrate genome as follows
Pi = 1−
∑
S(ls −Wp +1)
N −Wp
Where,
S = Total segments of consecutive genes in the vertebrate genome without any ortholog of the
outgroup gene Oi (e.g. blue segments of length Wp on the vertebrate genome between ortholog of
O8 in Figure 6.4)
ls = length of a stretch of consecutive genes in the vertebrate genome without any ortholog of Oi
Wp = window size in both genomes
N = total number of genes on the vertebrate chromosome under consideration
Here
∑
S(ls−Wp+1) represents the number of windows of size Wp in the vertebrate genome
without any ortholog of an outgroup gene Oi (e.g. windows highlighted in blue in the schematic
genome in Figure 6.4. We calculate Pi for all the genes in the outgroup window having or-
thologs in the vertebrate genome (Figure 6.4). These basic probabilities are used to calculate
significance measures.
For every synteny block, we then calculate the probability of observing at least k orthologs
by-chance between two given windows (around the anchor) in the vertebrate and outgroup
genomes using combinations of Pi for all genes in the window ranging from 0 to (k−1). For
example, in Figure 6.4, there are three more ortholog pairs (green) between the two windows
(boxes) in addition to the central anchor pair (red). Therefore, the P-value for the observed
synteny is the probability that we find orthologs of any 3 or more genes in the same window
of the vertebrate genome. We can use combinatorics to calculate the probability of finding
any 3 or 4 genes in a given window by chance. For example, the probability of finding any 3
genes can be calculated using all combinations of the Pi of 3 genes. For realistic window sizes
(100 to 500), however, the combinations exponentially increase the computational time and
complexity. Therefore, we first assume that the Pi for each gene in the block is comparable,
follow a mean-field approach and average the probability for all outgroup genes with orthologs
in the vertebrate genome (PO5,PO8,PO9) excluding the anchor (PO7) which defines the window
pairs centered around O7 and V18.
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Wp = 4
Figure 6.4: The calculation of Pi for an outgroup gene O8. O8 has 5 orthologs in the vertebrate genome:
V1,V8,V19,V23 and V32. 12 windows without any of these orthologs are highlighted in blue for Wp = 4. Pi
for this anchor then becomes 1 – 12/31 = 0.6, where 31 are the total possible windows on this schematic
vertebrate genome (N −Wp).
log(P)= 1
N0
N0∑
i 6=anchor
log(Pi)
Where P is the geometric average of Pi (excluding the anchor) for the window under con-
sideration. The probability of observing ≥ k genes where k is the observed orthologs between
two windows can then be estimated using the following binomial formula.
P(≥k) =
N0∑
j=k
[(
N0
j
)
×P j × (1−P)No− j
]
= 1−
k−1∑
j=0
[(
N0
j
)
×P j × (1−P)No− j
]
Where,
P(≥k) ≡ P − value = probability of observing at least k homologs by chance between two win-
dows
No = Number of outgroup genes in the outgroup window having at least one ortholog in the
vertebrate genome (excluding the anchor pair)
k = observed number of orthologs between the two windows (excluding the anchor pair)
The same approach can be utilized while comparing two windows within the same verte-
brate genome.
This P-value defines our confidence for each anchor pair between any two regions of the
outgroup and vertebrate genomes. By definition, the P-value is affected by the number of
orthologs (or paralogs) between the genomes being compared and the genomic context, i.e., the
distribution of orthologs of anchor and other genes residing in the same window.
6.4 Identify putative ohnolog pairs (6.1D)
Due to two rounds of genome duplication in the vertebrate genome, each synteny window in the
outgroup genome should ideally correspond to up to four windows in the vertebrate genome,
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however, only a few ohnologs are retained in > 2 copies. To identify such candidate ohnolog
pairs, we identify anchors in the vertebrate genome that share the same outgroup gene (e.g.
O7 −V7 and O7 −V ′7, Figure 6.3 A). Vertebrate genes belonging to such anchors thus become
the ohnolog candidates. Yet, at this step the duplication time of ohnolog candidates can be
incorrect. In fact, due to our very relaxed synteny criteria, many of these candidate ohnologs
are not duplicated at the correct time in Ensembl. Therefore, we already exclude such putative
ohnolog pairs that are not duplicated at the base of vertebrates, or if the pair does not exist in
Ensembl. In later steps, we will further filter these ohnolog candidate pairs by combining their
P-values (see Section 6.5).
For vertebrate genome self-comparison, since we have restricted ourself to paralogs at the
base of vertebrates, anchors can be directly taken to be the candidate ohnologs if they pass our
probability filters.
6.5 Combine P-value from anchors (6.1E)
Note that the P-value is calculated for each anchor pair. Therefore, for the candidate ohnolog
pairs, we obtain two P-values corresponding to each anchor. For example, for the ohnolog
candidate pair V7−V ′7 in Figure 6.3 A, we obtain two P-values from anchors PO7−V7 and PO7−V ′7 .
Since the P-value depends on genomic context, these values can be very different. Therefore,
for each ohnolog candidate pairs we take the P-value from the least conserved block to be the
P-value of the ohnolog candidate pair. Hence,
PV7−V ′7
= Max.(P≥k(O7−V7), P≥k(O7−V ′7))
Similarly, for self comparison, because self comparison is directional (each block being al-
ternatively chosen to play the role of the outgroup region to calculate P-vlaue as described in
6.3) we also get two P-values, e.g. for V7 →V ′7 and V
′
7 →V7 comparison (Figure 6.3 B). We take
geometric mean of these as the representative P-value for the ohnolog candidate pair V7 −V ′7.
log(PV7−V ′7
)=
log(P≥k(V7→V ′7)
)+ log(P≥k(V ′7→V7))
2
6.6 Sample genomes with multiple window sizes (6.1F,G)
Typically in window based approaches for inferring synteny, only a single window is used [De-
hal and Boore, 2005; Makino and McLysaght, 2010]. However, there is no optimum size of the
window. Since we have a quantitative measure of the statistical significance of our comparison,
we repeat the steps A-E in Figure 6.1 using multiple window sizes. We start with a relatively
small window size of 100 and sample each genome with increasing window sizes of 200, 300,
400 and 500; with a minimum required number of orthologs/paralogs in each window, k = 2
(including the anchor).
If an ohnolog pairs is identified by multiple window sizes, we obtain a representative P-
value for that pair using geometric mean of P-values from all the window sizes by which the
pair is identified.
log (P(≥k)W )=
1
nW
nW∑
log(Pw)
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Here, nW is the total windows by which a pair can be identified, and P(≥k)W is the geometric
average probability from all these windows. A pair can only be identified by larger windows
or smaller windows (for pairs on the same chromosome). We compute the average P-value and
store all the ohnolog pairs for a particular outgroup.
For self comparison, these pairs can now be filtered based on desired criteria.
6.7 Combine P-value from all outgroups (6.1H)
We perform comparison of each vertebrate genome with six different outgroups to overcome lin-
eage specific rearrangements. If an ohnolog pair is identified by multiple outgroups, it strongly
suggests that the pair is a ‘true’ ohnolog. Therefore, we combine ohnolog pairs from multiple
outgroups using ‘AND’ rule by multiplying the P-values from all the outgroups. This amounts
to assume that the synteny conservation is independent for different outgroups due to lineage
specific rearrangements.
P-value =
all outgroups∏
P(≥k)W o
This value hence, is the final P-value for a particular ohnolog candidate pair from all win-
dows and outgroups. Using multiple outgroups thereby improves the statistical significance of
the inferred ohnolog pairs.
6.8 Filter ohnolog pairs to remove false positives (6.1I)
For each pair that is identified by both the outgroup (at least one) and self comparison, we
obtain two P-values. There are many pairs identified only by self or outgroup comparison. Any
custom criteria can now be used to filter high confidence ohnologs. We filter ohnolog pair can-
didates (1) having duplication timing at the base of vertebrates, and (2) with three different
synteny criteria combining P-values from both outgroup and self-comparison, as follows.
• Strict criteria: Poutgroup < 0.01 AND Psel f < 0.01
• Intermediate criteria: Poutgroup < 0.05 AND Psel f < 0.3
• Relaxed criteria: (Poutgroup < 0.05) OR (Poutgroup < 0.5 AND Psel f < 0.01)
These three sets represent decreasing confidence in the ohnolog status of the identified
ohnolog pairs. In principle, the relaxed criteria may also include a number of paralogs from
large scale segmental duplicates from the origin of vertebrates.
6.9 Construction of ohnolog families (6.1J)
Using the filtered ohnolog pairs from strict, intermediate and relaxed P-value criteria, we then
built ohnolog families i.e. paralogous families of genes retained from vertebrate WGDs. Due to
the two rounds of WGDs, we expect that most of these ohnolog families should consist in size 2,
3 and 4. However, SSDs and large scale segmental duplicates may lead to family sizes larger
than four.
34 CHAPTER 6. IDENTIFICATION OF OHNOLOGS
To construct ohnolog families, we start with an ohnolog pair and use depth first search
[Tarjan, 1972] to traverse ohnolog pair space using both the genes as start nodes until no new
ohnolog partner can be found for start nodes or for any of the branches1. Ohnolog families
constructed using this exhaustive approach may contain genes which are SSD with respect to
each other but are ohnolog partner for a third gene in the family.
We identify and merge such SSDs together. If any two genes within the same family reside
on the same chromosome inside the smallest window in our comparison (i.e. within 100 genes)
it is assumed to be an SSD. For all the genes within an ohnolog family, we also check if any of
the possible pairs have duplicated earlier or later than the time of vertebrate WGD. We also
merge such SSDs together.
We observed instances where two or more genes (or regions) are ohnologs with respect to
the same third region, and yet duplicated later than the time of 2R-WGD. For example, in the
human genome TLX2 (on chromosome 2) and TLX3 (on chromosome 5) are both ohnologs with
TLX1 (on chromosome 10). In such instances, we count the number of unique pairs within the
largest window between the two regions duplicated later and their ohnolog partner (e.g. TLX1
- TLX2 and TLX1 - TLX3). We consider the window having more genes to be the original region
that duplicated by WGD.
Therefore, the final duplication aware families consist of ohnolog partners along with the
information on recent and/or old SSD if the ohnolog has undergone additional duplication
episodes according to Ensembl family trees.
6.10 Randomization of the human genome
To verify that our algorithm to combine ohnolog information based on P-value incorporates a
limited number of false positive ohnolog pairs, we perform the same comparison to identify
ohnologs in randomized human genome. We shuffle the human genome to place each gene on
a random chromosome at a random position. Keeping chromosome size, ortholog and paralog
relations fixed, we repeat our approach to identify ohnologs and calculate combined P-value
using randomized human and the original outgroup genomes for a moderate window size of
300. We then combine the P-values for both the cases by multiplication and compare the results
of the randomized and original comparison (Results, section 9.1.1).
6.11 Small Scale Duplicates (SSD)
All the paralogs from Ensembl compara which we could not identify as ohnologs can be taken
to be SSD duplicates. These SSD duplicates correspond to duplicates from all ages, before and
after the 2R-WGD.
We also generated another dataset of SSDs based on sequence comparison. We ran an all-
against-all BLASTp using entire human proteome, and selected the best non-self hit for each
gene. If the best non-self hit does not correspond to one of the ohnolog partners of the gene, the
pair can be taken to be an SSD pair.
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Figure 6.5: Schematic species tree of the sequenced fish genomes and the duplication nodes from
Ensembl. Species marked by red boxes have assembled chromosomes and were analysed in this study.
Paralogs from the three nodes marked in red were taken to be the candidates with correct duplication
time.
6.12 Ohnologs in the teleost fish genomes: the 3R-WGD
Teleost fishes have experienced an additional whole genome duplication (3R-WGD) after di-
vergence from tetrapods [Amores et al., 1998; Jaillon et al., 2004]. We also identified ohnologs
from both the 2R and 3R-WGD in four sequenced teleost fish genomes where the genomes have
been assembled into chromosomes: Zebrafish (Danio rerio), Tetraodon (Tetraodon nigroviridis),
Stickleback (Gasterosteus aculeatus) and Medaka (Oryzias latipes).
6.12.1 The 2R-WGD
We used the same approach, as described for tetrapods in the previous sections to identify
ohnologs from 2R-WGD in the four fish genomes. All the protein coding genes and their ge-
nomic coordinates for these four fish genomes were downloaded from Ensembl v70. The same
six invertebrate outgroups were used and the fish orthologs sharing outgroup genes were also
identified by running BLASTp. Paralogs for all the fishes were also obtained from Ensembl.
However, paralogs from only three nodes: Chordata, Euteleostomi and Vertebrata were con-
sidered to have correct duplication timing for fish 2R-WGD.
1http://en.wikipedia.org/wiki/Depth-first_search
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Synteny comparison between all outgroups and fish genomes and within the same fish
genomes were performed using exactly the same approach. The three set of ohnologs and
families were also constructed for all of the four fish genomes.
6.12.2 The 3R-WGD
Since the third WGD occurred around 350 MY ago, i.e. after the divergence of the tetrapods,
the tetrapod genomes can be used as the outgroups to identify ohnologs retained from the
third round of WGD. Recently, the genome of Coelacanth (Latimeria chalumnae) have been
sequenced and added to Ensembl [Amemiya et al., 2013]. The Coelocanth genome is the only
available fish genome in Ensembl that has diverged from the teleost fishes before the third
round of WGD [Noonan et al., 2004; Amemiya et al., 2010]. Therefore, to identify ohnologs from
3R-WGD, we used human, chicken, dog, mouse, rat and coelacanth genomes as outgroups.
Teleost fish orthologs sharing the same tetrapod/coelacanth sequence were identified us-
ing BLASTp, and paralogs were downloaded from Ensembl. We used three Ensembl compara
nodes near the base of the origin of teleost fishes: clupeoceptala, holocanthopterygii and perco-
morpha as the candidate 3R-WGD nodes Figure 6.5.
Self synteny comparison using paralogs belonging to these three nodes, and synteny com-
parison with the five tetrapods and coelacanth genomes were performed. Ohnologs from all the
comparisons were filtered using the same three P-value criteria. Finally, we also constructed
the ohnolog families from the genes retained from the 3R-WGD in all the four fish genomes.
6.13 Development of the OHNOLOGS server
To give easy access to these ohnolog pairs to the biologist community, we also developed a
server named OHNOLOGS from where, as of now, all the ohnolog pairs and families from the
2R-WGD in the six tetrapod genomes can be retrieved.
The server was implemented in Perl-CGI and has been hosted on one of the virtual ma-
chines at Institut Curie. The server can be accessed at: http://Ohnologs.Curie.fr.
7
Collection of Cancer/Disease Genes &
Functional Genomic Data
TO assess the evolution of “dangerous” genes, we first collected a comprehensive set of hu-man genes either known to be mutated in different diseases, or having certain functional
properties, making them highly susceptible to deleterious mutations. This includes genes
known to be mutated in different human cancers, genes implicated in genetic diseases other
than cancer, genes having dominant negative or haplo-insufficient mutations in human dis-
eases and genes with autoinhibitory folds. We also obtained information of other functional
genomic properties known to affect the retention of genes after duplication e.g. essentiality,
genes involved in formation of protein complexes, genes having variable copy numbers (CNV)
in the human genome and expression level of genes in healthy human tissues. For the en-
tire analysis Ensembl database (release-70) was used as a reference, and genes from all other
databases were mapped to Ensembl.
7.1 Cancer genes
Candidate cancer genes were obtained from multiple databases. Table 7.1 lists details of
these databases along with the methodology of obtaining the gene lists. Out of these 14
databases, Cancer Gene Census (CGC), Atlas of Over-expressed Genes In Cancer (AOGIC),
UniProt Knowledge Base (UniProtKB: SwissProt) and Tumor Suppressor Gene database (TS-
Gene) contain experimentally verified or manually curated cancer genes. These databases are
also regularly updated. Other databases however, may include some false positives as the
gene lists are either old, not regularly updated or parsed using text searches. Gene lists for
AGCOH, TGFDB and TSGDB were downloaded from F-census [Gong et al., 2010] using their
export facility, as they could not directly be downloaded from their respective websites.
Majority of cancer genes were obtained from the Catalogue Of Somatic Mutation In Cell
(COSMIC) that contains genes found to be mutated in high-throughput cancer genome se-
quencing projects, along with the information on mutation type in different human primary
tumor tissues.
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Table 7.1: Cancer Databases & the Details of Obtaining Cancer Genes
Database
Name
Priority Methods Total
genes
Onc/TS
Status
Reference
CGC 1 Downloaded and processed gene
list from CGC homepage.
420 Yes [Futreal et al.,
2004]
AOGIC v-1 2 Downloaded and processed gene
list from Supplementary infor-
mation S2.
79 Yes [Santarius et al.,
2010]
UniProtKB:
Swiss-Prot
3 Searched using: (key-
word:"Oncogene [KW-0553]" OR
keyword:"Proto-oncogene [KW-
0656]") AND organism:"Human
[9606]" and keyword:"Tumor
suppressor [KW-0043]" AND
organism:"Human [9606]"
360 Yes [Magrane and Con-
sortium, 2011]
TSGene 4 Downloaded gene list using
download facility
637 Yes [Zhao et al., 2013]
OMIM 5 Searched using keywords:
"oncogene"[Title] OR "pro-
tooncogene"[Title] AND "has
locus"[Properties] and "tumor
suppressor"[Title] AND "has
locus"[Properties]
1023 Yes [Hamosh et al.,
2005]
Ensembl (re-
lease 70)
6 Searched gene names using:
tumor, cancer, oncogene/”proto
oncogene” and “tumor suppres-
sor” as keywords
332 Yes [Flicek et al., 2013]
NCBI Gene 7 Searched using: "oncogene"[All
Fields] OR "protooncogene"[All
Fields] AND "homo sapi-
ens"[ORGN] AND "current
only"[Filter] AND "genetype pro-
tein coding"[Properties] and "tu-
mor suppressor"[All Fields] AND
"homo sapiens"[ORGN] AND
"current only"[Filter]AND "gene-
type protein coding"[Properties]
1,236 Yes [Maglott et al.,
2011]
GeneCards
v-3
8 Using advanced search: Aliases
& Descriptions or Disorders or
Gene Function or Summaries has
“oncogene” or “tumor suppressor”
AND Category: Protein Coding
775 Yes [Safran et al., 2010]
TAG 9 All genes were downloaded and
processed from website.
501 Yes [Chen et al., 2013a]
TSGDB 10 Gene list was downloaded via F-
census.
141 Yes [Yang and Fu, 2003]
Candidate
TS Genes
11 Candidate tumor suppressor
genes were downloaded and
processed from Table 1 in article.
154 Yes [Volinia et al., 2008]
COSMIC
v-64
12 Entire database was downloaded
from COSMIC FTP and pro-
cessed using custom perl scripts.
4,237 No [Forbes et al., 2008]
TGFDB 13 Gene list was downloaded via F-
census.
302 No [Baxevanis, 2001]
Continued on next page...
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Database
Name
Priority Methods Total
genes
Onc/TS
Status
Reference
CancerGenes
database
14 All genes were downloaded using
export facility and processed us-
ing custom scripts.
3,058 No [Higgins et al.,
2006]
* Further information on these dataset can be found at http://www.oxfordjournals.org/nar/
database/subcat/8/33. CGC: Cancer Gene Census, AOGIC: Amplified and Overexpressed Genes In
Cancer, TSGene: Tumor Suppressor Gene Database, OMIM: Online Mendelian Inheritance in Man,
TAG: Tumor Associated Gene Database, TSGDB: Tumor Suppressor Gene Database, COSMIC: Cata-
logue Of Somatic Mutations In Cancer, F-Census: A Database of Functional Census of Human Cancer
Genes, AGCOH: Atlas of Genetics and Cytogenetics in Oncology and Haematology, TGFDB: The Tu-
mor Gene Family of Databases
Many of these may simply be passenger mutations not affecting tumor progression signif-
icantly. Therefore, we downloaded entire COSMIC database and counted mutations in each
gene across all mutated samples. Only genes having at least 15 non-synonymous mutations
including at least one recurrent mutation were taken as candidate cancer genes from COSMIC.
Genes from all these databases were mapped to Ensembl release-70 if the Ensembl id was
not provided, using either Entrez gene id, gene name or symbol, or SwissProt id. The non-
protein coding genes or genes that could not be matched to Ensembl were discarded. The
number of genes from each database is listed in Table 7.1.
7.1.1 Oncogenes and tumor suppressors
We classified candidate cancer genes into oncogenes or tumor suppressors depending on mode
of inheritance of mutations (dominant/recessive). Databases such as CGC, TSGene, AOGIC,
TAG, TSGDB and SwissProt readily provide information on oncogenes and tumor-suppressor
status of cancer genes. The same information could also be obtained from text searches and
manual curation of related keywords in OMIM, NCBI gene and GeneCards databases. COS-
MIC database does not contain information about dominant or recessive nature of mutations.
Therefore, we predicted this using a procedure adopted by [Bozic et al., 2010].
Oncogenes typically are activated in tumors by point mutations. Expression of tumor sup-
pressor genes on the other hand, are silenced by degenerating mutations. Identification of
activating point mutations is difficult, yet silencing mutations can be easily identified. Follow-
ing Bozic et al., we counted type of mutations in all samples in COSMIC- v64 using custom
Perl scripts, and calculated ratio of inactivating mutations to other mutations. Inactivating
mutations included whole gene deletion, frame-shift insertion/deletion , nonsense substitution
and complex frame-shift mutations. If the ratio was greater than 0.2, the gene was considered
to be a tumor suppressor, and oncogene otherwise. Using this approach most of the tumor
suppressors from curated databases can correctly be classified [Bozic et al., 2010].
Different databases may disagree on oncogene/tumor-suppressor status of the same gene in
many instances. Therefore to uniquely identify a gene as oncogene or tumor suppressor, each
database was assigned a priority (Table 7.1) depending on level of manual and experimental
curation or prediction from text searches and COSMIC. For each gene, the status was taken
from the database with highest priority. We could finally classify 5,996 genes as oncogenes
and 1,829 genes as tumor suppressors. If a gene was identified as both oncogene and tumor
suppressor, we considered it as oncogene.
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7.1.2 “Core” cancer genes
A high quality subset of all cancer genes containing genes which are either experimentally
known to be implicated in cancer, or are highly mutated from tumor sequencing projects was
then computed, called as “core” cancer genes. Core cancer genes consist of genes from CGC,
SwissProt, TSGene and AOGIC, including COSMIC genes with at least 50 non-synonymous
and one recurrent mutation. The purpose of this classification was to obtain a high confidence
subset of cancer genes without any likely false positive candidates. A total of 2,743 genes were
classified as core cancer genes with 1,932 oncogenes and 811 tumor suppressors.
7.2 Dominant & recessive disease genes
Genes implicated in Mendelian diseases and their inheritance patterns were also obtained
from multiple resources. These genes primarily consist of genes mutated in genetic diseases,
however, it may include some cancer genes having only somatic mutation. OMIM is the most
comprehensive resource of human Mendelian disease genes. OMIM text file was downloaded
on 27-June-2013 and processed using custom Perl scripts. Another set of human disease genes
was obtained from GeneCards database 1. For both OMIM and GeneCard genes, Ensembl
ids were matched using MIM Ids and gene symbols respectively in Ensembl BioMart 2. Dis-
ease genes were also obtained from two published reports: [Blekhman et al., 2008] & [Chen
et al., 2013b]. Blekhman et al.’s study was based on a hand curated list of genes from OMIM
(hOMIM). Chen et al.’s data includes hOMIM, other OMIM genes and genes from [Podder and
Ghosh, 2011], and directly provided the Ensembl Ids. Ensembl Ids from Blekhman et al. were
also obtained from BioMart using gene symbols. Reconciliation of all these datasets led to a
total of 5,172 disease genes.
Inheritance pattern of these genes were obtained from OMIM and hOMIM. Perl regular ex-
pressions were used to parse Inheritance section from each OMIM entry. This section describes
the inheritance pattern of diseases, which includes: dominant, recessive, multifactorial, poly-
genic, X/Y-linked, heterogeneous or unknown. The same gene can also be classified to be both
dominant or recessive under different diseases or from different studies. We carefully curated
all the inheritance patterns and obtained 679 and 888 genes unambiguously classified to be
dominant and recessive disease genes respectively. Out of all genes, 446 genes had ambiguous
inheritance patterns and 3,159 genes without the inheritance information.
7.3 Haploinsufficient and dominant negative genes
Haploinsufficient genes are the genes for which a single functional copy does not produce suf-
ficient gene product, leading to a disorder. These genes are dosage sensitive. However, inac-
tivating mutations have a dominant effect in these genes. Haploinsufficiency underlies many
dominant diseases in humans including many cancers.
Dominant negative phenomena occurs when a mutated allele adversely interferes with the
functional allele. The effect primarily occurs by dimerization between mutated and functional
allele.
We obtained experimentally verified genes having dominant negative and haploinsufficient
mutations from OMIM. Candidate genes were obtained from parsing OMIM text files with Perl
1http://www.genecards.org/cgi-bin/listdiseasecards.pl?type=full
2http://www.ensembl.org/biomart/martview/a16f093905d2e2f78a33931b6766eca0
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regular expressions by searching for keywords mentioning these properties. Entire paragraphs
having these keywords were put in a text file and then carefully reviewed to exclude any false
positives or negative mentions. We could obtain 618 OMIM entries having mentions of haplo-
insufficiency and 901 entries including a reference to dominant negative mutations. Out of
these, 525 and 670 OMIM entries were identified to be true positives.
BioMart was used to map the MIM accessions on Ensembl, yielding a total of 382 haploin-
sufficient and 566 dominant negative genes.
7.4 Genes with autoinhibitory protein folds
Most genes in the human genome code for proteins having multiple domains. In the encoded
protein, domain-domian interactions are crucial for proper functions. Autoinhibitory proteins
are also multidomain proteins where a part of protein interacts with the domain having the
functional property. Such interaction keeps a protein in inactive form, unless this autoinhibi-
tion is counteracted by conformational changes triggered by events such as interactions with
other partners, proteolysis or phosphorylation (Figure 7.1) [Pufall and Graves, 2002] . Inside
cells, autoinhibited proteins are tightly regulated in signalling cascades, however, mutations
may disrupt this inhibition leading to permanent activation of these proteins and diseases.
Autoinhibition therefore, is a very important and widespread regulatory mechanism in cells.
A few examples of autoinhibitory proteins include most tyrosine kinases [Hubbard et al., 1998;
Hubbard, 2002, 2004], phosphatases [Denu and Dixon, 1998], Guanine Exchange factor (GEF)
and GTPase Activating Proteins (GAP) from many growth hormone signalling pathways in-
cluding RAS-RAL signalling pathway [Bodemann and White, 2008].
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Figure 1 Autoinhibition is a regulatory mechanism. (A) An autoinhibitory domain
modulates the activity of a second, separable domain (ce ter). Autoinhibition can be
counteracted and reinforced by modification (left) or by association with a second
molecule, partner protein (right). Autoinhibition is often identified experimentally by
deletion of the autoinhibitory domain. Proteolysis is also a regulatory strategy in vivo
(lower). (B) Modularity of proteins facilitates autoinhibition. A transcription factor with
two functional domains (one for DNA binding and one for transactivation) illustrates
the specificity of an autoinhibitory domain for a second, separable target domain.
Alternatively, a specialized autoinhibitory domain mediates inhibition (t p); a dual
function domain mediates both inhibition and transactivation (center); or two domains
are mutually inhibitory and carry out other functions (lower).
Figure 7.1: Mechanism of Autoinhibition. An autoinhibitory protein in its inhibited confirma-
tion (centre). The autoinhibition can be activated and reinforced by mechanisms such as phosphoryla-
tion (left), interacting with a partner protein (right) or proteolysis (bottom). Adapted from [Pufall and
Graves, 2002]
.
Although there has been hundreds of experimental studies identifying autoinhibitory do-
mains in many human proteins, there is no systematic resource to obtain this information.
Therefore, to obtain genes coding for proteins with autoinhibitory folds, PubMed was searched
with keyword “autoinhibitory domain” on 19-November-2010 producing a total of 502 refer-
ences having this keyword. Abstracts of these results were then carefully reviewed to identify
“true” autoinhibitory genes. In cases where the information was not clear in the abstract, en-
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tire paper was read to identify any verified autoinhibitory proteins or domains. Using protein
or gene names mentioned in the text, we obtained Ensembl Ids manually. A total of 373 genes
could be identified to be autoinhibitory using this approach.
Further gene candidates with autoinhibitory folds were obtained from databases, NCBI
Gene, OMIM, SwissProt and GeneCards. Search terms: ‘auto/self-inhibit*’ was used on their
respective homepage to identify candidate genes. Careful manual curation of these lists yielded
81/106, 50/60, 90/109, 167/273 true positives from NCBI Gene, OMIM, SwissProt and GeneCards
respectively. Reconciling data from all these sources led to a total of 461 genes with autoin-
hibitory folds.
7.5 Genes coding for protein complexes
To test the impact of dosage balance on ohnolog retention we also collected genes involved in
formation of verified protein complexes in the human genome. Relative expression of genes
or dosage of interacting proteins is considered to be important for proper functioning [Liang
and Fernandez, 2008]. Subunits of protein complexes in particular, are argued to be under
strong dosage constraints as relative imbalance of the level of proteins may lead to malformed
complexes detrimental to fitness [Birchler and Veitia, 2010; Veitia, 2009].
We obtained experimentally verified and manually curated protein complexes from Human
Protein Reference Database (HPRD) [Keshava Prasad et al., 2009], COmprehensive ResoUrce
of Mammalian protein complexes (CORUM) [Ruepp et al., 2010], Census of Soluble Human
Protein Complexes [Havugimana et al., 2012] and Gene Ontology [Ashburner et al., 2000].
For all these databases, Ensembl Ids were matched after careful manual curation as described
in sections below. Complex partners without Ensembl mapping were discarded. Our objective
was to obtain a high confidence set of genes involved in formation of protein complexes, and
therefore we did not include high throughput studies on protein-interactions in our analysis.
Dosage balanced genes were defined as the genome coding for protein complexes or haploinsuf-
ficient genes Section 7.3.
7.5.1 Human protein reference database
HPRD 3 is a resource of manually curated information on human protein complexes from pub-
lished literature. Total 1,521 protein complexes were downloaded from HPRD Release-9, which
is based on RefSeq Id from NCBI. BioMart was used to obtain Ensembl-to-RefSeq mapping for
their constituent genes (2,727 genes).
7.5.2 COmprehensive ResoUrce of Mammalian protein complexes
CORUM 4 is another manually curated repository of experimentally characterized protein com-
plexes for mammals. Ensembl Ids for 5,947 CORUM complexes were obtained using NCBI
Gene Ids provided in the downloaded file using custom Perl scripts (2,500 genes).
3http://www.hprd.org/index_html
4http://mips.helmholtz-muenchen.de/genre/proj/corum
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7.5.3 Gene ontology
Gene Ontology 5 also contains expert curated biomedical ontologies. Term GO:0043234 for
protein complex ontology was searched in AmiGo browser [Carbon et al., 2009], to obtain all
gene products associated to protein complexes according to Gene Ontology (total of 4,198 GO
terms). BioMart was used to associate Ensembl gene ids to these gene ontology ids leading to
2,432 protein complex genes.
7.5.4 Census of soluble human protein complexes
Finally, we downloaded 6 602 soluble protein complexes having 3,006 soluble proteins from
[Havugimana et al., 2012]. Ensembl Ids for these complexes were obtained from SwissProt Ids
provided in the downloaded file using BioMart yielding 2,996 genes.
7.5.5 Permanent complexes
As no distinction between transient and permanent complexes is made in all the above databases,
we obtained a manually curated data set of permanent complexes from [Zanivan et al., 2007].
11 permanent and 21 transient complexes were obtained from Additional data file 10 and En-
sembl Ids for 239 permanent and 308 transient complex genes were obtained from NCBI Gene
Ids. A detail of these complexes is listed in Table 7.2.
Gene products participating in permanent complexes are only functional within their com-
plexes, associated with obligatory complexes e.g. ATP_F0 and ribosomal subunits. However
many cellular assemblies such as centrosome and replication complexes are transient and are
easy to be disassociated. Our hypothesis was that genes in permanent complexes must show
even higher susceptibility to relative dosage as compared to transient complexes.
Genes were considered to be a “complex” genes if they were included in any one of the five
datasets (total 6,119 complex genes).
7.6 Essential genes
Essential genes are the genes which are critical for organismal/cellular health and on silencing
mutations, lead to lethality or sterility. Essentiality has also been known to affect ohnolog re-
tention [Makino et al., 2009]. Since no direct information of human essential genes is available,
two different approaches were used to collect genes associated with essentiality in the human
genome.
7.6.1 Human orthologs of Mouse essential genes
We used phenotype section of Mouse Genome Informatics7 (MGI) database version MGI_4.42
[Eppig et al., 2012]. MGI is a comprehensive resource of mouse functional genomics and gath-
ers data from published literature and screens on phenotypic effect of different mutations.
We searched mouse mutant alleles matching mammalian phenotype ontology terms: prenatal
lethality (MP:0002080), perinatal lethality (MP:0002081), post natal lethality (MP:0002082),
5http://www.geneontology.org/GO.doc.cc-prot-complex.shtml
6http://human.med.utoronto.ca
7http://www.informatics.jax.org/phenotypes.shtml
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Table 7.2: Details of 32 permanent & Transient Complexes from [Zanivan et al., 2007]
Symbol Complex Type Full Name Total Subunits
ATP_F0 Permanent ATP synthase, H+ transporting, mitochondrial F0 complex 11
ATP_F1 Permanent ATP synthase, H+ transporting, mitochondrial F1 complex 5
COX Permanent Cytochrome c oxidase 11
SRS Permanent Small ribosomal subunit 32
LRS Permanent Large ribosomal subunit 43
MLRS Permanent Mitochondrial large ribosomal subunit 48
MSRS Permanent Mitochondrial small ribosomal subunit 30
Proteasome Permanent Proteasome Complex 31
PD Permanent Pyruvate dehydrogenase 8
RNA Pol II Permanent RNA polymerase II 12
RNA Pol III Permanent RNA polymerase III 9
AP2 Transient Adaptor-related protein complex 2 5
APC Transient Anaphase promoting complex 9
Arp2-3 Transient Arp2-3 Complex 7
ARC Transient Axin related complex 5
Centrosome Transient Centrosome Complex 64
Dynactin Transient Dynactin Complex 11
Exocyst Transient Exocyst Complex 9
Exosome Transient Exosome Complex 8
FA Transient Focal adhesion 54
GTC Transient Golgi transport complex 8
Nucleopore Transient Nucleopore complex 33
Nucleosome Transient Nucleosome Complex 32
ORC Transient Origin recognition complex 6
RFC Transient Replication complex 5
SRP Transient Signal recognition particle 6
SCF Transient Skp1-cull-F-box complex 3
SNARE Transient SNARE Complex 7
SWI/SNF Transient SWItch/Sucrose Non Fermentable (Nucleosome Remodeling) 13
TAFIID Transient Transcription Factor IID Complex 17
TRAPP Transient Trafficking protein particle complex 7
VHL Transient Von Hippel-Lindau complex 5
premature death (MP:0002083) and infertility (MP:0001924), generated by either knock-out,
random gene disruption or gene trap mutagenesis [Liao and Zhang, 2008]. These genes rep-
resent a set of mouse essential genes. Alleles in which the above loss-of-function mutations
resulted in other phenotypes (neither lethal nor infertile) were considered to be non-essential
genes. Ensembl Ids for these essential and non-essential mouse genes were obtained using
report file provided by MGI.
Human 1-to-1 orthologs (to remove effects of gene duplication in one of the lineages) of these
mouse genes were obtained using BioMart. Discarding genes without a clear 1-to-1 mouse
orthologs we obtained 2,938 human genes having an essential mouse ortholog and 3,498 genes
having non-essential mouse orthologs (6,436 genes tested for essentiality in mouse).
7.6.2 Human essential genes from In-vitro knock-out experiments
Another set of human essential genes were obtained from Online Gene Essentiality Database
(OGEE) 8 [Chen et al., 2012]. OGEE collected human essential genes from [Silva et al., 2008],
who performed knock-out experiments using RNAi screening in five human mammary cell
lines. Ensembl Ids obtained from OGEE were mapped to version-70 using BioMart, leading to
8http://ogeedb.embl.de/
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a total of 18,938 protein coding genes tested for essentiality, with 2,701 essential and 16,237
non-essential human genes.
7.7 Genes with copy number variations
Copy number variations (CNV) are structural variants in the individual human genomes hav-
ing different copies of a part of DNA. They represent a form of small scale duplications not yet
fixed in the population. To study the effect of CNV genes on ohnolog retention [Makino and
McLysaght, 2010], genes having CNV regions were obtained from Database of Genomic Vari-
ants (DGV) [Zhang et al., 2006] 9. DGV collects copy number gains (CGV) or losses (CLV) data
from published studies and reports the genomic coordinates of the variants. The variant file
was downloaded from DGV, and using genome start-end coordinates of genes from Ensembl v-
70, we identified human genes whose entire coding sequence fell within one of the CNV regions
(either CLV or CGV). A total of 5,185 CNV genes were identified using this approach.
7.8 Expression Level
Absolute expression level of a gene has also been reported to be a determinant of gene reten-
tion after WGD [Seoighe and Wolfe, 1999; Gout et al., 2009, 2010]. Therefore, expression level
of human genes in 78 healthy tissues and cell types were obtained from BioGPS10 [Wu et al.,
2009], which provides GC content adjusted-robust multi-array (GC-RMA) normalized expres-
sion levels (Average Difference or AD values) from microarray experiments [Su et al., 2004].
The expression data was based on Affi-U133-Plus2 microarray from Affimetrix.
Affymatrix tags and the expression values for all tissues were downloaded in form of a CSV
file from BioGPS. These tags are small stretches of gene sequence used as reporters of expres-
sion levels for the corresponding gene. Mapping from these tags to NCBI Gene Id, UniGene
Id or gene symbol were obtained by annotation file provided by BioGPS. Another set of direct
mapping between Ensembl and Affi-U133-Plus2 tags was obtained using BioMart. Annotation
file from Gene Expression Omnibus (GEO) was also referred to map tags to NCBI Gene Id.
Using the three resources, a total of 31,154 out of 44,775 tags could be mapped to at least one
of the gene Id/symbol. For tags mapping to other datbase Ids, corresponding Ensembl Ids were
then obtained using BioMart resulting in 28,2237 tags matching an Ensembl gene.
These tags are regularly updated and to remove tags which could map to multiple genes
or had become obsolete, we only kept tags having “..._at” suffix, which is used to characterize
best quality tags. For each gene having multiple associated tags, the expression value from all
mapping tags was averaged for each tissue. Finally, we used the median value of expression
for all of the 78 healthy tissues as the representative expression level for each gene. We could
obtain expression levels for 13,425 of a total 20,415 protein coding genes using this approach.
7.9 Disease genes in other vertebrates
We also obtain the genes implicated in cancer and diseases for the two mammalian model
organisms as follows.
9http://dgv.tcag.ca/dgv/app/faq?ref=NCBI36/hg18
10http://biogps.org/#goto=welcome
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7.9.1 Mouse
Mouse genes associated with OMIM diseases were downloaded from Mouse Genome Informat-
ics (Report: MGI_OMIM.rpt)11. Mouse Ensembl ids were obtained using MGI Id to Ensembl
id mapping from BioMart leading to a total of 1,242 mouse disease genes.
7.9.2 Rat
Genes implicated in cancer and other genetic diseases in the Rat genome were obtained from
Rat Genome database (RGD) using RatMine [Laulederkind et al., 2013] 12. A total of 1,921
genes implicated in diseases such as respiratory, neurological and cardiovascular disorders and
cancer could be mapped to Ensembl ids for the rate genome using gene symbols from BioMart.
Table 7.3: Summary of gene counts in different categories
CAREGORY TOTAL GENES
All protein coding 20415
All cancer 8899
Oncogene 5996
Tumor-Suppressor 1829
Core cancer 2743
Oncogene 1932
Tumor-Suppressor 811
All disease 5172
Dominant 679
Recessive 888
Haploinsufficient 382
Dominant negative 566
Autoinhibitory 461
Protein complexes 6119
Permanent complexes 239
Expression level 13425
Essential genes (mouse orthologs) 6436
Essential 2938
Non-essential 3498
Essentiality genes (in-vitro experiments) 18938
Essential 2701
Non-essential 16237
Mouse disease genes 1242
Rat disease genes 1921
7.10 Analysis of ohnologs conservation using Ka/Ks ratios
To quantify the susceptibility of ohnologs versus nonohnologs to deleterious mutations through
comparative sequence analysis, we used Ka/Ks ratio estimates (also called DN /DS) [Yang
and Nielsen, 2000], which measure the proportion of nonsynonymous substitutions (Ka) to
the proportion of synonymous substitutions (Ks). Ka/Ks ratios were calculated to evaluate
the selection pressure on human ohnolog and nonohnolog genes and their respective inverte-
brate orthologs as follows. Protein sequences for B. floridae, C. intestinalis, C. savignyi, D.
11ftp://ftp.informatics.jax.org/pub/reports/index.html
12http://ratmine.mcw.edu/ratmine/bag.do
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melanogaster, C. elegans, S. purpuratus and H. sapiens were obtained as described in Section
6.1.1 and [Singh et al., 2012]. These genes were based on Ensembl release 61 [Singh et al.,
2012]. Human-invertebrate orthologs were identified using BLASTp (E− value :< 10−7). The
best human-to-invertebrate hits were identified and used for Ka/Ks ratio calculations [Yang
and Nielsen, 2000]. Each human ohnolog pair and human-invertebrate ortholog pair was
aligned using clustalW [Larkin et al., 2007]. Ka and Ks values (Yang and Nielsen, 2000) have
been calculated using the KaKs_Calculator 2.0 [Wang et al., 2010a]. Ohnolog or ortholog pairs
for which Ka/Ks ratio could not be calculated (0.1%–0.7% of pairs) or having saturated Ks val-
ues (2%–7% of pairs) were discarded from the analysis. As these calculations were performed
on the older release of Ensembl, these ratios were mapped to release 70.

8
Causal Inference Analysis
MULTIPLE genomic and functional properties are known to affect the retention of genesafter duplication. In particular, dosage balance constraints have been argued to under-
lie the observed antagonistic retention pattern of genes in different functional categories after
WGD and SSD. In this work, we provide evidence (in Chapter 10) that the human disease-
related genes have also retained most of their duplicates from WGD but not from SSD. There-
fore, susceptibility to dominant deleterious mutations also influences retention of ohnologs. To
assess the relative contribution of each of these properties in the context of the retention of
ohnologs, we needed a framework where the relative importance of each of these properties
could be evaluated quantitatively. Rather than study two property correlation, we made the
effort to disentangle the indirect effects from the direct effects of these functional constraints
on the resulting biases in ohnolog retention.
8.1 Mediation Analysis
To this end, we have performed a Mediation analysis following the approach of Judea Pearl
[Pearl, 2001, 2009, 2012a,b]. The Mediation framework, developed in the context of causal
inference analysis [Pearl, 2009], aims at uncovering, beyond statistical correlations, causal
pathways along which changes in multivariate properties are transmitted from a cause, X , to
an effect, Y . More specifically, a Mediation analysis assesses the importance of a mediator,
M, in transmitting the indirect effect of X on the response Y ≡ Y (x,m(x)), as shown in the
Mediation diagram (Figure 8.1).
8.1.1 Total, direct & indirect effects
In mediation the framework, the total effect denotes the strength of the effect a causal variable
X has on an outcome Y . However, a significant fraction of the total effect (TE) may not be
direct, instead can be indirectly mediated by a third variable called a Mediator (M). Therefore,
the term “direct effect” (DE) in a Mediation model quantifies the effect that is not affected by
any other variable (mediators) in the model [Pearl, 2001].
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Supplementary Note 1 Quantitative Mediation Analysis
We analyze in this supplementary note the retention statistics of ohnolog genes with respect to their susceptibility todeleterious
mutations (‘delet.mut.’) and dosage balance (‘dosage.bal.’) constraints. We aim at discriminating theindirect effects from the
direct effects of these functional constraints on the resulting biases in ohnolog retention.
To this end, we have performed a Mediation analysisfollowing the approach of Pearl.176,177 The Mediation framework,
developed in the context of causal inference analysis,178 aims at uncovering, beyond statistical correlations,causalpathways
along whichchangesin multivariate properties are transmitted from a cause,X, to an effect,Y . More specifically, a Mediation
analysis assesses the importance of a mediator,M , in transmitting the indirect effect ofX on the responseY ≡ Y
(
x,m(x)
)
, see
Mediation diagram, below.
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Y(x,m(x))X
Mediation diagram
The direct andM -mediated effects onY to a changex → x′ are then quantified using counterfactual expressions, which
formally enable to decouple the direct (x1) and indirect (x2) conditions onX seen by the outcomeY , i.e., Y
(
x1,m(x2)
)
. Hence,
the direct effect ofX onY , DExx′ , can be defined as the hypothetical change thatY would experience, ifx could be changed to
x′ while keeping the mediatorM to its original valuem(x). Likewise, the indirect effect ofX onY , IExx′ , corresponds to the
hypothetical change thatY would experience, if the mediatorM could be changed tom(x′), while keeping the direct influence
of X onY to its original valuex. This yields the following counterfactual definitions176 for the direct (DExx′ ), indirect (IExx′)
and total (TExx′) effects onY to a changex → x′,
DExx′ = Y
(
x′,m(x)
)
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whereDExx′ , IExx′ andTExx′ can be evaluated within the framework of bayesian statistics,176,178 using the counterfactual
expressions,Y
(
x1,m(x2)
)
=
∑
m E(Y |x1,m)P (M |x2),
DExx′ =
∑
m
[
E(Y |x′,m)− E(Y |x,m)
]
P (M |x)
IExx′ =
∑
m
E(Y |x,m)
[
P (M |x′)− P (M |x)
]
TExx′ = E(Y |x′)− E(Y |x)
Note, in particular, that total effect,TExx′ , is not, in general, the simple sum of direct and indirect effects. Indeed,TExx′ =
DExx′ −Y
(
x′,m(x)
)
+Y
(
x′,m(x′) 6= DExx′ + IExx′ for non-linear systems. Instead, the total effectTExx′ is related to the
indirect effect of thereversedtransition changingx′ into x, i.e. IEx′x = Y
(
x′,m(x)
)
− Y
(
x′,m(x′)
)
, that is,
TExx′ = DExx′ − IEx′x
Yet, althoughDE + IE 6= TE, owing to possible non-linear couplings between direct andindirect causal effects,176 the
Mediation analysis can be interpreted in terms of proportions f the total effect,DE/TE andIE/TE, as well as necessary and
suffisant contributions from the direct and indirect causalpathways.177 Namely, for a total effectTE of X onY , the Mediation
Analysis assesses that,
• the direct effectX → Y is sufficientas sole cause to account for a proportion Dir.=DE/TE of the total effect, while,
• the indirect effectX → M → Y is necessaryas complementary cause to account for a proportion1−DE/TE,
and, likewise,
• the indirect effectX → M → Y is sufficientas sole cause to account for a proportion Ind.=IE/TE, while,
• the direct effectX → Y is necessaryas complementary cause to account for the proportion1− IE/TE of the total effect.
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Figure 8.1: The Mediation Diagram
The direct and M-mediated effects of a control variable X to a change x → x′, on an outcome
Y can be quantified using counterfactual expressions, which formally enable to decouple the
direct (x1) and indirect (x2) conditions on X seen by the outcome Y , i.e., Y (x1,m(x2)). Hence,
the direct effect of X on Y , DExx′ , can be defined as the hypothetical change that Y would
experience, if x could be changed to x′ hile keepi g the mediator M to its original value m x).
Likewise, the indirect effect of X on Y , IExx′ , corresponds to the hypothetical change that
Y would experience, if the mediator M could be changed to m(x′), while keeping the direct
influence of X on Y to its original value x. This yields the following counterfactual definitions
[Pearl, 2001] for the direct (DExx′), indirect (IExx′) and total (TExx′) effects on Y to a change
x → x′,
DExx′ = Y (x′,m(x))−Y (x,m(x))
IExx′ = Y (x,m(x′))−Y (x,m(x))
TExx′ = Y (x′,m(x′))−Y (x,m(x))
where DExx′ , IExx′ and TExx′ can be evaluated within the framework of Bayesian statistics
[Pearl, 2001, 2009], using the counterfactual expressions,
Y (x1,m(x2))=∑m E(Y |x1,m)P(M|x2),
DExx′ =
∑
m
[
E(Y |x′,m)−E(Y |x,m)
]
P(M|x)
IExx′ =
∑
m
E(Y |x,m)
[
P(M|x′)−P(M|x)
]
TExx′ = E(Y |x′)−E(Y |x)
Note, in particular, that the total effect, TExx′ , is not, in general, the simple sum of direct
and indirect effects. Indeed, TExx′ = DExx′ −Y (x′,m(x))+Y (x′,m(x′) 6= DExx′ + IExx′ for non-
linear systems. Instead, the total effect TExx′ is related to the indirect effect of the reversed
transition changing x′ into x, i.e. IEx′x =Y (x′,m(x))−Y (x′,m(x′)), that is,
TExx′ = DExx′ − IEx′x
8.1.2 Mediation calculations
We have applied the Mediation analysis to genomic data using a recent approach developed
by Judea Pearl for non-linear systems using binary categories [Pearl, 2012a,b] (X , M,Y =0/1;
DE, IE,TE ∈ [−1,1]). To discriminate between direct and indirect effects in the case of binary
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categories, Pearl’s Mediation Formulae for direct effect (DE), indirect effect (IE) and total
effect (TE) simply read, (page 23 in [Pearl, 2012a]),
DE = (g10 − g00)(1−h0)+ (g11 − g01)h0 (8.1)
IE = (h1 −h0)(g01 − g00) (8.2)
TE = f1 − f0 = g11h1 + g10(1−h1)− [g01h0 + g00(1−h0)] (8.3)
where f0, f1, g00, g01, g10, g11, h0 and h1 are obtained from the association table of the binary
variables X , M and Y .
Table 8.1: Association table of binary variables to calculate direct and indirect effects
X M Y nxmy fx = E(Y |x) gxm = E(Y |x,m) hx = P(M|x)
0 0 0 n1
f0 = n2+n4n1+n2+n3+n4
g00 = n2n1+n2
h0 = n3+n4n1+n2+n3+n4
0 0 1 n2
0 1 0 n3 g01 = n4n3+n40 1 1 n4
1 0 0 n5
f1 = n6+n8n5+n6+n7+n8
g10 = n6n5+n6
h1 = n7+n8n5+n6+n7+n8
1 0 1 n6
1 1 0 n7 g11 = n8n7+n81 1 1 n8
n5 +n6 n3 +n4 n2 +n4 ∑8
1 ni f =
n2+n4+n6+n8∑8
1 ni
h = n3+n4+n7+n8∑8
1 ni+n7 +n8 +n7 +n8 +n6 +n8
8.1.3 Interpretation of Mediation results
The validity of the assumed Mediation model can be quantified in terms of the total effect
of X on the outcome Y . A large total effect implies the strong overall causal effect of X on
Y . Although DE+ IE 6= TE, owing to possible non-linear couplings between direct and indirect
causal effects [Pearl, 2001], the direct and indirect effects can be interpreted in terms of propor-
tions of the total effect, DE/TE and IE/TE, as well as necessary and sufficient contributions
from the direct and indirect causal pathways [Pearl, 2012a,b]. Namely, for a total effect TE of
X on Y , the Mediation Analysis assesses that,
• the direct effect X →Y is sufficient as sole cause to account for a proportion Dir. = DE/TE
of the total effect, while,
• the indirect effect X → M → Y is necessary as complementary cause to account for a
proportion 1−DE/TE,
and, likewise,
• the indirect effect X → M → Y is sufficient as sole cause to account for a proportion
Ind.= IE/TE, while,
• the direct effect X →Y is necessary as complementary cause to account for the proportion
1− IE/TE of the total effect.
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Hence, the Mediation analysis [Pearl, 2001, 2009, 2012a,b] yields the following summary
table for direct and indirect effects and their interpretations in terms of sufficient or necessary
causes,
Table 8.2: Interpretation of Direct & Indirect Effects
↗ M ↘ direct effect indirect effect non-linear combination of
X −→ Y X −→ Y X → M → Y direct and indirect effects
sufficient
DE/TE IE/TE
if DE+ IE 6= TE(as sole cause)
necessary
1−IE/TE 1−DE/TE
(as complementary cause)
8.1.4 Application on genomic properties
We applied the Mediation formula to assess the relative importance in terms of the total, direct
and the indirect effects of various genomic properties on the retention of ohnologs. A numer-
ical example to assess the direct effect of susceptibility to cancer mutations, cancer = X , and
its mediation by dosage balance, dosage.bal. = Z, on the retention of ohnologs, ohno = Y is
described below. Dosage balanced genes contain 6,119 genes implicated in protein complexes,
and cancer genes consist of 8,899 genes from all cancer gene set. 7,351 Ohnologs are from the
relaxed P-value criteria.
First, we interpret each property as a binary variable e.g. Y = 1 reads that the gene is
ohnolog and Y = 0 that it is not an ohnolog. Similarly, X = 1 implies that the gene is susceptible
to cancer mutations; and X = 0, that it is not a cancer gene; and likewise for the mediator Z.
Then we compute the association table of the above three properties to keep treatment or
mediator fixed at 0 or 1, and assess the retention of ohnologs for each of these combinations, as
depicted below.
dosage.bal cancer Ohno nxzy fx gxz hx
0 0 0 6567
0 0 1 2271 25.7% Ohno
0 1 0 2919 33.6% Ohno 38.2% Cancer
0 1 1 2539 46.5% Ohno
1 0 0 1834
1 0 1 844 31.5% Ohno
1 1 0 1744 41.5% Ohno 56.2% Cancer
1 1 1 1697 49.3% Ohno
6119 8899 7351 20415 36.0% Ohno 43.6% Cancer
Hence, from the above association table we find that f0 = 0.336, f1 = 0.415, g00 = 0.256,
g01 = 0.465, g10 = 0.315, g11 = 0.493, h0 = 0.381 and h1 = 0.562. Substituting this data in
equation 8.1, 8.2 and 8.3 yields TE = 0.0788, DE = 0.0467 and IE = 0.376, and the fractions
DE/TE = 59.2% and IE/TE = 47.7%. This example, along with other mediation models has
been interpreted in details in Chapter 12.
Part III
Results
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Characterization of Vertebrate Ohnologs
OHNOLOGS were identified in six vertebrate (Tetrapod) genomes (Human, Chicken, Dog,Pig, Rat and Mouse) using the P-value method to detect ohnologs (Chapter 6). The
OHNOLOGS program was run for all six vertebrates using six different invertebrate out-
groups (Section 6.1). Each genome was scanned with five window sizes ranging from 100 to
500. Similarly, comparison of each vertebrate genome with itself was performed using the
same approach (See Figure 6.1).
A number of previous studies have identified ohnologs in the human genome [Dehal and
Boore, 2005; Putnam et al., 2008; Makino and McLysaght, 2010; Huminiecki and Heldin, 2010].
However, only [Putnam et al., 2008] used genome-scale comparison with a reference genome
(Amphioxus), diverged before 2R-WGD. Other studies only performed comparison of the human
genome with itself. [Makino and McLysaght, 2010] and [Huminiecki and Heldin, 2010] adapted
the approach described in [Dehal and Boore, 2005], using only a single window (100 genes). If
there were at least two paralogs that were duplicated at the base of vertebrates in this window,
the paralogs were taken as ohnolog candidates. More importantly, there has not been any
quantitative measure to detect if the two paralogs can be identified on any window by-chance,
or to give more weight to the windows with many paralogs. In this chapter, I will discuss the
results of our approach, and how combining information from multiple outgroups can indeed
improve our confidence in the identified candidates using the human genome as reference.
The results for other vertebrates follow exactly the same trend and will be discussed in later
sections.
9.1 Combining information from Multiple outgroups im-
proves ohnolog detection
Table 9.1 lists the numbers of ohnologs identified by all six outgroups and Human-Human
synteny comparison without any filtering on P-value or duplication time for outgroups. For
self-comparison however, only paralogs duplicated at the base of vertebrate were considered.
As we used the most relaxed criteria possible, this data is ridden with false positive candidates,
either duplicated before or after WGD, or having very high P-values.
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Table 9.1: Number of Human Ohnologs Identified by Outgroup and Self Comparison without
any filter on P-value and duplication time
Comparison
Ohnolog Pairs for Window Size
Total Ohno Pairs
100 200 300 400 500
Human Amphioxus 2012 4227 5930 7401 8368 8596
Human Ciona intestinalis 4647 18318 27457 33994 39812 40589
Human Ciona savignyi 7200 36130 47056 51144 52026 56521
Human Drosophila 5843 32102 59613 62622 62624 63658
Human Sea Urchin 1603 2106 2389 2685 3156 3337
Human Worm 4367 30474 86869 104086 105079 106085
Human Human 10200 12757 14041 14344 14204 15054
Total Ohnologs 165779
Therefore, from the 165,779 combined ohnologs first we removed ohnologs not duplicated
at the base of vertebrates for all outgroups leading to 15,107 ohnolog pairs (only 9.1 % “true”
candidates) with P-values ranging from 3.1×10−20 to 0.9999. Of these 15,107 ohnolog pairs
11,428 were identified with at least one outgroup and 15,054 were identified by self comparison
alone. We then constructed three set of ohnologs with increasing confidence by combining P-
values from both outgroups and self-comparison (Section 6.8), leading to three sets of true
positive ohnolog pairs:
• Strict Criteria: 2,935 ohnolog pairs
• Intermediate Criteria: 5,119 ohnolog pairs
• Relaxed Criteria: 7,270 ohnolog pairs
Otherwise noted, the ohnolog pairs characterized in this thesis refer to the 7,270 pairs
from the Relaxed Criteria. To emphasize the importance of using multiple outgroups to detect
ohnologs, a six way Edwards’ Venn diagram (Figure 9.1) depicts the distribution of ohnolog
pairs with respect to all outgroups. Ohnolog pairs range from 1,417 with sea urchin com-
parison to a maximum of 4,983 using the Worm, C.elegans as outgroup. There are only 290
ohnolog pairs identified by all outgroups, and a minimum of 27 (for Sea urchin) to 246 (for C.
intestinalis) ohnolog pairs are identified by a single outgroup alone. To identify ohnologs in
the vertebrate genomes, only the study by [Putnam et al., 2008] used comparison of human
and a single reference genome of Amphioxus on a genome wide scale. Although a slightly dif-
ferent approach was utilized to perform macro-synteny comparison based upon construction
of ancient chordate linkage group, where the window size may cover entire human chromo-
somes. However, as depicted in Figure 9.1, many ohnologs would not be identified using just
a single outgroup genome owing to lineage specific rearrangements in the outgroup genomes,
limitations of genome assembly/annotation or homology criteria.
9.1.1 Comparison with randomized human genome
Although it is clear that multiple outgroups lead to more ohnolog pairs. Yet, to make sure
that our approach to combine P-values from the outgroups by multiplication does not include
noise in the ohnologs in the form of false positives, we compared P-values from comparison
by original and shuffled human genome. We randomized the human genome as described in
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Figure 9.1: A six-way Venn diagram showing distribution of 7,270 human ohnolog pairs from relaxed
criteria wrt all outgroups
Section 6.10. We then identified ohnologs using the window size of 300 using our approach by
all the outgroups, in randomized and original genome. Finally we combined the P-values by
multiplication for both the cases.
To avoid any bias due to number of identified ohnologs from comparison by original or
random genomes, we assigned a probability value of 1 to any paralog pair which shares the
same outgroup ortholog, is duplicated at the correct time, yet not identified in any of the two
comparisons. It implies that the probability of these pairs not being ohnologs is one. This
equalizes the total number of possible ohnologs (14,966).
The distribution of combined P-values (25 bins) for both of the scenarios is depicted in (Fig-
ure 9.2). While we can observed a sharp increase of the genes belonging to lowest probability
bins for original human genome, for the randomized human genome considerably less genes
belong to the low probability classes. If we remove the two basal invertebrates, which are ex-
pected to have least conserved synteny owing to the long time period of independent evolution
since the divergence of vertebrate ancestors, we observed that there is hardly any enrichment
of genes in the lower probability bins, as opposed to sharp increase observed for the actual
genomes. These observations imply that our P-value based approach indeed does not incorpo-
rate much noise in the ohnolog dataset.
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Figure 9.2: Comparisons of combined P-value distribution from original and randomized genomes
9.2 Comparison of ohnologs with published datasets
We then performed comparison of our ohnolog pairs with ohnolog pairs available from two
published ohnolog datasets by [Makino and McLysaght, 2010] and [Huminiecki and Heldin,
2010]. [Makino and McLysaght, 2010] have identified 9,057 ohnolog pairs using comparison
of human genome with itself with a window size of 100, having at least 2 ohnolog candidates
in the window. Similarly, [Huminiecki and Heldin, 2010] also used human-human synteny
comparison using i-ADHoRe 2.4 [Simillion et al., 2008].
9,057 ohnolog pairs from Makino and McLysaght were mapped on Ensembl version 70
leading to 8,378 pairs having both the ohnolog genes in version 70. Makino and McLysaght
used sequence clustering to generate gene families using each of the six outgroup genome as
reference one by one. Within these families, BLAST scores were used to identify candidates du-
plicated before fish tetrapod split. Finally ohnologs were combined from all the six outgroups.
In our initial study [Singh et al., 2012], we have used ohnologs from Makino and Mclysaght and
associated a confidence index with each ohnolog in terms of number of outgroups supporting
the duplication time of a pair (1 to 6). Note however, that this outgroup support does not rep-
resent syntenic support unlike in the present method, rather it just represents the confidence
that a paralog has been duplicated at the base of vertebrates.
Out of the 8,378 pairs from Makino and McLysaght, 5,448 also have correct duplication
timing according to reconciled paralogs from Ensembl v-70 (Section 6.1.2). Of these only 11
pairs could not be identified using our approach from self-comparison and 286 from outgroup
comparison. In total, only 7 ohnolog pairs with correct duplication timing from Makino and
McLysaght ohnologs dataset are not covered by both self and outgroup synteny comparison
without any filter on P-value. This shows that our approach identifies most ‘true’ ohnologs.
However, we suspect that many ohnolog candidates from Makino and Mclysaght are in fact
likely false-positives.
For example, of the 2,930/8,378 ohnologs from Makino and McLysaght that are not dupli-
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cated at the base of vertebrates in our dataset, 79% (2,310) pairs have a confidence index of
only 1, 16% (475 pairs) of 2 or 3, and only 5% had the confidence index of more than half
of [Makino and McLysaght, 2010] ohnologs [Singh et al., 2012]. These observations suggest
that although they lie on a macro-synteny window, many of these pairs are not true positive
candidates. In our outgroup comparison, since the orthologs are not filtered initially based on
the correct duplication time, it was observed that 2,070/2,930 ohnolog pairs could be identified
with at least one outgroup comparison. However, the average P-value of these 2,070 ohnolog
pairs was 0.2, as opposed to the average P-value of 0.006 for ohnologs from the Relaxed criteria
from our method. Yet, 223 of these 2,070 pairs have a combined P-values less than 0.001 from
the outgroup comparisons. Moreover, 455 pairs have been identified by synteny comparison
by more than half of the outgroups, suggesting that these pairs may likely be ‘true’ ohnologs.
Therefore, the accurate identification of duplication time is also critical in the identification of
ohnologs.
-45 -40 -35 -30 -25 -20 -15 -10 -5 0
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
log (P-value) from self comparison
D
en
si
ty
 
 
Ohnologs from relaxed criteria
Makino & Mclysaght ohnologs in relaxed criteria
Makino & McLysaght ohnologs NOT in relaxed criteria
Figure 9.3: Density distribution of P-values from self comparison for Makino & McLysaght ohnolog
pairs that are included or excluded as ohnologs with our Relaxed criteria
23%, 33% and 40% of the pairs respectively from strict, intermediate and relaxed criteria
from our analysis are not part of ohnologs in Makino and McLysaght dataset. Figure 9.3
shows the density distribution of P-values from human-human comparison for Makino and
McLysaght ohnologs that are identified by our relaxed criteria, and the ones that are excluded
as ohnologs due to our P-value filters. Note that while P-value distribution of 4,395 Makino and
McLysaght ohnologs is highly similar to overall distribution of 7,270 pairs from the Relaxed
criteria, high peak at greater P-value for 1,042 ohnolog pairs that are not part of Relaxed
criteria strongly suggests that most of these are false positive candidates.
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Figure 9.4: Density distribution of P-values from Huminiecki & Heldin ohnolog pairs that are included
or excluded as ohnologs with our Relaxed criteria
We also obtained 56,053 ohnolog pairs from [Huminiecki and Heldin, 2010] who used du-
plication time from TreeFam database, based on reconciliation of gene trees in TreeFam with
species tree [Li et al., 2006]. Saccharomyces cerevisiae and Arabidopsis thaliana have been
used as the outgroups to root these trees. Out of these pairs 12,939 were redundant, where
directionality of the homolog relation was not treated properly e.g. RPS6KB1–RPS6KA3 and
RPS6KA3–RPS6KB1 were taken to be two different pairs. We could map 29,344 non-redundant
pairs on Ensembl v70. Of these only 11,397 are duplicated at the base of vertebrates accord-
ing to Ensembl gene trees. Without any filter on P-value we could identify 8,895 pairs using
self-comparison and 7,578 using outgroup comparison. A total of 2,471 pairs could not be
identified from both outgroup and self comparison. Most of these un-identified pairs belong
to large paralogous families with high sequence similarity e.g. chemokines, interleukins and
protocadherins. A distribution of P-values (self-comparison) from our Relaxed criteria and for
the Huminiecki and Heldin ohnologs that are covered (5,295) or excluded (3,600) by our anal-
ysis is shown in Figure 9.4. Similar to Makino and McLysaght ohnologs we observe that for
the ohnolog pairs excluded by our approach, the peak at higher P-value is even higher. These
observations suggest that our approach to combine ohnolog pairs from multiple windows and
more importantly filtering based on P-value can indeed improve the detection of true positive
candidates and exclude ohnologs with low confidence.
In summary, while the approach of [Makino and McLysaght, 2010] works reasonably well,
[Huminiecki and Heldin, 2010] dataset has much more false positives. In particular both the
studies incorrectly includes genes duplicated much before the origin of vertebrates as ohnolog
candidates. Owing to a very relaxed synteny criteria most of these are identified as ohnologs.
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While a possibility of whole genome duplication before 2R-WGD can not be ruled out, these
pairs are certainly not ohnologs from the 2R-WGD.
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Figure 9.5: Genomic distribution of human ohnologs identified by all the three criteria
9.3 Ohnolog family size distribution
Using the ohnolog pairs we next set to construct paralogous families retained from 2R-WGD. If
a gene retains all ohnolog partners, the maximum family size is expected to be four. However,
as most genes loose their partners after duplication, most ohnolog families should belong to
size two or three.
We could generate 1,473, 2,102 and 2,551 ohnolog families from strict, intermediate and
relaxed filters respectively for the human genome. Most remarkably, for almost all of these
families, the size never exceeds mores than four, as expected for the two rounds of genome
duplications. As depicted in Table 9.2, all but 7 ohnolog families belong to a size of at least
four with strict filters on P-value. Even with the most relaxed P-values filters, 96.6% ohnolog
families have only 2, 3 or 4 ohnolog partners. Furthermore, a sharp decline in the number
of families could be observed beyond size four, another strong sign of two rounds of genome
duplications.
We also used our approach to generate the ohnolog families from the pairs provided by
[Makino and McLysaght, 2010] and [Huminiecki and Heldin, 2010]. The number of families
with size upto four all pairs from Makino & McLysaght was found to be 93.8%, lower than from
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Figure 9.6: Genomic distribution of human ohnologs identified by intermediate (left) and only relaxed
criteria (right)
Table 9.2: Individual ohnologs, pairs and families for different criteria in the human genome
Criteria Ohno
Pairs
Individual
Ohnologs
Ohnolog
Families
Family Sizes % of families
with size ≤ 42 3 4 > 4
Ohnologs from our study
Strict 2935 3783 1473 1011 365 89 7 99.5%
Intermediate 5733 5719 2102 1393 500 162 46 97.7%
Relaxed 7270 7351 2551 1644 601 219 82 96.6%
Ohnologs from [Makino and McLysaght, 2010]
All pairs 8378 6989 2352 1466 543 199 97 93.8%
Conf. Ind. ≤ 3 5347 4116 1267 792 260 92 79 90.2%
Conf. Ind. ≥ 4 3031 3923 1582 1099 364 102 11 98.7%
Ohnologs from [Huminiecki and Heldin, 2010]
All pairs 29344 9557 2600 1222 618 332 348 86.6%
the relaxed criteria in this study. This fraction becomes even lower for the ohnolog pairs with
confidence index [Singh et al., 2012] less than four (90.2%). Only ‘high quality’ ohnolog pairs
with confidence index greater than three have 98% gene families within size four, comparable
to our approach. Ohnolog pairs from Huminiechi & Heldin performed even worse with only
86.6% ohnolog families belonging to a size of 2, 3 or 4.
9.4 Ohnolog pairs for other vertebrates
In addition to the human genome, we also identified ohnologs in five other vertebrate genomes:
chicken, dog, mouse, pig and rat. The same approach and the six outgroups were used to com-
pute ohnolog pairs and generated ohnolog families. Table 9.3 shows a summary of individual
ohnologs, pairs and ohnolog families for these genomes using strict, intermediate and relaxed
P-value criteria.
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Table 9.3: Individual ohnologs, pairs and families for all the three criteria in five vertebrate genomes
Organism Criteria
Ohno
Pairs
Individual
Ohnologs
Ohnolog
Families
Family Sizes % of families
with size ≤ 42 3 4 > 4
Strict 1286 2010 890 752 122 15 1 99.9%
Intermediate 1895 2809 1210 974 204 28 4 99.7%
Relaxed 3030 4214 1753 1356 330 57 10 99.4%
Strict 924 1432 610 474 117 18 1 99.8%
Intermediate 2257 3098 1266 926 271 61 8 99.4%
Relaxed 3940 4893 1878 1285 448 124 21 98.9%
Strict 2495 3225 1262 917 260 73 12 99.0%
Intermediate 5701 5809 2085 1309 534 178 63 96.9%
Relaxed 8315 7007 2413 1487 600 226 95 95.7%
Strict 1911 2597 1005 768 191 42 4 99.6%
Intermediate 3801 4470 1609 1114 350 108 37 97.7%
Relaxed 5496 5886 1999 1342 451 140 66 96.7%
Strict 2698 3472 1320 934 280 87 19 98.6%
Intermediate 6623 6482 2164 1286 552 221 102 95.2%
Relaxed 8811 7693 2451 1411 645 245 141 93.9%
The level of annotation of these genomes is variable and annotated protein coding genes
also range from 15,310 for chicken to 22,865 for the rate genome. Using relaxed P-value filters
a minimum of 3,030 to a maximum of 8,811 ohnolog pairs could be identified for chicken and
rat respectively. Ohnolog family size consistently follows the same distribution where there
is a sharp decline in the number of families after size four and, almost all families belong to
size 2, 3 or 4. Remarkable, for the chicken, only 1, 4 and 10 ohnolog families belongs to a size
more than 4 with strict, intermediate and relaxed criteria respectively. This might, in part
reflect the slow rate of rearrangements in the chicken lineage [Hillier et al., 2004]. However,
the total annotated protein coding genes in chicken are highly underestimated (only 15,310)
by current annotations in Ensembl. Therefore, the total number ohnologs are also less as
compared to other analysed vertebrates. In fact, we suspect that the differences in the number
of ohnologs and families in different vertebrates is primarily due to limited genome annotation
or discrepancies in the ortholog or paralog dataset, rather than lineage specific gene loss.
9.5 The OHNOLOGS server
The data of all the ohnolog pairs and families for the six tetrapod genomes has been made ac-
cessible on the web sever: http://ohnologs.curie.fr/. Using OHNOLOGS, users can search
for a particular gene browse pre-compiled ohnolog families and pairs or generate ohnolog fam-
ilies based on P-value filters.
9.5.1 Search
On the Search page (Figure 9.7), the user can search for the gene of their interest in any of
the six vertebrates using either Ensembl Id, gene symbol or any desired keywords. A keyword
search, if it does not match any gene symbol directly, displays all the genes matching that
keyword in gene symbol or description. A hyperlink from this page directs to the page having
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Figure 9.7: Search Page on the OHNOLOGS server
details of ohnolog families. If the gene exists in our analysis, and is an ohnolog, user will
directly be directed to the details about ohnolog families.
On the search page user can also generate ohnolog families using our approach, for any of
the six vertebrate genome using a desired P-value criteria for outgroup or self comparison. The
default values are from the Strict criteria. The results page displayed all the generated fami-
lies, which can also be downloaded easily. To implement this feature, all the 165,779 ohnolog
pairs are taken as input and pairs are filtered based on the criteria combination provided by
the user. Followed by a depth first search run, locally on the server to generate desired families.
9.5.2 Interpretation of an ohnolog family
The result page for ohnolog family search for human Ubiquilin genes is depicted in Figure 9.8.
Families from all the three P-value criteria are displayed. using the strict criteria, only the pair
UBQLN1 – UBQLN4 can be identified as ohnologs. Relaxing the P-value results in a family of
size three. Ohnolog partners for the families are displayed in different columns. Genes within
the same cell are small scale duplicates e.g. UBQLN1 – UBQLN2 and UBQLN3 – UBQLBNL.
We use two different separators for SSDs: a comma (,) to distinguish if it is a recent SSD (after
2R-WGD), and a pipe (|) for an ancient SSD (before 2R-WGD). Hence, UBQLN3 – UBQLBNL
have been duplicated by an SSD before the 2R-WGD, while UBQLN1 – UBQLN2 have been
duplicated by a recent SSD. It implies that the entire region having UBQLN3 – UBQLBNL
genes was duplicated by the genome duplications. Duplication time are taken from Ensembl
Compara.
As described in Section 6.9, if the SSDs do not lie within the same window, we also attempt
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 PDFmyURL.comFigure 9.8: Ohnolog Family Page on the OHNOLOGS server, for Ubiquilin family for human.
to identify the region which might actually have been duplicated by WGD. In such instances,
the ohnolog(s) on the region having strong synteny are kept outside the brackets e.g. UBQLN1,
and the ones with weaker synteny are in the brackets, e.g. UBQLN2.
Clicking on the gene symbols directs to Ohnog Pairs page, where the pairs used to construct
the family and the P-values for all the comparisons can be viewed.
A link to ohnolog family for the searched gene for other vertebrates has also been pro-
vided, along with the disease association (from COSMIC) and the details of the genes (from
GeneCards database).
9.5.3 Browse & Download
We have also kept pre-calculated ohnolog pairs and families for all the vertebrates on the
server. Using the Browse facility, users can view the ohnologs with the details of outgroups
identifying them and the P-values for all comparisons. These pairs can also be downloaded
for custom analysis. Similarly, ohnolog families from all the three P-value criteria can also be
explored or downloaded from the OHNOLOGS server.
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9.6 Ohnologs in the Teleost fish genomes
Teleost fishes are arguably the most species rich vertebrate group, having almost half of all
vertebrate species [Taylor et al., 2003; Santini et al., 2009]. More importantly, they hold great
potential to understand vertebrate genome evolution, due to an additional WGD (the 3R-WGD)
that occurred after the divergence of teleost lineage from tetrapods [Amores et al., 1998; Jaillon
et al., 2004]. Many of the teleost fish genomes have been sequenced and are phylogenetically
uniquely poised to understand the impact of genome duplications on the evolution of verte-
brates. We therefore selected four teleost fish genomes: Medaka (Oryzias latipes), Stickleback
(Gasterosteus aculeatus), Tetraodon (Tetraodon nigroviridis) and Zebrafish (Danio rerio), where
the chromosome level assemblies were available. We used our approach to calculate ohnologs
retained from both the 2R and the 3R-WGD in all of the four fish genomes.
9.6.1 Ohnologs from the 2R-WGD
To identify the ohnologs retained from the vertebrate ancestral WGDs, we used the same six
invertebrate genomes as outgroups. Table 9.4 lists the numbers of identified ohnolog pairs and
families. Similar to the tetrapod genomes, we observed that most of the families belong to a
size two or three, with very few above size four. The numbers of total ohnolog pairs identified
are also comparable to the tetrapod genomes. The large number of pairs observed in Zebrafish
is primarily due to the large number of annotated protein coding genes and total paralog pairs.
Yet, with the relaxed P-value criteria, 95% of all 2R-ohnolog families are below size five. The
results from the strict P-value filters are highly consistent for all the four genomes with close to
99% families below size five for Medaka and Stickleback genomes. Best results were obtained
from the Tetraodon genome where even with the relaxed criteria almost all families belong to
size of 2, 3 or 4. These results further validate that our approach works very well, even for a
relatively recent WGD.
Table 9.4: Individual ohnologs, pairs and families from the 2R-WGD for all the three criteria in
Medaka, Stickleback, Tetraodon and Zebrafish genomes
Organism Criteria
Ohno
Pairs
Individual
Ohnologs
Ohnolog
Families
Family Sizes % of families
with size ≤ 42 3 4 > 4
Strict 2377 2997 1095 819 209 54 13 98.8%
Intermediate 6489 5865 1886 1269 432 137 48 97.5%
Relaxed 8562 6974 2132 1407 492 159 74 96.5%
Strict 3373 3205 1109 842 191 59 17 98.5%
Intermediate 8787 6693 2064 1359 495 144 66 96.8%
Relaxed 11238 7788 2271 1454 555 162 100 95.6%
Strict 1482 1929 733 590 119 20 4 99.5%
Intermediate 3969 4172 1427 1050 281 79 17 98.8%
Relaxed 5516 5266 1691 1194 351 107 39 98.4%
Strict 4686 4378 1422 1042 268 87 25 98.2%
Intermediate 14460 9006 2419 1567 545 200 107 95.6%
Relaxed 19097 10455 2616 1643 604 234 135 94.8%
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Table 9.5: Individual ohnologs, pairs and families from the 3R-WGD for all the three criteria in
Medaka, Stickleback, Tetraodon and Zebrafish genomes
Organism Criteria
Ohno
Pairs
Individual
Ohnologs
Ohnolog
Families
Family Sizes % of families
with size ≤ 22 > 2
Strict 1897 3621 1756 1748 8 99.5%
Intermediate 2095 3903 1878 1864 14 99.3%
Relaxed 2209 4019 1918 1903 15 99.2%
Strict 2229 3934 1883 1874 9 99.5%
Intermediate 2463 4234 2009 1993 16 99.2%
Relaxed 2706 4350 2049 2032 17 99.2%
Strict 1418 2644 1263 1260 3 99.8%
Intermediate 1579 2936 1396 1389 7 99.5%
Relaxed 1602 2979 1416 1409 7 99.5%
[Jaillon et al., 2004] 1973 3647 1713 1687 26 98.4%
Strict 4916 4725 2000 1989 11 99.5%
Intermediate 4773 5516 2371 2345 26 98.9%
Relaxed 5903 5855 2430 2399 31 98.7%
9.6.2 Ohnologs from the 3R-WGD
To identify ohnologs retained from the third fish specific WGD, we used Coelacanth along with
the four tetrapods genomes as outgroups. The results are shown in Table 9.5, show remarkable
consistency. Due to a single round of WGD, as expected, almost all of the ohnologs have just
one more ohnolog partner. With the strict P-value filters, close to 100% ohnologs make a family
of two ohnologs for all the four genomes. Even using the intermediate and relaxed filters, more
than 99% ohnologs have just one more paralog.
We also compared the 3R-ohnolog pairs for Tetraodon identified from our approach to [Jail-
lon et al., 2004; Howe et al., 2013] 1. We noticed that our approach cannot identify only 48/1,973
ohnologs by [Jaillon et al., 2004]. None of these 48 has been duplicated at the three nodes we
took as the candidate ohnolog duplication time. However, after applying our P-value filters:
1,299, 1,413 and 1,429 ohnologs out of 1,973 were identified to be the true ohnologs. More in-
terestingly, we noticed that 414/1,973 pairs in the [Jaillon et al., 2004] dataset were duplicated
at the base of vertebrates, and were in fact identified as ohnologs from 2R-WGD in fish genome
rather than 3R. All in all, our approach works very well for fish specific WGD and the ohnolog
pairs have a very good correspondence with [Jaillon et al., 2004] dataset.
1Courtesy: Camille Berthelot and Hugues Roest-Crollius

10
Enhanced Retention of “Dangerous” Genes
by WGD
JUST as some genes happen to be more “essential,” owing to their deleterious loss-of-functionor null mutations, some genes can be classified as more “dangerous,” due to their propen-
sity to acquire deleterious gain-of-function mutations. This is, in particular, the case for onco-
genes, dominant disease genes and genes with autoinhibitory protein folds. Mutation in these
genes typically lead to constitutively active mutants with dominant deleterious phenotypes,
often detrimental for the life and fitness of organisms.
Disease genes in humans have been shown to be under strong purifying selection [Furney
et al., 2006; Blekhman et al., 2008; Cai et al., 2009]. Yet, “dangerous” gene families impli-
cated in cancer and severe genetic diseases have also been greatly expanded by duplication in
the course of vertebrate evolution. The emergence and evolutionary expansion of these gene
families is an evolutionary oddity from a natural selection perspective. In this chapter, I will
characterize the mechanism of duplication of these genes, and shed some light on the evolu-
tionary constraints that gave rise to their biased retention in the human genome.
To analyze a possible association between the susceptibility of human genes to deleterious
mutations and their duplication mechanism, we considered multiple classes of genes suscep-
tible to deleterious mutations from experimentally verified databases and literature. These
classes include cancer genes, Mendelian disease genes in human, dominant negative genes
and genes with autoinhibitory protein folds (Chapter 7). Our aim was to look at the relative
contributions of WGD and SSD in the expansion of these “dangerous” gene classes.
10.1 The Majority of “dangerous” genes retain more ohnologs
We first investigated the retention of ohnologs among these “dangerous” genes classes. We
overlaid the disease genes classes with our ohnologs from the Relaxed criteria. As depicted
in Figure 10.1, there is indeed a strong association between the retention of human ohnologs
from vertebrate WGD and their reported susceptibility to deleterious mutations.
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Figure 10.1: Prevalence of Human Ohnologs in Gene Classes Prone to Deleterious Mutations
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All gene classes susceptible to mutations have retained significantly more ohnologs than
expected by chance. Overall, 45% of Mendelian disease genes in the human genome belong to
ohnologs as opposed to the expected genome distribution of ohnologs i.e. 36% (45%; 2,322/5,172;
p-value = 1.879×10−15,χ2 test) (Figure 10.1 A). Similarly, all cancer associated genes in the
human genome have also retained significantly higher ohnologs (48%; 4,236/8,899; p-value =
6.806×10−115,χ2 test). Furthermore, these associations, which do not take into account the
actual severity of the gene mutations are clearly enhanced when the analysis is restricted to
genes with dominant deleterious mutations, such as oncogenes (49%; 2,941/5,996; p-value =
2.966×10−98,χ2 test), dominant disease genes (57%; 389/679; p-value = 7.136×10−31,χ2 test),
dominant negative genes (61%; 345/566; p-value = 4.104×10−35,χ2 test) and autoinhibitory
genes (75%; 345/461; p-value = 1.441× 10−67,χ2 test). The biased retention of ohnologs is
even stronger for genes combining several factors associated with an enhanced susceptibility to
deleterious mutations, such as Mendelian disease genes mutated in cancer (52%; 1,654/3,192;
p-value = 2.812×10−77,χ2 test), cancer genes with autoinhibitory folds (78%; 296/381; p-value
= 1.944×10−64,χ2 test), or oncogenes with autoinhibitory folds (83%; 207/248; p-value = 1.162×
10−54,χ2 test).
Ohnologs and small scale duplications (SSD) are known to have antagonistic retention pat-
terns [Davis and Petrov, 2005; Hakes et al., 2007; Fares et al., 2013]. It has been shown that
Ohnologs in the human genome are also refectory to copy number variations (CNV) [Makino
and McLysaght, 2010]. Therefore, to remove any bias from SSD or CNV, we next restricted
ourself to ohnologs that have not experienced any recent SSD after WGD, and that do not have
variable copy numbers in the human genome (12,437 genes after removing SSD & CNV genes).
We were again able to observe an even more pronounced retention of ohnologs without SSD nor
CNV in dangerous genes (Figure 10.1 B). Both Mendelian disease genes (49%; 1,661/3,419; p-
value = 5.519×10−18,χ2 test) and cancer genes (53%; 3,123/5,877; p-value = 7.993×10−76,χ2
test) have retained even greater number of ohnologs without SSD/CNV. Similar to our observa-
tions on all protein coding genes, oncogenes (56%; 2,169/3,895; p-value = 2.973×10−74,χ2 test),
dominant disease genes (57%; 270/475; p-value = 6.085× 10−12,χ2 test), dominant negative
genes (63%; 266/423; p-value = 1.985×10−19,χ2 test), and autoinhibitory genes (77%; 266/345;
p-value = 1.483×10−41,χ2 test), have also retained significantly greater ohnologs. Cancer & dis-
ease genes (55%; 1,227/2,240; p-value = 2.345×10−38,χ2 test), cancer and autoinhibitory genes
and (79%; 235/296; p-value = 2.064×10−40,χ2 test), autoinhibitory oncogenes (85%; 163/191;
p-value = 4.291×10−35,χ2 test), also show greater retention in ohnologs.
If we restrict ourself to cancer genes from core dataset, we expect that the disease associ-
ation of ohnologs would be even stronger. Consistent with our hypothesis, (Figure 10.1 C &
D) 2,743 genes from our core cancer dataset are highly enriched in ohnologs, with all genes,
(59%; 1,612/2,43; p-value = 3.987× 10−136,χ2 test), and without SSD/CNV duplicates (63%;
1,269/2,009; p-value = 2.495×10−88,χ2 test). Genes susceptible to dominant deleterious muta-
tions, such as all oncogenes (61%; 1,180/1,932; p-value = 1.317×10−116,χ2 test), and oncogenes
without SSD/CNV (65%; 921/1,407; p-value = 8.928×10−76,χ2 test), from core cancer genes
also display stronger ohnolog associations. Similarly, focusing on genes belonging to multiple
disease categories from core cancer genes, e.g. cancer and dominant disease (65%; 168/259;
p-value = 3.860×10−22,χ2 test), cancer genes with autoinhibitory folds (80%; 160/199; p-value
= 6.662× 10−39,χ2 test), and oncogenes with autoinhibitory folds (84%; 125/148; p-value =
1.168× 10−34,χ2 test), stronger enrichment in ohnologs can be observed. In protein coding
genes without recent SSD and CNV, this prevalence reaches up to 86% vs global ohnolog re-
tention of 41% for 118 autoinhibitory-oncogenes from core dataset (86%; 102/118; p-value =
2.188×10−23,χ2 test), with consistent pattern from, cancer and dominant disease genes (66%;
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132/201; p-value = 2.158× 10−12,χ2 test), and cancer genes with autoinhibitory folds (83%;
131/158; p-value = 2.188×10−26,χ2 test).
10.1.1 Ohnolog–disease association is consistent for high confidence
ohnolog datasets
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Figure 10.2: Prevalence of high confidence ohnologs in disease genes in the human genome
To test the robustness of our observations for disease genes’ association with ohnologs, we
restricted ourselves to ohnologs from intermediate and strict P-value criteria. We assumed
that all the paralog pairs, not identified as ohnologs with the stricter criteria are in fact not
ohnologs. Yet, we were able to confirm that indeed disease genes in the human genome have
retained significantly more ohnologs than expected by chance (Figure 10.2).
Against the genome average of 28% (5,733/20,514) ohnologs from intermediate criteria, all
the classes susceptible to mutations, e.g. disease genes (35%; 1,811/5,172; p-value = 1.326×
10−28,χ2 test), cancer genes (38%; 3,398/8,899; p-value = 8.625×10−100,χ2 test), and both can-
cer & disease genes (41%; 1,310/3,192; p-value = 1.156× 10−59,χ2 test), have consistently
retained more ohnologs with extremely lower χ2 p-values. The retention bias is stronger
for the genes susceptible to dominant mutations, with oncogenes (40%; 2,374/5,996; p-value
= 1.527× 10−87,χ2 test), dominant disease genes (45%; 303/679; p-value = 8.669× 10−22,χ2
test), dominant negative genes (48%; 271/566; p-value = 1.060×10−25,χ2 test), autoinhibitory
genes (65%; 301/461; p-value = 1.046×10−70,χ2 test), cancer genes with autoinhibitory folds
(67%; 257/381; p-value = 1.466×10−65,χ2 test), and oncogenes with autoinhibitory folds (72%;
178/248; p-value = 6.494×10−53,χ2 test) have retaining significantly more ohnologs (Figure
10.2 A).
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Even if we assume that all but 3,783 ohnologs from strict criteria are non-ohnologs, the
stronger retention bias for “dangerous” genes persists. Against 19% genome average of ohnologs,
mendelian disease genes (23%; 1,200/5,172; p-value = 5.318×10−18,χ2 test), cancer associated
genes (26%; 2,307/8,899; p-value = 4.689×10−72,χ2 test), genes implicated in both cancer &
other diseases (28%; 902/3,192; p-value = 2.009×10−45,χ2 test), oncogenes (27%; 1,603/5,996; p-
value = 4.356×10−60,χ2 test), dominant disease genes (32%; 217/279; p-value = 2.144×10−19,χ2
test), dominant negative genes (35%; 197/566; p-value = 2.161×10−23,χ2 test), genes with au-
toinhibition (47%; 215/461; p-value = 2.106×10−54,χ2 test), and autoinhibitory genes impli-
cated in cancer with all types of mutations (48%; 183/381; p-value = 1.082×10−49,χ2 test), or
with dominant cancer mutations (51%; 126/248; p-value = 4.189×10−39,χ2 test), show strong
bias towards ohnologs.
10.1.2 Enhanced retention of “dangerous” ohnologs in Mouse & Rat
genomes
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Figure 10.3: Prevalence of A. Mouse and B. Rat disease genes in ohnologs
We also investigated the prevalence of ohnologs in disease genes in the mouse and rat
genomes. Since, mouse and rat are model organisms, we could obtain the information on 1,242
disease associated genes for mouse and 1,921 disease and cancer genes for rat, from Mouse
Genome Informatics (MGI) [Eppig et al., 2012] and Rat Genome database (RGD) [Laulederkind
et al., 2013] respectively.
We investigated the disease association of ohnologs for mouse and rat from relaxed P-value
criteria. Consistent with our observations for the human ohnologs, we observe that disease as-
sociated genes in mouse have retained significantly more ohnologs 51% vs 31% (51%; 629/1,242;
p-value = 4.525×10−49,χ2 test). Similarly cancer and disease genes in the rat genome have
also retained more ohnologs than expected by chance, 52% vs 34% (52%; 992/1,921; p-value =
1.502×10−62,χ2 test).
All in all, these observations clearly suggest that human genes that are susceptible to dele-
terious mutations have retained a significant proportion of their ohnolog partners. Importantly,
this retention is more pronounced for genes susceptible to dominant deleterious mutations.
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10.2 “Dangerous” genes show no biased retention by SSD
or CNV
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Figure 10.4: Retention of SSD/CNV duplicates in the gene classes prone to deleterious mutations
We then sought to investigate the retention of human disease genes by small scale dupli-
cates (SSD). Unlike WGD, organisms frequently encounter SSDs in their genomes. The rate of
SSD has been estimated to be 0.01 per gene per million years, which is comparable to single
nucleotide mutations [Lynch and Conery, 2000, 2003]. Therefore, it is expected that majority of
cancer genes must have also experienced SSDs during their evolutionary history. Copy number
variations (CNVs) are another form of SSDs that are not yet fixed in the genome. To examine
the proportion of “dangerous” genes retained by SSDs or that have variable copy numbers in
the human genome, we reconciled our data in all the aforementioned disease gene classes with
SSD or CNV duplicates from two different approaches.
10.2.1 Small scale duplicates from Ensembl
We first specifically focused on recent SSDs i.e. SSDs that occurred after the 2R-WGD as
per relative duplication time estimations from Ensembl compara. We also merged data of re-
cent SSDs (4,465) and CNV genes (5,185) leading to a total of 7978 locally duplicated genes.
As depicted in Figure 10.4 A, human disease genes are significantly depleted in SSD/CNV
genes. All cancer genes in the human genome have retained significantly less SSD dupli-
cates, and they also remain refractory to CNVs in the human genome (34%; 3,032/8,899; p-
value = 3.594×10−22,χ2 test), as opposed to the global proportion of 39% SSD/CNV duplicates.
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Figure 10.5: Retention of SSD duplicates from sequence comparison in the gene classes prone to dele-
terious mutations. Bars in light blue have non significant p-values.
Similarly, Mendelian disease genes have also retained fewer SSD/ CNV duplicates than ex-
pected by chance, (34%; 1,754/5,172; p-value = 2.132×10−14,χ2 test). We observed even weaker
retention of SSD/CNV duplicates in gene classes prone to dominant deleterious mutations,
with oncogenes (35%; 2,101/5,996; p-value = 1.455× 10−10,χ2 test), dominant disease genes
(30%; 204/679; p-value = 1.399× 10−06,χ2 test), dominant negative genes (25%; 143/566; p-
value = 1.632×10−11,χ2 test), and genes with autoinhibitory folds (25%; 116/461; p-value =
9.135× 10−10,χ2 test), having significant depletion in SSD/CNV duplicates. Likewise, com-
bining these properties also leads to even lower SSD/CNV retention biases, with cancer and
Mendelian disease genes (30%; 952/3,192; p-value = 8.566×10−27,χ2 test), cancer and autoin-
hibitory genes (22%; 85/381; p-value = 1.966×10−11,χ2 test), and oncogenes with autoinhibitory
domains (23%; 57/248; p-value = 2.049×10−07,χ2 test), retaining least SSD/CNV genes.
Consistent with above trends, we observed that genes belonging to our core cancer dataset
also display significant reduction in paralogs formed by SSD or CNV Figure 10.4 B. All cancer
genes from core dataset have retained only 27% SSD/CNV paralogs as opposed to 39% of the
genome average (27%; 734/2,743; p-value = 6.356×10−40,χ2 test). Oncogenes from the core
dataset also display similar depletion in SSD/CNV (27%; 525/1,932; p-value = 7.795×10−27,χ2
test), which becomes even stronger when the categories are combined together, e.g. cancer
and dominant disease genes (22%; 58/259; p-value = 3.726×10−08,χ2 test), cancer and autoin-
hibitory genes (21%; 41/199; p-value = 9.206× 10−08,χ2 test), and autoinhibitory oncogenes
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(20%; 30/148; p-value = 2.737×10−06,χ2 test).
10.2.2 Small scale duplicates from sequence comparisons
Ensembl compara estimates duplication nodes by reconciling gene trees with the species tree
of the organisms in Ensembl database[Vilella et al., 2009]. The estimation depends on the
available species and the duplication node of a paralog pair can change from version to version.
Therefore, we also identified 9,916 recent duplicates using sequence comparisons as described
in the Section 6.11.
As shown in Figure 10.5, we again observed that either there is no bias for the disease
genes’ retention by SSD, or there is a substantial depletion, as seen for Ensembl SSD and CNV
duplicates. Against a genome average of 49% SSDs, all disease genes (47%; 2,448/5,172; p-
value = 0.08 test), all cancer genes (48%; 4,254/8,899; p-value = 0.14χ2 test), oncogenes (49%;
2,958/5,996; p-value = 0.28χ2 test) show no bias for SSDs. Dominant disease genes are only
slightly depleted (43%; 291/679; p-value = 0.003χ2 test), whereas other classes that are highly
susceptible to dominant deleterious mutations, such as dominant negative (41%; 231/566; p-
value = 2.211×10−04,χ2 test), autoinhibitory genes (32%; 141/461; p-value = 7.625×10−13,χ2
test), autoinhibitory genes mutated in cancer (31%; 119/381; p-value = 1.275×10−11,χ2 test),
or autoinhibitory oncogenes (29%; 72/248; p-value = 7.423×10−10,χ2 test), are highly depleted
in SSD.
In conclusion, we observed that cancer and disease genes either show no biased retention
of SSD, or they are strongly depleted (especially the gene classes very highly susceptible to
dominant mutations) in both the dataset of recent SSD/CNV paralogs.
10.2.3 Ohnolog and SSD retention bias in different human primary
tumors
We also investigated the ohnolog retention bias for different human primary tumor types from
COSMIC database [Forbes et al., 2008]. Out of total 8,899 genes mutated in cancer 8,837
are part of COSMIC datbase. For each of the primary tumor types classified by COSMIC, we
obtained the information of all the genes that are found to be mutated in them. Table 10.1 lists
20 tissues where the total mutated genes exceeds 100. Against the genomic reference of 36%
ohnologs and 49% SSD duplicates (from sequence comparison), it can be clearly shown that all
ohnologs are highly enriched in all the tumor types. χ2 p-values range from 4.17×10−118 for
lung cancer to the lowest, yet highly significant 1.99×10−05 for soft tissues.
In contrast, we observed that for all the cancer types, there is no significant bias in retention
of SSD duplicates. Either the SSD retention in the human tumors is slightly less than the
genomic average (e.g. for prostate cancer, χ2 p-value 0.004) or does not deviate significantly for
most of the other tissues. This clearly demonstrates that while cancer genes are highly likely
to be retained after duplication by WGD, there is no bias for their retention by small scale
duplications.
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Table 10.1: Dangerous gene retention in ohnologs and SSD for different human primary tumors
from COSMIC
Human Primary
Tumor Types
# of Genes # of WGD % of WGD WGD P-value # of SSD % of SSD SSD P-value
All protein coding
genes
20415 7351 36.0 Reference 9916 48.6 Reference
All primary tumors 8837 4222 47.8 1.58×10−117 4203 47.6 0.06
Lung 8621 4134 48.0 4.17×10−118 4108 47.7 0.09
Large intestine 8449 4059 48.0 1.75×10−117 4014 47.5 0.05
Endometrium 7435 3620 48.7 7.49×10−115 3537 47.6 0.08
Kidney 6218 3079 49.5 4.05×10−109 2950 47.4 0.07
Ovary 5771 2889 50.1 1.42×10−109 2733 47.4 0.06
Skin 5742 2826 49.2 1.50×10−96 2753 47.9 0.34
Prostate 5428 2729 50.3 2.62×10−106 2612 48.1 0.51
Breast 5143 2644 51.4 3.69×10−117 2371 46.1 0.0004
Upper aerodigestive
tract
3838 1962 51.1 1.01×10−84 1897 49.4 0.29
Urinary tract 3312 1707 51.5 2.16×10−77 1536 46.4 0.01
Central nervous sys-
tem
3155 1683 53.3 1.72×10−91 1463 46.4 0.01
Pancreas 3143 1579 50.2 4.97×10−62 1472 46.8 0.05
Haematopoietic &
lymphoid tissue
2612 1393 53.3 5.87×10−76 1238 47.4 0.23
Stomach 1878 888 47.3 2.43×10−24 941 50.1 0.18
Cervix 1810 912 50.4 3.37×10−37 865 47.8 0.51
Liver 1179 623 52.8 2.16×10−33 552 46.8 0.14
Oesophagus 917 490 53.4 4.09×10−28 441 48.1 0.77
Autonomic ganglia 356 175 49.2 2.36×10−07 187 52.5 0.11
Biliary tract 148 89 60.1 9.67×10−10 61 41.2 0.07
Soft tissue 112 62 55.4 1.99×10−05 41 36.6 0.15
10.3 Mapping cancer and disease gene duplications on En-
sembl duplication nodes
To clearly emphasize the global picture of the retention of cancer and disease genes by the
2R-WGD in the human genome, Figure 10.6 A & B show the distribution of all the duplication
events, involving at least one cancer and disease gene on the phylogenetic nodes leading to
humans. Of the total 9,852 duplication events involving cancer genes, 56% can be traced back
to the base of vertebrates, of which 73% belong to the 2R-WGD in our dataset. Similarly, for
the disease genes, 59% of the 5,410 retained duplicates are mapped to the node Vertebrata,
and 68% of these belong to 2R-WGD.
It can be clearly seen that after vertebrates, hardly any small scale duplicates of these
“dangerous” genes have been retained. In fact, most of the duplication events not belonging to
WGD can be traced back to nodes older than vertebrates, most notably coelomata. Although
the possibility of additional WGD events before the 2R cannot be excluded, after more than
600-700 MY of evolution, traces of such duplication would be extremely difficult to prove.
We still suspect that some of the cancer and disease gene duplicates at the base of ver-
tebrates that we could not identify as ohnologs (or were excluded by P-value filters) can still
be “true” ohnologs. Nevertheless, the global picture of disease-ohnolog association is already
highly significant.
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Figure 10.6: Duplication of A. cancer and B. Mendelian disease genes at each phylogenetic node leading
to humans
10.4 Ohnologs are more conserved than non-ohnologs
We then investigated whether the susceptibility of ohnologs to deleterious mutations could be
directly quantified through comparative sequence analysis. We used Ka/Ks ratio (also called
DN /DS) estimates, which measure the proportion of nonsynonymous substitutions (Ka or DN)
to the proportion of synonymous substitutions (Ks or DS). Ohnologs exhibit statistically lower
Ka/Ks ratios (Table 10.2) which provides direct evidence of strong conservation, consistent
with a higher susceptibility of ohnologs to deleterious mutations. Similar trends have also
been reported for ohnologs specific to teleost fishes [Brunet et al., 2006] or to the more recent
WGD in Xenopus laevis lineage [Sémon and Wolfe, 2008].
We used human orthologs from all the six invertebrate outgroups to calculate Ka/Ks ratios.
As detailed in Table 10.2, non-ohnologs have significantly lower p-values of Mann–Whitney U
(also called the Mann–Whitney–Wilcoxon or MWW) test. While for ohnologs from strict and
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Table 10.2: Analysis of sequence conservation with respect to all invertebrate outgroups
Human – Invertebrate pair Mean Median n Distribution Mean Median n Distribution p-value MWW test
Strict ohnologs versus Non-ohnologs
Strict ohnologs Non-ohnologs
A H. sapiens - B. floridae 0.1283 0.1095 3,438 0.1755 0.1409 12,070 2.15×10−100
B H. sapiens - C. intestinalis 0.1708 0.1486 3,262 0.1915 0.1673 9,361 8.36×10−21
C H. sapiens - C. savignyi 0.1663 0.1415 3,199 0.1903 0.1633 9,118 6.75×10−27
D H. sapiens - S. purpuratus 0.1669 0.1445 3,007 0.1835 0.1585 8,787 2.13×10−12
E H. sapiens - D. melanogaster 0.1784 0.1632 3,282 0.1956 0.1818 9,066 5.89×10−26
F H. sapiens - C. elegans 0.2047 0.189 3,147 0.2223 0.205 8,511 1.39×10−19
Intermediate ohnologs versus Non-ohnologs
Intermediate Ohnologs Non-Ohnologs
A H. sapiens - B. floridae 0.1355 0.1144 5,221 0.1801 0.1449 10,287 1.26×10−103
B H. sapiens - C. intestinalis 0.1745 0.1531 4,921 0.1936 0.1686 7,702 5.03×10−18
C H. sapiens - C. savignyi 0.1727 0.1479 4,857 0.1914 0.1643 7,460 3.03×10−20
D H. sapiens - S. purpuratus 0.1716 0.1487 4,479 0.184 0.159 7,315 4.52×10−08
E H. sapiens - D. melanogaster 0.1824 0.1675 4,907 0.1967 0.183 7,441 1.02×10−21
F H. sapiens - C. elegans 0.2081 0.1912 4,724 0.224 0.2066 6,934 2.45×10−20
Relaxed ohnologs versus Non-ohnologs
Relaxed Ohnologs Non-ohnologs
A H. sapiens - B. floridae 0.144 0.122 6,697 0.181 0.1422 8,811 5.82×10−56
B H. sapiens - C. intestinalis 0.1833 0.1618 6,192 0.1889 0.1624 6,431 0.3682
C H. sapiens - C. savignyi 0.1825 0.1559 6,118 0.1855 0.1579 6,199 0.0517
D H. sapiens - S. purpuratus 0.1785 0.1568 5,647 0.1801 0.154 6,147 0.2838
E H. sapiens - D. melanogaster 0.1892 0.1739 6,157 0.1928 0.1795 6,191 0.0024
F H. sapiens - C. elegans 0.2152 0.1971 5,872 0.2199 0.2041 5,786 0.0013
intermediate probability filters, the Ka/Ks distributions are significantly lower for ohnologs
than for non-ohnologs for all the six outgroups. For relaxed filters, we observed that this dif-
ference is reduced for C. intestinalis and Sea urchin, yet the Ka/Ks are still significantly lower
for Amphioxus, Drosophila, Worm and C. savignyi.
The distributions of Ka/Ks ratios for ohnologs from all the three criteria, along with non
ohnologs have been shown in Figure 10.7. All the three distributions are significantly different
than the one for non-ohnologs from relaxed criteria (Table 10.2). We also observed that the
Ka/Ks ratios from the strict criteria are also significantly different than the ones from inter-
mediate criteria (Median = 0.109 for strict ohnologs versus 0.114 for intermediate ohnologs;
p-value = 1.838×10−4, MWW test). Similarly ohnologs from strict and relaxed criteria (Me-
dian = 0.109 for strict ohnologs versus 0.122 for relaxed ohnologs; p-value = 2.922×10−16, MWW
test), and intermediate and relaxed criteria also show significant differences in the distribu-
tions (Median = 0.114 for intermediate ohnologs versus 0.122 for relaxed ohnologs; p-value =
6.687×10−9, MWW test). Note, however, that these p-values for MWW test are considerably
lower than the difference of all the three criteria from non-ohnologs (Table 10.2 A). Yet, this
difference signifies that ohnologs for lower P-value from our approach tend too be even more
highly conserved.
Note, also, that the functional consequences of such deleterious mutations, leading either
to a gain or a loss of function, cannot be directly inferred from these Ka/Ks distributions. Yet,
as outlined in the next section, we found marked differences in the retention of “dangerous”
ohnologs prone to dominant gain-of-function mutations and “essential” ohnologs exhibiting
lethal loss-of-function or null mutations, or recessive disease mutations.
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10.5 Dominant, and not recessive disease genes have re-
tained more ohnologs
As noted in Section 10.1 above, the ohnolog retention is most enhanced for the genes suscepti-
ble to dominant deleterious mutations such as oncogenes, autoinhibitory or dominant negative
genes. To further characterize the ohnologs with respect to the inheritance pattern of muta-
tions, we explored the retention bias of genes susceptible to recessive disease mutations.
10.5.1 Recessive disease genes
First, we focused on recessive disease genes in our dataset. We observed that, unlike dominant
disease genes, recessive disease genes do not present any significant retention bias from 2R-
WGD. 888 experimentally verified autosomal recessive disease genes from OMIM have not
retained more ohnologs than expected by chance in the human genome, 39% vs 35% (35%;
314/888; p-value = 0.68,χ2 test). The observation is also consistent on a slightly larger dataset
of 1,002 genes (37%; 367/1,002; p-value = 0.67,χ2 test), where we just excluded the genes
known to be implicated in dominant disorders, but kept all other inheritance patterns provided
by OMIM (e.g. polygenic, multifactorial, heterogeneous or uncertain).
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10.5.2 Essential genes
We then, estimated the retention pattern of “essential” genes in ohnologs. Essential genes were
defined as the genes whose knock-out leads to lethality of infertility. Unless haploinsufficient,
such mutations are typically recessive. As described in Section 7.6, we have obtained essential
genes from two different resources, from OGEE [Chen et al., 2012; Silva et al., 2008] based on
knock-out experiments in human cell lines, and orthologs of mouse essential genes from MGI
[Eppig et al., 2012], based large-scale null mutant studies in mouse.
Of the 6,436 orthologs of mouse genes tested for essentiality, 46% (2,938) have been identi-
fied to be essential. The global proportion of ohnologs in these 6,436 genes is 52%(3,319). We
observed that the human orthologs of the mouse essential genes, are only slightly enriched in
ohnologs 54% vs 52% (54%; 1,597/2,938; p-value = 0.008,χ2 test), where 54% is the proportion
of ohnologs among the 2,938 genes found to be essential in mouse. Furthermore, this small
enrichment becomes hardly significant, once genes with dominant allelic mutants are removed
from the list of 6,436 genes tested for essentiality in mouse 47% vs 44% (47%; 664/1,406; p-
value = 0.03,χ2 test), where 44% = 1,519/3,427 is the global proportion of ohnologs among the
3,427 genes tested for essentiality in mouse, after removing dominant disease genes, onco-
genes, and genes with dominant negative mutations or auto-inhibitory folds.
These results are also consistent for ohnologs from intermediate and strict criteria. When
we explored the enrichment of the essential genes in 5,733 ohnologs from intermediate crite-
ria, we could find the low enrichment of essential genes in ohnologs, 44% (44%; 1,306/2,938;
p-value = 5.527×10−04,χ2 test) against 41% intermediate ohnologs in all genes tested for es-
sentiality. For the 3,783 ohnologs from the strict P-value criteria, which we expect to be very
strong ohnolog candidates, essential genes display even lower enrichment with only 32% high
confidence ohnologs constituting essential genes (32%; 928/2,938; p-value = 0.004,χ2 test),
against a global retention of 29% (1,843/6,436) ohnologs in all genes tested. For both these
cases, after removal of “dangerous” ohnologs, this slight prevalence becomes non-significant.
After removal of “dangeous” genes, the proportion of ohnologs from intermediate criteria is
38% (38%; 530/1,406; p-value = 0.02,χ2 test), against a global retention of 35% intermediate
ohnologs in all tested genes. Similarly, only 25% ohnologs from strict criteria are essential
(25%; 354/1,406; p-value = 0.06,χ2 test) against global average of 23% strict ohnologs in all
tested genes after removal of dominant disease genes.
We also explored the ohnolog retention statistics on the 18,938 genes tested for essentiality,
directly in human cell lines. We noticed that essential genes from these cell line knock-outs
are significantly enriched in the ohnologs form relaxed criteria, 48% vs 37% (48%; 1,280/2,701;
p-value = 4.157×10−27,χ2 test), where 37% = 7,074/18,938 is the global proportion of ohnologs
in the genes tested for essentiality. This enrichment also persists, when we restrict ourselves
to genes not implicated in dominant diseases as discussed above. Ohnologs without dominant
diseases are also enriched in essential genes from the cell line knock outs, however, the bias
is less than that for all genes, 39% vs global ohnolog retention of 31% (3,793) in 12,283 genes
tested for essentiality after removal of “dangerous” genes, (39%; 519/1,344; p-value = 8.321×
10−10,χ2 test).
We then looked for this enrichment in the ohnologs from intermediate and strict P-value
criteria. Unlike orthologs of mouse essential genes, we still could find that essential genes
from OGEE are enriched in both intermediate (37%; 1,004/2,701; p-value = 2.749×10−20,χ2
test), and strict ohnologs (26%; 711/2,701; p-value = 6.431× 10−09,χ2 test), against a global
retention of 29% (5,512/18,938) intermediate and 19% (3,645/18,938) strict ohnologs in essen-
tial genes. This enrichment persisted even if we removed the genes susceptible to dominant
deleterious mutations, however, it was reduced considerably. In 12,283 genes with essential-
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ity information and without dominant disease genes, the global proportion of ohnologs is 23%
and 15% respectively from intermediate and strict P-value filters. Yet, 1,344 essential genes
have retained 29% (29%; 393/1,344; p-value = 6.431×10−20,χ2 test), and 21% (21%; 285/1,344;
p-value = 1.976×10−09,χ2 test), of their ohnolog partners from intermediate and strict criteria
respectively.
Finally, we looked at the enrichment of mouse essential genes in mouse ohnologs directly.
We observed that 3,242 (50%) of the total 6,435 gene tested for essentiality in mouse were
ohnologs. The global proportion of mouse ohnologs from strict criteria in essential genes how-
ever was only 53% (53%; 1,548/5,268; p-value = 0.012,χ2 test). Furthermore, mouse ohnologs
from intermediate and strict criteria are only slightly enriched in essential genes. Against the
global retention of 42% mouse ohnologs from intermediate criteria in all tested genes, 46%
esential genes have retained ohnologs (46%; 1,343/2,938; p-value = 0.0002,χ2 test). Against
the 25% strict ohnologs in the genes tested for essentiality, proportion of ohnologs in essentila
genes is 29% (29%; 830/2,938; p-value = 7.42×10−5,χ2 test).
To study if this slight enrichment is contributed in fact by disease genes, we removed 1,242
mouse disease genes from our dataset. After removing the mouse disease genes, we observed
that this slight enrichment of ohnologs in essential genes diminishes considerably for all the
three datasets. Against the global proportion of 50%, 42% and 25% ohnologs in the 5,438 tested
genes (after removal of disease genes) from relaxed, intermediate and strict P-value criteria
respectively, we observed that ohnologs show very weak enrichment: (52%; 1,177/2,270; p-
value = 0.03,χ2 test) for relaxed, (45%; 1,020/2,270; p-value = 0.001,χ2 test) for intermediate
and (28%; 640/2,270; p-value = 0.002,χ2 test) for strict ohnologs.
In conclusion therefore, we observed that there is no robust enrichment of essential genes
in ohnologs in the human or mouse genome. The results from human cell lines also show con-
siderable reduction after removal of “dangerous” genes. We argue that the results for essential
genes from cell lines knock outs should be interpreted with caution, as the genes not found to
be essential in mammary cells can be essential for other cell lines and vice-versa. In addition,
a gene found to be essential for survival of individual cells may not always have adverse effect
on the fitness of organism, owing to the removal of slow dividing cells by cell-cell competition
[Baker, 2011].
All in all, this shows that the retention of ohnologs has been most enhanced for genes prone
to autosomal-dominant deleterious mutations and not autosomal-recessive deleterious muta-
tions. This suggests that the retention of ohnologs is more strongly related to their “danger-
ousness,” as defined by their high susceptibility to dominant deleterious mutations, than their
functional importance or “essentiality”. Ultimately, we will argue that the “dangerousness” of
ohnologs effectively controls their individual retention in the genomes of post-WGD species, as
will be shown below in the section Model for the Retention of Dangerous Ohnologs.
11
Dosage Balance, Expression level & Human
Ohnologs
WE have seen in the previous chapter that the susceptibility to dominant deleterious mu-tation is highly correlated with the retention of ohnologs, but not SSD in the vertebrate
genomes, suggesting that gene families prone to dominant deleterious mutations have been
particularly expanded by WGD. Antagonistic retentions of ohnologs and SSD across different
functional categories has also been observed previously [Davis and Petrov, 2005; Hakes et al.,
2007]. Yet, many of the evolutionary concepts explaining the retention of genes after duplica-
tion (e.g. neofunctionalization, subfunctionalization) were developed before the realization of
this antagonistic retention pattern of ohnologs and SSD, and the overall impact of polyploidy
on genome evolution.
However, an alternative hypothesis, focusing on the collective retention of interacting ohnologs,
has been frequently invoked to account for the biased retention of ohnologs in unicellular or-
ganisms like yeast [Papp et al., 2003] or the paramecium [Aury et al., 2006] and in higher
eukaryotes [Birchler et al., 2001; Makino and McLysaght, 2010]. This “dosage balance” hy-
pothesis posits that interacting protein partners tend to maintain balanced expression levels
in the course of evolution, in particular, for protein subunits of conserved complexes [Birch-
ler et al., 2001; Veitia, 2002; Papp et al., 2003; Makino and McLysaght, 2010]. Thus, SSD
of dosage balanced genes are thought to be generally detrimental through the dosage imbal-
ance they induce, thereby raising the odds for their rapid nonfunctionalization [Papp et al.,
2003; Maere et al., 2005]. By contrast, rapid nonfunctionalization of ohnologs after WGD has
been suggested to be opposed by dosage effect, in particular, for highly expressed genes, and
genes involved in protein complexes or metabolic pathways [Aury et al., 2006; Evlampiev and
Isambert, 2007; Gout et al., 2010; Makino and McLysaght, 2010]. This is because WGD ini-
tially preserves correct relative dosage between expressed genes, whereas subsequent random
nonfunctionalization of individual ohnologs disrupts this initial dosage balance.
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Figure 11.1: Enrichment of dosage balanced genes in the human ohnologs from relaxed criteria. Total
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11.1 Mixed susceptibility of human ohnologs to dosage
balance
11.1.1 High retention of protein complexes in ohnologs
The dosage balance hypothesis has been supported by the enrichment of protein complex sub-
units in ohnologs in a variety of organisms [Papp et al., 2003; Aury et al., 2006; Makino and
McLysaght, 2010]. Following these results, we studied the enrichment of human protein com-
plexes in ohnologs. To this end, we compiled a dataset of genes involved in the formation of
human protein complexes from multiple resources (Section 7.5). A total of 6,119 genes could
be identified to be associated to experimentally verified and manually curated protein complex
subunits in the human genome.
As depicted in Figure 11.1, we observed in agreement with [Makino and McLysaght, 2010],
that the genes implicated in multiprotein complexes have retained significantly more ohnologs
from relaxed criteria than expected by chance, 42% versus 36% (42%; 2,541/6,119; p-value =
2.406×10−19,χ2 test). This trend is also enhanced when focusing on haploinsufficient genes,
that are known for their actual sensitivity to dosage balance constraints [Qian and Zhang,
2008] (56%; 215/382; p-value = 1.516×10−16,χ2 test). Haploinsufficient mutations are in fact
dominant disease mutations, affecting normal phenotype by gene dosage. Therefore, their
enrichment in ohnologs is also expected from their susceptibility to dominant deleterious mu-
tations as discussed in Section 10.5.
These observations are also consistent for the ohnologs from intermediate and strict P-
values. Against genome average of 28% ohnologs from intermediate criteria, all protein com-
plex genes (34%; 2,072/6,119; p-value = 3.065×10−22,χ2 test), and haploinsufficient genes (46%;
174/342; p-value = 6.596×10−14,χ2 test), have retained more ohnologs. Similarly, ohnologs from
the strict criteria also display enhanced ohnolog retention in all complexes (24%; 1,442/6,119;
p-value = 3.760×10−24,χ2 test), and haploinsufficient genes (36%; 136/382; p-value = 8.891×
10−18,χ2 test), against the genome average of 19%.
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11.1.2 Transient versus permanent complexes
We then focussed our attention on manually curated dataset of the 239 genes involved in for-
mation of permanent complexes. While most of the complex 6,119 genes involved in forma-
tion of transient complexes show an enrichment in ohnologs. Surprisingly, an opposite trend
corresponding to the elimination of ohnologs is observed for genes implicated in permanent
complexes, that are presumably strongly sensitive to dosage balance constraints. (7%; 17/239;
p-value = 1.329×10−20,χ2 test).
These observations are also consistent for intermediate and strict ohnologs. A strong deple-
tion for manually curated permanent complexes (7%; 16/239; p-value = 1.270×10−13,χ2 test)
for 28% ohnologs from intermediate criteria was observed. Likewise, even from strict P-value
ohnologs, a mere (5%; 11/239; p-value = 2.995×10−8,χ2 test) ohnologs have been retained in
permanent complexes, against 19% of genome average. A recent study has also observed on a
larger dataset of 80,202 interactions between 12,839 gene products for various protein-protein
interaction databases that ohnologs do not have greater propensity to be retained in the same
protein complex than expected by chance [Chen et al., 2013b].
While in the human genome most of the ribosomal genes have lost their ohnologs, this trend
is opposite to what has been observed for Saccharomyces cerevisiae ohnologs where 76% of its
ribosomal gene ohnologs from a 150 MY old WGD [Kellis et al., 2004; Lin et al., 2007] have been
retained, although the maintenance of these ohnologs has been suggested to require frequent
gene conversion events [Kellis et al., 2004; Evangelisti and Conant, 2010] as well as fine-tuned
dosage compensation to ensure a balanced expression with the remaining 24% ribosomal genes
having lost their ohnologs [Zeevi et al., 2011].
In fact, looking more closely at the few human ohnologs, that have not been eliminated from
permanent complexes Table 11.1, we found that they are likely under less stringent dosage
balance constraints than most proteins in permanent complexes, as they typically coassociate
with mitochondrial proteins or form large multimeric subcomplexes with intrinsic stoichiome-
try disequilibrium.
This suggests that the elimination of most ohnologs from permanent complexes is, in fact,
strongly favored under dosage imbalance and becomes likely inevitable once a few of those
ohnologs have been accidentally lost following WGD. Indeed, the uneven elimination of ohnologs
in permanent complexes is expected to lead to the assembly of nonfunctional, partially formed
complexes detrimental to the cell, unless dosage compensation mechanisms effectively re-
establish proper dosage balance at the level of gene regulation [Birchler et al., 2001], as for
yeast ribosomal proteins [Zeevi et al., 2011]. By contrast, transient complexes, which are typ-
Table 11.1: Low retention of ohnologs from the strict criteria in permanent complexes
Permanent complexes Ohnologs Intrinsic stoichiometry disequilibrium of ohnologs in permanent complexes
ATP F0 3 / 12 The 3 ohnologs ATP5G1-3 form the 10-mer C-ring of the F-type ATP synthase
ATP F1 0 / 5
COX 2 / 11 The 2 ohnologs COX4I1,2 coassemble with 3 mitochondrial encoded genes
SRS 1 / 32 RPS27L has an ohnolog RPS27, both are part of 40s subunit
Mitochondrial SRS 0 / 30
LRS 2 / 50 RPL3 and RPL22 have ohnologs RPL3L and RPL22L1 with unknown functions
Mitochondrial LRS 0 / 48
Proteasome 1 / 31 Ohnologs PSMA7 or PSMA8 are included in the 2 rings of 7 alpha subunits
PD 2 / 5 PDK1/2 are part of mitochondrial PD
RNA Pol II 0 / 12
RNA Pol III 0 / 9
RNA Pol III 0 / 9
COX, Cytochrome-c Oxidase; LRS, Large Ribosomal Subunit; PD, Puryvate Dehydrogenase; SRS, Small Ribosomal Subunit.
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ically more modular than permanent complexes, are expected to accommodate such dosage
changes more easily, as they do not usually require the same strict balance in the expression
levels of their protein partners.
These findings on the differences in retention of human ohnologs between permanent and
more transient complexes suggest the relevance of different underlying causes. Although
dosage balance presumably remains the primary evolutionary constraint in permanent com-
plexes (<2% of human genes), which lead to the elimination of ohnologs in permanent com-
plexes in vertebrate genomes, gene susceptibility to deleterious mutations may be more rele-
vant for the retention of ohnologs within the 17% of human genes participating in more tran-
sient complexes. For instance, transient complexes involved in phosphorylation cascades or
GTPase signaling pathways are known to be more sensitive to the level of activation of their
protein partners than to their total expression levels. Thus, although the active forms of multi-
state proteins typically amount to a small fraction of their total expression level, hence provid-
ing a large dynamic range for signal transduction, it also makes them particularly susceptible
to gain-of-function mutations. Such mutations can shift protein activation levels 10- to 100-
fold without changes in expression levels and likely underlie stronger evolutionary constraints
than the 2-fold dosage imbalance caused by gene duplication.
11.1.3 Susceptibility of human protein complexes to disease muta-
tions
To further investigate the relative effects of dosage balance and gene susceptibility to dele-
terious mutations, we analyzed whether the overall enhanced retention of ohnologs within
multiprotein complexes Figure 11.1 could indirectly result from an enhanced susceptibility to
deleterious mutations.
Indeed, as outlined in Figure 11.2, human disease genes are more prevalent in protein com-
plexes than expected by chance. While, an average of 30% genes are associated with the for-
mation of protein complexes, they show enhanced association with cancer (39%; 3,441/8,899; p-
value = 1.137×10−71,χ2 test), Mendelian diseases (42%; 2,188/5,172; p-value = 1.757×10−83,χ2
test), and oncogenes (34%; 2,020/5,996; p-value = 3.368×10−10,χ2 test). A slightly greater bias
towards protein complexes is observed for both cancer & disease genes (48%; 1,522/3,192; p-
value = 1.004×10−105,χ2 test), autoinhibitory cancer genes (45%; 170/381; p-value = 4.372×
10−10,χ2 test), and autoinhibitory oncogenes (47%; 116/248; p-value = 7.687×10−09,χ2 test).
Dominant disease genes (55%; 373/679; p-value = 9.578× 10−46,χ2 test) dominant negative
genes (64%; 365/566; p-value = 7.790×10−72,χ2 test) and genes with autoinhibitory protein
fold (63%; 291/461; p-value = 1.975×10−54,χ2 test) are highly biased towards complexes. By
contrast, ohnologs are only slightly, although significantly, more prevalent in complexes than
expected by chance, 35% versus 30% (35%; 2,541/7,351; p-value = 5.102×10−79,χ2 test). In sec-
tion Section 12.1, we will use a more advance statistical analysis to integrate this multivariate
correlations between ohnolog retention, and their association to protein complexes and genetic
disorders.
11.2 Gene expression level and human ohnologs
Gene expression levels have also been proposed to be correlated with the retention of ohnologs
in yeast [Seoighe and Wolfe, 1999] and paramecium [Gout et al., 2009, 2010] genomes. In both
these cases, it has been observed that genes with relatively high expression levels retain more
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Figure 11.2: Enrichment of genes associated to protein complexes in human disease genes. The total
number of genes in each category in the genome are given in brackets. Each bar represents the fraction
of genes associated to complexes in each category.
ohnologs. Therefore, we also evaluated if high expression levels is also correlated with the
ohnolog retention in the human genome.
We obtained expression levels of 13,425 human genes from BioGPS [Wu et al., 2009] as
described in Section 7.8. The global proportion of relaxed ohnologs in these genes was 40%. If
the higher expression levels affect ohnolog retention, we would expect that highly expressed
genes would retain more ohnologs than expected by chance i.e. > 40%. We used three different
percentile ranks of expression levels from our dataset to define highly expressed genes: 90th,
75th and median, corresponding to 61.9, 16.2 and 6.9 average difference (AD) values respec-
tively. For each category, genes having expression values greater than these were considered to
be highly expressed genes, leading to 1,342 genes corresponding to the highest 10% AD values,
and 3,355 and 6,695 genes belonging to the top 25% and 50% expression levels respectively.
Contrary to the observations for yeast and paramecium, we observed no significant differ-
ence in the retention of human ohnologs between highly expressed genes and genome aver-
age for all the three categories (Figure 11.3). Genes belonging to the highest 10% expression
levels were in fact slightly depleted in the ohnologs from relaxed criteria, 35% versus 40%,
(35%; 471/1,342; p-value = 0.0002,χ2 test). Similarly, genes having top 25% expression values
(39%; 1,293/3,355; p-value = 0.07,χ2 test), and expression levels greater than median (40%;
2,685/6,695; p-value = 0.97,χ2 test), have not retained more ohnologs than expected by chance.
These observations are also robust for the high confidence ohnologs from intermediate crite-
ria. Highly expressed genes having top 10% (28%; 375/1,342; p-value = 0.005,χ2 test), top 25%
(31%; 1,032/3,355; p-value = 0.33,χ2 test), and top 50% (32%; 2,144/6,695; p-value = 0.39,χ2
test) expression levels have not retained more ohnologs than the genome average of 32% from
the intermediate P-value criterion. Similarly, against a genome average of 21% strict ohnologs
in all genes with expression levels, there is no significant difference in the ohnologs retained
from any of the three expression categories: highest expression level (18%; 245/1,342; p-value =
0.014,χ2 test), top 25% expression levels (21%; 711/3,355; p-value = 0.74,χ2 test), or expression
levels greater than median value (22%; 1,476/6,695; p-value = 0.02,χ2 test).
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Figure 11.4: Expression level distribution for ohnologs and non-ohnologs for all the three P-value
criteria
We next compared the distribution of expression levels of all ohnologs and non-ohnologs,
and discovered the same trend. The distribution of the expression levels of all ohnologs and
non-ohnologs from the three P-value criteria are shown in Figure 11.4. We could not see
any significant difference in the distribution of expression levels between ohnologs and non
ohnologs from strict (2,816 ohno versus 10,611 non-ohno; p-value = 0.11, MWW test), inter-
mediate (4,234 ohno versus 9,191 non-ohno; p-value = 0.88, MWW test), and relaxed criteria
(5,387 ohno versus 8,038 non-ohno; p-value = 0.025, MWW test).
11.3 Sequence conservation and ohnolog retention
In addition to the aforementioned attributes, a number of previous studies have associated slow
evolutionary rate with high duplicability and higher retention of ohnologs after WGD [Davis
and Petrov, 2004; Brunet et al., 2006; Sémon and Wolfe, 2008; Jiang et al., 2013]. We also
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analyzed Ka/Ks for the human ohnologs and observed that they tend to be highly conserved
with lower Ka/Ks ratios, as discussed in detail in (Section 10.4) [Singh et al., 2012].
All in all, we observed a mixed susceptibility of human ohnologs for dosage balance, with
all protein complexes retaining more ohnologs, while permanent complexes have clearly lost
most of their ohnolog gene copies. Ohnologs also tend to have lower Ka/Ks ratios. However,
we could not observe a significant bias towards retaining highly expressed ohnologs. In the
next chapter, I will discuss in details the relative contribution of each of these properties in the
retention of ohnologs using Mediation analysis.

12
Indirect Causes of Ohnolog Retention
IN the previous chapters, we observed that the genes susceptible to dominant deleterious mu-tations have retained more ohnologs, clearly suggesting that the susceptibility to dominant
deleterious mutations is a critical factor in the retention of ohnologs after WGD. We further ob-
served, in agreement with previous studies [Papp et al., 2003; Makino and McLysaght, 2010],
that protein complex genes that are sensitive to dosage balance constraints have also retained
more ohnologs. However, many genes susceptible to dosage imbalance also display elevated
mutation susceptibility, reflected in their enrichment in the disease genes classes in the hu-
man genome (Figure 11.2).
Evolutionary constraint to maintain balance in the relative dosage of the interacting sub-
units in macromolecular complexes has been frequently invoked to explain the differential
retention of genes after SSD and WGD. However, based on our observations, we hypothesized
that the susceptibility of individual genes to deleterious mutations directly underlies their re-
tention after WGD. To further investigate the relative effects of dosage balance and gene sus-
ceptibility to deleterious mutations beyond these simple statistical associations, we quantified
the total, direct and indirect effects of deleterious mutations and dosage balance constraints
on the biased retention of human ohnologs.
To this end, we performed a Mediation analysis following the approach of Judea Pearl
[Pearl, 2001, 2012a]. The Mediation framework, developed in the context of causal inference
analysis, enabled us to evaluate the strength of total causal effect of these genomic properties
on ohnolog retention. More importantly, it allowed us to assess the importance of mediators
in transmitting the indirect effect of any property on the outcome of gene duplication via 2R-
WGD.
Mediation analyses have been typically used in social sciences research [Baron and Kenny,
1986] as, for instance, in the context of legal disputes over alleged discriminatory hiring. In
such cases, the problem is to establish that gender or race (X ) have directly influenced hiring
(Y ) and not simply indirectly through differences in qualification or experience (M). Mediation
analyses have also been used in epidemiology, as in a formal study [Robins and Greenland,
1992] that establishes the direct effect of smoking (X ) on the incidence of cardiovascular dis-
eases (Y ), while taking into account the indirect effect of other aggravating factors, such as
hyperlipidemia (M).
91
92 CHAPTER 12. INDIRECT CAUSES OF OHNOLOG RETENTION
In this report, we have applied the Mediation analysis to genomic data (Chapter 8) to dis-
criminate between direct effect (DE) and indirect effect (IE) of deleterious mutations (X or M)
and dosage balance constraints (M or X ) on the biased retention of human ohnologs (Y ).
12.1 The effect of dosage balance is mediated by mutation
susceptibility
First of all, we evaluated the effect of dosage balance constraints and deleterious mutation
susceptibility on the retention of human ohnologs. To this purpose, we performed Mediation
analysis with the three binary variables: dosage balance (‘Dosage.Bal.’), deleterious mutation
susceptibility (‘Delet.Mut.’) and ‘Ohnologs’.
Gene classes susceptible to deleterious mutations include cancer, Mendelian disease, dom-
inant negative and autoinhibitory genes; while protein complexes and haploinsufficient genes
constitute the dosage balanced genes. A detailed analysis of the association tables and four
mediation models involving ohnologs from the relaxed criteria, with all dosage balanced and
disease genes is presented in the following sections (Sections 12.1.1, 12.1.2, 12.1.3 and 12.1.4).
The results of these models, summarized in Figure 12.1 and Table 12.1, demonstrate that the
retention of ohnologs in the human genome is more directly caused by their susceptibility to
deleterious mutations than their interactions within multi-protein complexes.
Indeed, using the largest gene set, the direct causal effect of a change from “non-dosage
balance” to “dosage balance” proteins only accounts for 58.4% of a small total effect (TE) of
dosage balance on the retention of ohnologs (DE/TE = 58.4% with TE = 0.086), whereas 51%
of this small total effect is indirectly mediated by their susceptibility to deleterious mutations
(IE/TE = 50.7% with 9.1% non-linear coupling between direct and indirect effects, Section
12.1.1). By contrast, the alternative hypothesis, assuming a direct effect of deleterious mu-
tations, accounts for 97.1% of a more than twice as large total effect on ohnolog retention
(DE/TE = 97.1% with TE = 0.200), whereas the “dosage balance” versus “non-dosage balance”
status of human genes has a negligible indirect effect on ohnolog retention in this causal rela-
tion hypothesis (IE/TE = 6.1%, Section 12.1.2).
These trends are also further enhanced when the analysis is restricted to the 61% of human
genes (12,437) without SSD and CNV duplicates. In fact, for the human genes without SSD and
CNV, the total effect of dosage balance is even smaller, where most of this effect is indirectly
mediated by deleterious mutation susceptibility (IE/TE = 87.1%, with TE = 0.056). The direct
effect of protein complex membership and haploinsufficiency also becomes lower (DE/TE =
32.3%, Section 12.1.3). By contrast, the trend for the total effect of disease genes on ohnolog
retention is further strengthened with TE = 0.217, and mostly transmitted via the direct route
(DE/TE = 100.7%), with negligible indirect mediation (IE/TE = 3.9%, Section 12.1.4)
In fact, haploinsufficient genes can also be considered as susceptible to deleterious muta-
tions. Hence, to test the robustness of our observations, we then studied the direct effect of
protein complex subunits (removing dominant haploinsufficient genes) and its indirect media-
tion by cancer genes on the retention of ohnologs (Table 12.1A). Consistently, we observed that
the total effect of protein complexes on ohnolog retention is very low (TE = 0.078) and a large
proportion of this effect is again mediated by cancer associated genes (IE/TE = 47.7%). The al-
ternative model to assuming a direct effect of cancer genes on the retention of ohnologs is also
in agreement with the larger dataset, with a very high total and direct effect, and negligible
mediation by protein complexes genes (TE = 0.205,DE/TE = 97.9%, IE/TE = 4.4%, 12.1B). Re-
moving SSD and CNV genes from these models also confirms a very small total effect of protein
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Figure 12.1: Mediation analysis of the indirect effects of deleterious mutations on the retention of
ohnologs in multiprotein complexes. Dashed lines represent a small total effect.
complex membership on ohnolog retention with a highly significant mediation by cancer genes
(TE = 0.049,DE/TE = 32.3%, IE/TE = 91.1%, 12.1C), and a strong direct effect of cancer genes
without SSD/CNV on ohnolog retention (TE = 0.227,DE/TE = 99.5%, IE/TE = 1.7%, 12.1D).
We then studied the mediation model involving all protein complexes amd genes suscepti-
ble to dominant deleterious mutations (Dom.Mut.). Dom.Mut. included oncogenes, dominant
disease genes, dominant negative genes and genes with autoinhibitory folds. We consistently
observed a weak total effect of protein complexes on the ohnolog retention and a significant
mediation of the total effect by Dom.Mut. genes, whether the SSD/CNV genes are included
(12.1E), or not (12.1G). As expected, Dom.Mut. had a very strong direct effect for both gene
sets without any mediation of the total effect by protien complexes (12.1F & H).
We observed exactly the same trends with other models restricting ourselves to cancer
genes from core dataset and genes susceptible to dominant mutations with oncogenes from core
dataset (coreD.Mut.) as displayed in (Table 12.1 M – P). In fact, the highest total effect with the
least mediation on ohnolog retention could be observed for coreD.Mut. (TE = 0.262,DE/TE =
100.8%, IE/TE = 1.9%, 12.1P) for all genes excluding SSD/CNV, which is 5 times larger than
the total effect of protein complex genes on ohnolog retention for the alternative mediation
model (12.1O).
All in all, these observations strongly suggest that dosage balance has a small overall effect
on the retention of genes from 2R-WGD. More importantly, a large fraction of this small total
effect is in fact indirectly mediated by deleterious mutation susceptibility.
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Table 12.1: Summary of mediation analysis for dosage balance & deleterious mutation susceptibility
Mediation diagram Gene sets: Total effect Direct effect Indirect effect Non-linear coupling
↗ M ↘ all genes versus X =⇒ Y X −→ Y X → M → Y (% of TE)
X −→ Y w/o SSD & CNV TE DE/TE IE/TE DE+ IE−TE
12.1.1 ↗ Delet.Mut. ↘ all human genes 0.086 58.4% 50.7% 9.1%
Dosage.Bal. −→ Ohno (20,415)
12.1.2 ↗ Dosage.Bal ↘ all human genes 0.200 97.1% 6.1% 3.2%
Delet.Mut. −→ Ohno (20,415)
12.1.3 ↗ Delet.Mut. ↘ all genes w/o SSD 0.056 32.3% 87.1% 19.4%
Dosage.Bal. −→ Ohno & CNV (12,437)
12.1.4 ↗ Dosage.Bal. ↘ all genes w/o SSD 0.217 100.7% 3.9% 4.6%
Delet.Mut. −→ Ohno & CNV (12,437)
A ↗ Cancer ↘ all human genes 0.078 59.3% 47.7% 7.0%
Complex −→ Ohno (20,415)
B ↗ Complex ↘ all human genes 0.205 97.9% 4.4% 2.3%
Cancer −→ Ohno (20,415)
C ↗ Cancer ↘ all genes w/o SSD 0.049 32.3% 91.1% 23.4%
Complex −→ Ohno & CNV (12,437)
D ↗ Complex ↘ all genes w/o SSD 0.227 101.6% 3.0% 4.6%
Cancer −→ Ohno & CNV (12,437)
E ↗ Dom.Mut. ↘ all human genes 0.078 73.7% 25.3% 1.0%
Complex −→ Ohno (20,415)
F ↗ Complex ↘ all human genes 0.202 96.9% 2.7% 0.4%
Dom.Mut. −→ Ohno (20,415)
G ↗ Dom.Mut. ↘ all genes w/o SSD 0.049 53.8% 51.6% 5.4%
Complex. −→ Ohno & CNV (12,437)
H ↗ Complex ↘ all genes w/o SSD 0.222 99.5% 1.7% 1.1%
Dom.Mut. −→ Ohno & CNV (12,437)
I ↗ coreCancer ↘ all human genes 0.078 77.9% 28.3% 6.2%
Complex −→ Ohno (20,415)
J ↗ Complex ↘ all human genes 0.263 99.7% 3.7% 3.4%
coreCancer −→ Ohno (20,415)
K ↗ coreCancer ↘ all genes w/o SSD 0.049 64.5% 48.0% 12.5%
Complex. −→ Ohno & CNV (12,437)
L ↗ Complex ↘ all genes w/o SSD 0.261 101.8% 2.2% 3.9%
coreCancer −→ Ohno & CNV (12,437)
M ↗ coreD.Mut. ↘ all human genes 0.078 65.0% 39.5% 4.4%
Complex −→ Ohno (20,415)
N ↗ Complex ↘ all human genes 0.278 98.5% 3.6% 2.0%
coreD.Mut. −→ Ohno (20,415)
O ↗ coreD.Mut. ↘ all genes w/o SSD 0.049 45.4% 63.7% 9.1%
Complex. −→ Ohno & CNV (12,437)
P ↗ Complex ↘ all genes w/o SSD 0.262 100.8% 1.9% 2.6%
coreD.Mut. −→ Ohno & CNV (12,437)
Dosage.Bal., Dosage Balance; Delet.Mut., Deleterious Mutations; Ohno, Ohnologs from relaxed criterion; Complex,
Protein Complexes; Cancer, All cancer genes; Dom.Mut., Dominant Deleterious Mutations; coreCancer, Cancer genes from
core dataset; coreD.Mut., Dominant Mutations with Core Cancer Genes.
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12.1.1 Mediation of ‘Dosage.Bal.’ =⇒ ‘Ohnolog’ by ‘Delet.Mut.’
genes
We analyze below, the association table between the three binary categories: ‘Dosage.Bal.’, ‘Delet.Mut.’
and ‘Ohnolog’ genes to study the total & direct effect of dosage balance constraints on ohnolog retention,
and its mediation by deleterious mutation susceptibility.
Dosage.Bal. Delet.Mut. Ohnolog nxzy fx gxz hx
0 0 0 5694
0 0 1 1781 23.8% Ohnolog
0 1 0 3726 33.4% Ohnolog 47.1% Delet.Mut.
0 1 1 2935 44.1% Ohnolog
1 0 0 1368
1 0 1 601 30.5% Ohnolog
1 1 0 2276 42.0% Ohnolog 68.6% Delet.Mut.
1 1 1 2034 47.2% Ohnolog
6279 10971 7351 20415 36.0% Ohnolog 53.7% Delet.Mut.
Hence, we find,
• A significant global effect of Dosage.Bal. on Ohnolog retention: 42.0% vs 36.0% (p = 8.012×10−23,
χ2 test).
• A strong effect of Dosage.Bal. on Delet.Mut. genes: 68.6% vs 53.7% (p = 5.468×10−124, χ2 test).
• A significant effect of Delet.Mut. on Ohnolog retention for Dosage.Bal. genes: 47.2% vs 42.0%
(P = 3.553×10−12, χ2 test).
• A strong effect of Delet.Mut. on Ohnolog retention for non-Dosage.Bal. genes: 44.1% vs 33.4%
(P = 1.358×10−76, χ2 test).
The Mediation analysis Pearl [2001, 2012a,b] then yields a small total effect, TE= 0.0860, with
DE=0.0502, IE=0.0436, and the relative direct and indirect effects below,
↗ Delet.Mut. ↘ direct effect indirect effect non-linear combination of
Dosage.Bal. −→ Ohnolog Dosage.Bal. −→ Ohnolog Dosage.Bal. → Delet.Mut. → Ohnolog direct and indirect effects
sufficient
DE/TE =58.3% IE/TE =50.6%
8.9%
(as sole cause)
necessary
1−IE/TE=49.4% 1−DE/TE=41.7%
(as complementary cause)
which implies that,
• Only 49.4% of the global effect on Ohnolog retention is owed to the direct link: Dosage.Bal. → Ohnolog
(i.e. global expected effect if the mediation by Delet.Mut. were ‘deactivated’).
• 41.7% of the global effect on Ohnolog retention is owed to the indirect mediation by Delet.Mut.
(i.e. global expected effect if the direct link were ‘deactivated’).
hence,
• Mediation by Delet.Mut. is sufficient (as sole cause) to account for 50.6% of the
Dosage.Bal. =⇒ Ohnolog link.
• Mediation by Delet.Mut. is necessary (as complementary cause) to account for 41.7% of the
Dosage.Bal. =⇒ Ohnolog link.
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12.1.2 Mediation of ‘Delet.Mut.’ =⇒ ‘Ohnolog’ by ‘Dosage.Bal.’
genes
We analyze below, the association table between the three binary categories, categories: ‘Delet.Mut.’,
‘Dosage.Bal.’ and ‘Ohnolog’ genes to study the total & direct effect of deleterious mutation susceptibility
on the ohnolog retention.
Delet.Mut. Dosage.Bal. Ohnolog nxzy fx gxz hx
0 0 0 5694
0 0 1 1781 23.8% Ohnolog
0 1 0 1368 25.2% Ohno 20.8% Dosage.Bal.
0 1 1 601 30.5% Ohnolog
1 0 0 3726
1 0 1 2935 44.1% Ohnolog
1 1 0 2276 45.3% Ohnolog 39.3% Dosage.Bal.
1 1 1 2034 47.2% Ohnolog
10971 6279 7351 20415 36.0% Ohnolog 30.8% Dosage.Bal.
Hence, we find,
• A strong global effect of Delet.Mut. on Ohnolog retention: 45.3% vs 36.0% (p = 2.981×10−91, χ2
test).
• A strong effect of Delet.Mut. on Dosage.Bal. genes: 39.3% vs 30.8% (p = 1.774×10−83, χ2 test).
• A non-significant effect of Dosage.Bal. on Ohnolog retention for Delet.Mut. genes: 47.2% vs 45.3%
(0.012, χ2 test).
• A weak effect of Dosage.Bal. on Ohnolog retention for non-Delet.Mut. genes: 30.5% vs 25.2%
(p = 6.093×10−9, χ2 test).
The Mediation analysis Pearl [2001, 2012a,b] then yields a strong total and direct effect, TE=0.2007,
DE=0.1949, IE=0.0123 and the weak indirect effect.
↗ Dosage.Bal. ↘ direct effect indirect effect non-linear combination of
Delet.Mut. −→ Ohnolog Delet.Mut. −→ Ohnolog Delet.Mut. → Dosage.Bal. → Ohnolog direct and indirect effects
sufficient
DE/TE =97.1% IE/TE =6.2%
3.3%
(as sole cause)
necessary
1−IE/TE=93.8% 1−DE/TE=2.9%
(as complementary cause)
which implies that,
• 93.8% of the global effect on Ohnolog retention is owed to the direct link: Delet.Mut. → Ohnolog
(i.e. global expected effect if the mediation by Dosage.Bal. were ‘deactivated’).
• Only 2.9% of the global effect on Ohnolog retention is owed to the indirect mediation by Dosage.Bal.
(i.e. global expected effect if the direct link were ‘deactivated’),
hence,
• Mediation by Dosage.Bal. is sufficient (as sole cause) to account for only 6.2% of the
Delet.Mut. =⇒ Ohnolog link.
• Mediation by Dosage.Bal. is necessary (as complementary cause) to account for only 2.9% of the
Delet.Mut. =⇒ Ohnolog link.
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12.1.3 Mediation of ‘Dosage.Bal.’ =⇒ ‘Ohnolog’ by ‘Delet.Mut.’
genes after excluding SSD and CNV genes
We analyze below, the association table between the three binary categories, categories: ‘Dosage.Bal.’,
‘Delet.Mut.’ and ‘Ohnolog’ genes to study the total & direct effect of dosage balance constraints on
ohnolog retention, and its mediation by deleterious mutation susceptibility, restricted to 12,437 protein
coding genes after excluding both recent SSD and CNV genes.
Dosage.Bal. Delet.Mut. Ohnolog nxzy fx gxz hx
0 0 0 2945
0 0 1 1128 27.7% Ohnolog
0 1 0 1986 39.3% Ohnolog 49.9% Delet.Mut.
0 1 1 2067 51.0% Ohnolog
1 0 0 848
1 0 1 401 32.1% Ohnolog
1 1 0 1524 45.0% Ohnolog 71.0% Delet.Mut.
1 1 1 1538 50.2% Ohnolog
4311 7115 5134 12437 41.3% Ohnolog 57.2% Delet.Mut.
Hence, we find after excluding ‘SSD+CNV’ genes,
• A weak global effect of Dosage.Bal. on Ohnolog retention: 45.0% vs 41.3% (p = 8.158×10−07, χ2
test).
• A strong effect of Dosage.Bal. on Delet.Mut. genes: 71.0% vs 57.2% (p = 4.075×10−75, χ2 test).
• A not-so strong effect of Delet.Mut. on Ohnolog retention for Dosage.Bal. genes: 50.2% vs 45.0%
(p = 5.205×10−9, χ2 test).
• A strong effect of Delet.Mut. on Ohnolog retention for non-Dosage.Bal. genes: 51.0% vs 39.3%
(p = 2.432×10−52, χ2 test).
The Mediation analysis Pearl [2001, 2012a,b] then yields a very weak total effect, TE=0.0566, with
DE=0.0183, IE=0.0493 and the relative direct and indirect effects,
↗ Delet.Mut. ↘ direct effect indirect effect non-linear combination of
Dosage.Bal. −→ Ohnolog Dosage.Bal. −→ Ohnolog Dosage.Bal. → Delet.Mut. → Ohnolog direct and indirect effects
sufficient
DE/TE =32.3% IE/TE =87.1%
19.4%
(as sole cause)
necessary
1−IE/TE=12.9% 1−DE/TE=67.7%
(as complementary cause)
which implies that,
• Only 12.9% of the global effect on Ohnolog retention is owed to the direct link: Dosage.Bal. → Ohnolog
(i.e. global expected effect if the mediation by Delet.Mut. were ‘deactivated’).
• 67.7% of the global effect on Ohnolog retention is owed to the indirect mediation by Delet.Mut.
(i.e. global expected effect if the direct link were ‘deactivated’).
hence,
• Mediation by Delet.Mut. is sufficient (as sole cause) to account for 87.1% of the Dosage.Bal. =⇒ Ohnolog
link.
• Mediation by Delet.Mut. is necessary (as complementary cause) to account for 67.7% of the
Dosage.Bal. =⇒ Ohnolog link.
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12.1.4 Mediation of ‘Delet.Mut.’ =⇒ ‘Ohnolog’ by ‘Dosage.Bal.’
genes after excluding SSD and CNV genes
We analyze below, the association table between the three binary categories, categories: ‘Delet.Mut.’,
‘Dosage.Bal.’ and ‘Ohnolog’ genes to study the total & direct effect of deleterious mutation susceptibility
on the ohnolog retention from 12,437 genes after excluding recent SSDs or CNV genes.
Delet.Mut. Dosage.Bal. Ohnolog nxzy fx gxz hx
0 0 0 2945
0 0 1 1128 27.7% Ohnolog
0 1 0 848 28.7% Ohnolog 23.5% Dosage.Bal.
0 1 1 401 32.1% Ohnolog
1 0 0 1986
1 0 1 2067 51.0% Ohnolog
1 1 0 1524 50.7% Ohnolog 43.0% Dosage.Bal.
1 1 1 1538 50.2% Ohnolog
7115 4311 5134 12437 41.3% Ohnolog 34.7% Dosage.Bal.
Hence, we find after excluding ‘SSD+CNV’ genes,
• A strong global effect of Delet.Mut. on Ohnolog retention: 50.7% vs 41.3% (p = 3.337×10−58, χ2
test).
• A strong effect of Delet.Mut. on Dosage.Bal. genes: 43.0% vs 34.7% (p = 7.952×10−50, χ2 test).
• An insignificant effect of Dosage.Bal. on Ohnolog retention for Delet.Mut. genes: 50.2% vs 50.7%
(0.62, χ2 test).
• A very weak effect of Dosage.Bal. on Ohnolog retention for non-Delet.Mut. genes: 32.1% vs 28.7%
(p = 0.008, χ2 test).
The Mediation analysis Pearl [2001, 2012a,b] then yields a very strong total effect, TE=0.2194, with
DE=0.2209, IE=0.0086 and the relative direct and indirect effects,
↗ Dosage.Bal. ↘ direct effect indirect effect non-linear combination of
Delet.Mut. −→ Ohnolog Delet.Mut. −→ Ohnolog Delet.Mut. → Dosage.Bal. → Ohnolog direct and indirect effects
sufficient
DE/TE =100.7% IE/TE =3.9%
4.6%
(as sole cause)
necessary
1−IE/TE=96.1% 1−DE/TE=-0.7%
(as complementary cause)
which implies that,
• 96.1% of the global effect on Ohnolog retention is owed to the direct link: Delet.Mut. → Ohnolog
(i.e. global expected effect if the mediation by Dosage.Bal. were ‘deactivated’).
• -0.7% of the global effect on Ohnolog retention is owed to the indirect mediation by Dosage.Bal.
(i.e. global expected effect if the direct link were ‘deactivated’),
hence,
• Mediation by Dosage.Bal. is sufficient (as sole cause) to account for only 3.9% of the
Delet.Mut. =⇒ Ohnolog link.
• Mediation by Dosage.Bal. is necessary (as complementary cause) to account for only -0.7% of the
Delet.Mut. =⇒ Ohnolog link.
12.2. MEDIATION ANALYSIS WITH ESSENTIALITY 99
12.2 Small effect of essentiality on ohnolog retention
Table 12.2: Summary of mediation analysis for essentiality & deleterious mutation susceptibility
Mediation diagram Gene sets: Total effect Direct effect Indirect effect Non-linear coupling
↗ M ↘ all genes versus X =⇒ Y X −→ Y X → M → Y (% of TE)
X −→ Y w/o SSD & CNV TE DE/TE IE/TE DE+ IE−TE
A ↗ Delet.Mut. ↘ all genes tested 0.051 70.4% 37.8% 8.2%
mouseEss. −→ Ohno for Ess. (6,436)
B ↗ mouseEss. ↘ all genes tested 0.139 96.5% 7.5% 4.0%
Delet.Mut. −→ Ohno for Ess. (6,436)
C ↗ Delet.Mut. ↘ all genes tested w/o 0.036 61.0% 63.0% 24.0%
mouseEss. −→ Ohno SSD/CNV (4,633)
D ↗ mouseEss. ↘ all genes tested w/o 0.145 99.5% 9.0% 8.5%
Delet.Mut. −→ Ohno SSD/CNV (4,633)
E ↗ Delet.Mut. ↘ all genes tested 0.117 49.6% 45.4% 5.0%
humanEss. −→ Ohno for Ess. (18,938)
F ↗ humanEss. ↘ all genes tested 0.179 94.1% 4.3% 1.6%
Delet.Mut. −→ Ohno for Ess. (18,938)
G ↗ Delet.Mut. ↘ all genes tested w/o 0.096 46.4% 55.4% 1.8%
humanEss. −→ Ohno SSD/CNV (11,549)
H ↗ humanEss. ↘ all genes tested w/o 0.187 96.1% 4.5% 0.5%
Delet.Mut. −→ Ohno SSD/CNV (11,549)
Delet.Mut., Deleterious Mutations; Ohno, Ohnologs from relaxed criterion; mouseEss., human orthologs of mouse essential
genes; humanEss., human cell line essential genes; Ess., Essentiality.
The relationship between duplicability and essentiality has remained enigmatic. It has
been argued that duplicates confer robustness against null mutations in yeast [Gu et al., 2003]
and therefore essential genes are enriched in gene duplicates as compared to genes without any
detectable paralog i.e. singletons. However, other studies argued that there is no significant
association between gene duplicability and essentiality for yeast [He and Zhang, 2006] and
mammals [Liang and Li, 2007; Liao and Zhang, 2007]. No distinction between ohnologs and
SSD was made in these studies.
Lin et al. [Lin et al., 2007] divided yeast genes into WGD and Non-WGD duplicates and
found that, except for ribosomal proteins, most ohnologs in their dataset were dispensable or
non-essential. Similar observations have been made by [Hakes et al., 2007; Guan et al., 2007].
In mouse however, Makino et al. observed that essential genes are only enriched in ohnologs
but not SSDs [Makino et al., 2009] and attributed this differential retention to dosage balance
constraints.
We observed, in agreement with [Makino et al., 2009], that essential genes are slightly
enriched in ohnologs. However if genes susceptible to deleterious mutations are removed from
essential genes, this enrichment vanishes (Section 10.5.2), leading us to suspect that the effect
of essentiality could also be indirectly mediated by mutation susceptibility. To test this, we
performed Mediation analysis to study the total, direct and indirect effects of essentiality on
ohnolog retention. Essential genes were obtained from two different sources: human orthologs
of mouse genes tested for essentiality, and essential genes in human mammary cell lines, as
described in Section 7.6.
As depicted in Table 12.2, restricting to the genes tested for essentiality, for both the
datasets, we observe that the total effect of essentiality on ohnolog retention is very low. In
addition, there is a significant mediation of this total effect by deleterious mutation suscepti-
bility. The statistics becomes stronger if genes duplicated by recent SSD or CNV are removed.
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On the other hand, assuming that deleterious mutations play a prominent role in ohnolog
retention, we find, in agreement to our expectations that most of the effect of Delet.Mut. is
through direct path with three to four time as much total effect.
These trends confirm again that deleterious mutation susceptibility, and not essentiality is
the primary cause of ohnolog retention in the human genome.
12.3 Negative causal effect of high expression on ohnolog
retention
Table 12.3: Summary of mediation analysis for expression level & deleterious mutation susceptibility
Mediation diagram Gene sets: Total effect Direct effect Indirect effect Non-linear coupling
↗ M ↘ all genes versus X =⇒ Y X −→ Y X → M → Y (% of TE)
X −→ Y w/o SSD & CNV TE DE/TE IE/TE DE+ IE−TE
A ↗ Delet.Mut. ↘ genes with Expr. −0.0004 1175.0% -1075.0% 0%
Expr.50p −→ Ohno value (13,425)
B ↗ Expr.50p ↘ genes with Expr. 0.164 100.1% -0.1% 0.1%
Delet.Mut. −→ Ohno value (13,425)
C ↗ Delet.Mut. ↘ genes with Expr. w/o −0.0276 113.4% -14.5% 1.1%
Expr.50p −→ Ohno SSD & CNV (8,651)
D ↗ Expr.50p ↘ genes with Expr. w/o 0.172 100.5% -0.3% 0.1%
Delet.Mut. −→ Ohno SSD & CNV (8,651)
E ↗ Delet.Mut. ↘ genes with Expr. −0.021 85.1% 14.9% 0%
Expr.75p −→ Ohno value (13,425)
F ↗ Expr.75p ↘ genes with Expr. 0.164 99.9% 0.1% 0%
Delet.Mut. −→ Ohno (20,415)
G ↗ Delet.Mut. ↘ genes with Expr. w/o −0.052 92.1% 9.4% 1.5%
Expr.75p −→ Ohno SSD & CNV (8,651)
H ↗ Expr.75p ↘ genes with Expr. w/o 0.172 99.2% 0.3% 0.5%
Delet.Mut. −→ Ohno SSD & CNV (8,651)
I ↗ Delet.Mut. ↘ genes with Expr. −0.056 88.2% 11.6% 0.2%
Expr.90p −→ Ohno value (13,425)
J ↗ Expr.90p ↘ genes with Expr. 0.164 99.6% 0.5% 0.1%
Delet.Mut. −→ Ohno value (13,425)
K ↗ Delet.Mut. ↘ genes with Expr. w/o 0.081 86.0% 14.3% 0.4%
Expr.90p −→ Ohno SSD & CNV (8,651)
L ↗ Expr.90p ↘ genes with Expr. w/o 0.172 98.8% 1.0% 0.1%
Delet.Mut. −→ Ohno SSD & CNV (8,651)
Delet.Mut., Deleterious Mutations; Ohno, Ohnologs from relaxed criterion; Expr., Expression level; Expr.50p; Median
expression; Expr.75p; Expression 75th percentile; Expr.90p; Expression 90th percentile
Another functional genomic property known to be associated with ohnolog retention is the
total mRNA levels in cells [Seoighe and Wolfe, 1999; Gout et al., 2009, 2010]. However as
described in Section 11.2, we could not observe any significant association between higher ex-
pression level and human ohnologs. To confirm the observations from simple statistical associ-
ation, we also performed Mediation analysis with gene expression level, deleterious mutations
and ohnolog retention. We binarize the expression levels at three different percentile points:
median, 75th and 90th percentile. Genes having expression levels above these three cutoffs
were considered to be highly expressed, or else lowly expressed.
As depicted in Table 12.3, genes having expression levels above the median have a vanish-
ingly small negative effect on ohnolog retention (TE =−0.0004, 12.3A). Yet, Delet.Mut. have a
very large total effect, all of which is through direct path (TE = 0.164,DE/TE = 100.1%, IE/TE =
−0.1%, 12.3B). The negative effect of expression level on ohnolog retention becomes even
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greater for 8,651 genes with expression level without SSD and CNV genes from our dataset
(12.3C).
The alternative model assuming that Delet.Mut. is the direct cause of ohnolog reten-
tion consistently shows greater total and direct effects after removing SSD/CNV genes (TE =
0.172,DE/TE = 100.5%, IE/TE =−0.3%, 12.3D). The negative total and direct effects of expres-
sion level persist and become even stronger for genes having top 25% or top 10% expression
levels (12.3 E-G).
These observation confirm that expression level does not play an important role in the
retention of human ohnologs. In fact, high expression levels even have very small negative
total and direct effect on ohnolog retention, confirming the observed depletion of very highly
expressed genes in ohnologs.
12.4 Sequence conservation & ohnolog retention
Ohnologs tend to be highly conserved with low non-synonymous (Ka) to synonymous (Ks) mu-
tation ratios (Ka/Ks) [Brunet et al., 2006; Sémon and Wolfe, 2008]. It has also been suggested
that conserved protein are preferentially retained after duplication in the eukaryotic genomes
[Davis and Petrov, 2004]. In addition, evolutionary rate has been found to be correlated with
ohnolog retention [Jiang et al., 2013]. We also observed that human ohnologs tend to be highly
conserved with significantly lower Ka/Ks ratios than non-ohnologs (Section 10.4, [Singh et al.,
2012]). We asked whether, using mediation analysis, we can disentangle direct from indirect
effects of conservation and deleterious mutations on ohnolog retention, i.e. if the low conser-
vation is the prominent cause of the retention of genes after WGD or if it is their mutation
susceptibility. In the latter case, the observed high conservation would be just a by-product of
the high mutation susceptibility of ohnolog genes.
12.4.1 Mediation with low Ka/Ks values
First we performed mediation among three binary categories: Ka/Ks values from human-
amphioxus orthologs (15,508 genes with Ka/Ks values), Delet.Mut. and ohnolog retention.
Ka/Ks ratios were binarized using three different levels, at median, 25th and 10th percentiles.
For each case genes having less Ka/Ks ratios than the three cutoffs were taken to be highly
conserved and the rest were considered as not highly conserved.
The results depicted in Table 12.4 show that Ka/Ks ratios do not strongly influence or me-
diate the effect of deleterious mutations. Using median as a cutoff with 12,607 gene as highly
conserved, we observe a positive total and strong direct effect of Ka/Ks on ohnolog retention
(TE = 0.097, DE/TE = 89.4%, IE/TE = 8%, 12.4A). This total effect is further reduced after re-
moving SSD/CNV genes from the dataset (TE = 0.073, DE/TE = 87%, IE/TE = 11.2%, 12.4C).
The total effect of the alternative Mediation model using Delet.Mut. as primary direct cause
is found to be greater than that of Ka/Ks ratios, using all the three cutoffs (TE = 0.139 for all
genes, and TE = 0.147 for genes without SSD/CNV). Furthermore, almost all of this total effect
is exerted directly on ohnolog retention, without any mediation by sequence conservation.
These trends become even stronger for very highly conserved sequences having Ka/Ks ratios
lower than 25th or 10th percentile ranks. Ka/Ks ratios lower than 25th percentile have even
lower total effects, 0.054 and 0.030 with and without SSD/CNV respectively (12.4E & G). While
the total effect of Delet.Mut. is consistent (12.4F & H). Similarly for 6,460 genes with lowest
Ka/Ks, there is a ten times lower total effect of Ka/Ks than that of Delet.Mut. on ohnolog
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retention. Furthermore, all the effect of Delet.Mut. on ohnolog retention is direct with no
mediation at all (12.4 I–L).
Table 12.4: Summary of mediation analysis for low Ka/Ks ratios from Amphioxus & deleterious muta-
tion susceptibility
Mediation diagram Gene sets: Total effect Direct effect Indirect effect Non-linear coupling
↗ M ↘ all genes versus X =⇒ Y X −→ Y X → M → Y (% of TE)
X −→ Y w/o SSD & CNV TE DE/TE IE/TE DE+ IE−TE
A ↗ Delet.Mut. ↘ genes with Ka/Ks 0.097 89.4% 8.0% 2.6%
Ka/Ks50p −→ Ohno value (15,508)
B ↗ Ka/K.s50p ↘ genes with Ka/Ks 0.139 94.8% 3.4% 1.8%
Delet.Mut. −→ Ohno value (15,508)
C ↗ Delet.Mut. ↘ genes with Ka/Ks w/o 0.073 87.0% 11.2% 1.8%
Ka/Ks.50p −→ Ohno SSD & CNV (9,850)
D ↗ Ka/Ks.50p ↘ genes with Ka/Ks w/o 0.147 96.7% 2.3% 1.0%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
E ↗ Delet.Mut. ↘ genes with Ka/Ks 0.054 76.3% 20.6% 3.2%
Ka/Ks.25p −→ Ohno value (15,508)
F ↗ Ka/Ks.25p ↘ genes with Ka/Ks 0.139 97.7% 1.4% 0.9%
Delet.Mut. −→ Ohno value (15,508)
G ↗ Delet.Mut. ↘ genes with Ka/Ks w/o 0.030 64.1% 36.5% 0.7%
Ka/Ks.25p −→ Ohno SSD & CNV (9,850)
H ↗ Ka/Ks.25p ↘ genes with Ka/Ks w/o 0.147 99.2% 1.0% 0.1%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
I ↗ Delet.Mut. ↘ genes with Ka/Ks 0.010 24.3% 71.8% 3.9%
Ka/Ks.10p −→ Ohno value (15,508)
J ↗ Ka/Ks.10p ↘ genes with Ka/Ks 0.139 99.9% 0% 0.1%
Delet.Mut. −→ Ohno value (15,508)
K ↗ Delet.Mut. ↘ genes with Ka/Ks w/o 0.004 –76.2% 209.5% 33.3%
Ka/Ks.10p −→ Ohno SSD & CNV (9,850)
L ↗ Ka/Ks.10p ↘ genes with Ka/Ks w/o 0.147 100.2% 0.2% 0.4%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
Delet.Mut., Deleterious Mutations; Ohno, Ohnologs from relaxed criterion; Ka/Ks.50p, Ka/Ks lower than median; Ka/Ks.25p,
Ka/Ks lower than 25th percentile; Ka/Ks.10p, Ka/Ks lower than 10th percentile
12.4.2 Mediation with high Ka/Ks values
We then analyzed the complementary datasets, to see the effect of high instead of low Ka/Ks
values (Table 12.5). As for expression levels, we binarized Ka/Ks at median, 75th and 90th
percentile ranks, and investigated whether the genes having high Ka/Ks could be the primary
direct cause of ohnolog retention. As expected, for the genes having Ka/Ks higher than median
(Complement of Table 12.4 A–D), we observed that there is an equal but negative total effect
of high Ka/Ks on ohnolog retention, while the total effect of Delet.Mut. remains unchanged
(Table 12.5 A–D).
For higher Ka/Ks values while the total and direct effect of Delet.Mut. on ohnolog retention
is very strong (Table 12.5 F, H J & L), we observe interestingly, a very high negative total
effect of Ka/Ks. For example, genes with Ka/Ks greater than 75th percentile have a very strong
negative effect on ohnolog retention, TE = −0.181 with all genes and TE = −0.132 without
SSD/CNV. Majority of this effect is direct. Furthermore, genes which have tolerated a very high
non-synonymous mutations, with highest Ka/Ks values (i.e. positive selection) an even stronger
total negative effect, –0.204 and –0.152 with all genes or excluding SSD/CNV, respectively (12.5
I–K).
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Table 12.5: Summary of mediation analysis for high Ka/Ks ratios from Amphioxus & deleterious mu-
tation susceptibility
Mediation diagram Gene sets: Total effect Direct effect Indirect effect Non-linear coupling
↗ M ↘ all genes versus X =⇒ Y X −→ Y X → M → Y (% of TE)
X −→ Y w/o SSD & CNV TE DE/TE IE/TE DE+ IE−TE
A ↗ Delet.Mut. ↘ genes with Ka/Ks – 0.097 92.0% 10.5% 2.5%
Ka/Ks50p −→ Ohno value (15,508)
B ↗ Ka/K.s50p ↘ genes with Ka/Ks 0.139 94.8% 3.4% 1.8%
Delet.Mut. −→ Ohno value (15,508)
C ↗ Delet.Mut. ↘ genes with Ka/Ks w/o –0.073 88.8% 13.2% 1.9%
Ka/Ks.50p −→ Ohno SSD & CNV (9,850)
D ↗ Ka/Ks.50p ↘ genes with Ka/Ks w/o 0.147 96.7% 2.3% 1.0%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
E ↗ Delet.Mut. ↘ genes with Ka/Ks – 0.181 97.0% 6.3% 3.2%
Ka/Ks.75p −→ Ohno value (15,508)
F ↗ Ka/Ks.75p ↘ genes with Ka/Ks 0.139 91.2% 5.5% 3.2%
Delet.Mut. −→ Ohno value (15,508)
G ↗ Delet.Mut. ↘ genes with Ka/Ks w/o – 0.132 94.8% 8.9% 3.6%
Ka/Ks.75p −→ Ohno SSD & CNV (9,850)
H ↗ Ka/Ks.75p ↘ genes with Ka/Ks w/o 0.147 94.5% 3.1% 2.4%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
I ↗ Delet.Mut. ↘ genes with Ka/Ks – 0.204 97.7% 4.7% 2.4%
Ka/Ks.90p −→ Ohno value (15,508)
J ↗ Ka/Ks.90p ↘ genes with Ka/Ks 0.139 95.8% 2.9% 1.3%
Delet.Mut. −→ Ohno value (15,508)
K ↗ Delet.Mut. ↘ genes with Ka/Ks w/o – 0.152 92.7% 9.3% 2.0%
Ka/Ks.90p −→ Ohno SSD & CNV (9,850)
L ↗ Ka/Ks.90p ↘ genes with Ka/Ks w/o 0.147 96.8% 2.5% 0.7%
Delet.Mut. −→ Ohno SSD & CNV (9,850)
Delet.Mut., Deleterious Mutations; Ohno, Ohnologs from relaxed criterion; Ka/Ks.50p, Ka/Ks lower than median; Ka/Ks.25p,
Ka/Ks lower than 25th percentile; Ka/Ks.10p, Ka/Ks lower than 10th percentile
This suggests that although conserved sequences have a weaker relation with ohnolog re-
tention, rapidly evolving sequences have retained less ohnologs. Sequence that have tolerated
many mutations even oppose the retention of ohnologs. Although higher Ka/Ks ratio is not a
perfect measure of positive selection, these observation hints towards a lack of positive selec-
tion in ohnologs, likely owing to population bottleneck in post WGD populations (See Discus-
sion).
All in all, the results from mediation analysis strongly suggest that — (1) Deleterious muta-
tion susceptibility has the strongest causal effect on ohnolog retention. (2) All the other studied
genomic attributes have relatively weaker causal effects on ohnolog retention. (3) Almost all
of the effect of deleterious mutation susceptibility is through a direct path, with negligible me-
diation from other properties. (4) The effect of other genomic attributes is mostly mediated by
the deleterious mutation susceptibility.
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13
Population Genetic Model for the Retention
of “Dangerous” Ohnologs
AS demonstrated in previous chapters, human genes with a documented sensitivity to dom-inant deleterious mutations have retained statistically more ohnologs from the two WGD
events at the onset of jawed vertebrates. This suggests that ohnologs have been retained in the
vertebrate genomes, not because they initially brought selective advantages following WGD,
but because their mutations were more likely detrimental or lethal than nonfunctional, thereby
preventing their rapid elimination from the genomes of surviving individuals following WGD
transitions, as outlined in the evolutionary model depicted in Figure 13.1. For completeness
and clarity, Figure 13.1 examines all possible evolutionary scenarios following either a SSD or
a WGD duplication event in the genome of one or a few individuals in an initial population.
The first and critical difference between SSD and WGD duplication events occurs at the
population genetics level with an obligate speciation following WGD event, owing to the dif-
ference in ploidy between pre- and post-WGD individuals. As a result, all individuals in the
post-WGD population carry twice as many genes as their pre-WGD relatives, whereas only a
few individuals in the post-SSD population carry a single small duplicated region. Figure 13.1
then outlines the three mutation/selection scenarios focusing on a single gene duplicate in the
genomes of post-SSD or post-WGD populations:
(A) Beneficial mutations after SSD or WGD are expected to spread and become eventually
fixed in the new populations, although the bottleneck in population size following WGD
limits in practice the efficacy of adaptation in post-WGD species.
(B) Neutral or nearly neutral mutations mainly lead to the random nonfunctionalization of one
copy of most redundant gene duplicates and, therefore, to their elimination following both
SSD and WGD events. In post- WGD populations, this results in the “reciprocal gene loss”
of most gene duplicates, which is also known to lead to further speciations in post-WGD
species, owing to the interbreeding incompatibility between post-WGD individuals with
different “reciprocal gene loss” pattern [Lynch and Force, 2000b]. Alternatively, neutral
or nearly neutral mutations can also result in the eventual retention of both duplicate
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onset of jawed vertebrates. This suggests that ohnologs have
been retained in vertebrate genomes, not because they initially
brought selective advantages following WGD, but because their
mutations were more likely detrimental or lethal than nonfunc-
tional, thereby preventing their rapid elimination from the
genomes of surviving individuals following WGD transitions, as
outlined in the evolutionary model depicted in Figure 4.
For completeness and clarity, Figure 4 examines all possible
evolutionary scenarios following either a SSD or a WGD duplica-
tion event in the genome of one or a few individuals in an initial
population. The first and critical difference between SSD and
WGD duplication events occurs at the population genetics level
with an obligate speciation following WGD event, owing to the
difference in ploidy between pre- and post-WGD individuals.
As a result, all individuals in the post-WGDpopulation carry twice
as many genes as their pre-WGD relatives, whereas only a few
individuals in the post-SSD population carry a single small dupli-
cated region. Figure 4 then outlines the three mutation/selection
scenarios focusing on a single gene duplicate in the genomes of
post-SSD or post-WGD populations: (A) Beneficial mutations
after SSD or WGD are expected to spread and become eventu-
ally fixed in the new populations, although the bottleneck in
population size following WGD limits in practice the efficacy of
adaptation in post-WGD species. (B) Neutral or nearly neutral
mutations mainly lead to the random nonfunctionalization of
one copy of most redundant gene duplicates and, therefore, to
their elimination following both SSD and WGD events. In post-
WGD populations, this results in the ‘‘reciprocal gene loss’’ of
most gene duplicates, which is also known to lead to further
speciations in post-WGD species, owing to the interbreeding
incompatibility between post-WGD individuals with different
‘‘reciprocal gene loss’’ pattern (Lynch and Force, 2000a). Alter-
natively, neutral or nearly neutral mutations can also result in
the eventual retention of both duplicate copies through subfunc-
tionalization (Hughes, 1994; Lynch and Force, 2000b), that is, by
rendering each duplicate copy unable to perform all the func-
tions of their ancestral gene (see Discussion). (C) Finally, domi-
nant deleteriousmutations favor the elimination of the individuals
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Figure 4. Evolutionary Trends of Duplicated Genes following SSD or WGD
(A–C) Horizontal lines represent the genome of different individuals. Square blocks symbolize the genes, duplicated (SSD: blue; WGD: red) or not (black). Black
crosses highlight the loss of one gene (small crosses) or the elimination of an individual (larger crosses), whereas bordered square blocks emphasize retained
mutated copies. Evolutionary scenarios are depicted at the population genetics level following either a SSD (left panel) or a WGD (right panel) in one or a few
individuals of an initial population. Unlike SSD, WGD is invariably coupled to a speciation event, owing to the difference in ploidy between pre- and post-WGD
individuals. Three possible scenarios—beneficial (A), neutral or nearly neutral (B), or deleterious mutations (C) in one gene duplicate—are outlined in post-SSD
and post-WGD populations. The main difference concerns the mutation/selection process of ‘‘dangerous’’ genes, i.e. genes prone to autosomal-dominant
deleterious mutations (C). See main text for a detailed description.
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Figure 13.1: Evolutionary trends of duplicated genes following SSD or WGD.
( –C) Horizontal lines represent th genome of different individuals. Squar blocks symbolize the genes,
duplicated (SSD: blue; WGD: red) or not (black). Black crosses highlight the loss of one gene (small
crosses) or the elimination of an individual (larger crosses), whereas bordered square locks emphasize
retained mutated copies. Evolutionary scenarios are depicted at the population genetics level following
either a SSD (left panel) or a WGD (right panel) in one or a few individuals of an initial population. Un-
like SSD, WGD is invariably coupled to a speciation event, owing to the difference in ploidy between pre-
and post-WGD individuals. Three possible scenarios—beneficial (A), neutral or nearly neutral (B), or
deleterious mutations (C) in one gene duplicate—are outlined in ost-SS and post-WGD populations.
The main difference concerns the mutation/selection process of the genes prone to dominant deleterious
mutations (C).
copies through subfunctionalization [Hughes, 1994; Ly ch and Force, 2000a], that is, by
rendering each duplicate copy unable to perform all the functions of their ancestral gene.
(C) Finally, dominant deleterio s mutations favor the elimina ion of the ind vidua (or thei
descendants) harboring them through purifying selection. However, this typically leads
to opposite outcomes in post-SSD and post-WGD populations. In post-SSD populations,
domi ant d let rious mutations will tend to eliminate SSD duplicates before they ave
the time to reach fixation (see below). By contrast, in post-WGD populations, where all
ohnologs have been initially fixed through WGD-induced speciation, purifying selection
will effectively favor the retention of dangerous ohnologs, as all surviving individuals still
present (non-deleterious) functional copies of these dangerous genes.
Note, in particular, that this somewhat counterintuitive evolutionary model for the reten-
tion of “dangerous” ohnologs hinges on two unique features:
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1. It requires an autosomal dominance of deleterious mutations, in agreement with our
observation, above, that retained ohnologs are more “dangerous” than “essential.”
2. It relies on the fact that successful WGD events start with a concomitant speciation
event, which immediately fixes all ohnolog duplicates in the initial post-WGD population
Figure 13.1.
Note, also, that the same evolutionary trend is expected for dangerous SSD duplicates that
would have the time (t) to become fixed through genetic drift in a population of size N before
deleterious mutations can arise at a rate K, i.e., t = 4N < 1/K. This corresponds to a population
bottleneck effect with N < 1/(4K) ' 5,000–10,000 for typical vertebrates.

Part IV
Discussion & Perspectives
109

14
Discussion & Perspectives
BEYOND the human and vertebrate genomes, WGD events have now been established inall major eukaryote kingdoms [Sémon and Wolfe, 2007; Evlampiev and Isambert, 2007].
Unlike SSD events, WGD transitions provide a unique evolutionary mechanism, enabling the
simultaneous duplication of entire genetic pathways and multiprotein complexes, followed by
long periods of functional divergence and extensive loss of ohnologs [Aury et al., 2006]. More-
over, although both WGD and SSD events have expanded the gene repertoires and resulting
protein networks [Evlampiev and Isambert, 2007, 2008] of eukaryotes, it has become increas-
ingly clear that WGD and SSD events actually lead to the expansion of different gene classes in
the course of evolution, [Maere et al., 2005; Aury et al., 2006; Sémon and Wolfe, 2007; Freeling,
2009; Makino and McLysaght, 2010; Huminiecki and Heldin, 2010; Singh et al., 2012].
In this thesis, we report that WGD have effectively favored the expansion of gene families
prone to deleterious mutations in the human genome, such as Mendelian disease genes, genes
implicated in cancer and genes with autoinhibitory interactions. Furthermore, we also noticed
that SSD do not present any significant bias towards the retention of these genes susceptible to
dominant deleterious mutations. Our observations clearly highlight the need to discriminate
between different duplication mechanisms while analyzing the evolution by gene duplication,
to avoid erroneous conclusions. For example, in recent study, [Chen et al., 2013b] have ana-
lyzed the evolution of human monogenic disease genes (MD) and concluded that human MD
genes have more duplicates (SSDs and ohnologs lumped together) than singletons. We noticed
in our analysis, however, that only ohnologs and not SSDs are enriched in disease genes. Fur-
thermore, this bias only concerns dominant disease genes, as recessive disease genes do not
exhibit any biased retention of ohnologs, SSD or singletons.
Using causal inference analysis and the Mediation framework, we also showed that the re-
tention of many ohnologs suspected to be dosage balanced is in fact indirectly mediated by their
susceptibility to deleterious mutations. From a broader perspective, a number of studies have
now shown that many genomic properties, such as gene essentiality, duplicability, functional
ontology, network connectivity, expression level, mutational robustness, divergence rates, etc.,
all appear to be correlated to some extent. In the light of the present study, we expect that many
of these statistically significant correlations mainly result from indirect rather than direct as-
sociations, as observed for dosage balance, expression level, essentiality and Ka/Ks ratio in our
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analysis. This highlights the need to rely on more advanced inference methods to analyze the
multiple, direct, and indirect causes underlying the evolution of specific gene repertoires. Our
results are also clearly supported by partial correlation analysis [Singh et al., 2012], however,
the two approaches are not equivalent. In particular, while mediation effects require partial
correlation, partial correlation does not imply mediation in general and can exist in absence of
mediation [Singh et al., 2012].
To explain our observations we have proposed a simple evolutionary mechanism from a
population genetic perspective. We argue that the biased retention of genes susceptible to
dominant disease genes by WGD is a consequence of WGD-induced speciation and subsequent
purifying selection in the post WGD population. With this sympatric speciation event, all the
genes are already fixed in the population to start with and during subsequent evolution most
genes prone to loss of function mutations are lost. On the contrary, there is typically no such
speciation event coupled to SSD events. Therefore, an SSD duplicate has to rise in frequency
in the population to reach fixation. Mutations provide the engine for evolution, and since, most
of the mutations in oncogenes, dominant disease genes and genes with autoinhibitory folds
are expected to be deleterious, the loss of these genes after WGD and their fixation after SSD
would be difficult.
Our schematic model presented in Figure 13.1, is not only strongly supported by the ge-
nomic data, but also by a proper population genetics model [Malaguti et al., 2013]. In this
analysis, first a deterministic haploid model including initial duplicated loci has been solved,
to study the retention of duplicated genes through sub-functionalization against their neutral
loss-of-function or deleterious gain-of-function at one locus. Then, to go beyond determinis-
tic solutions for large populations, the formalism of one-step-process master equations and
stochastic simulations have been used to analyze the effect of finite population sizes on the
retention of SSD versus WGD duplicates. The deterministic solution predicts that the fixa-
tion of individual genes through WGD versus SSD duplicates depends on the rate of dominant
deleterious mutations against the total mutation rate. Stochastic simulations are in strong
agreement with the predictions of the deterministic solution, suggesting that while deleterious
gain-of-function mutations favor the elimination of “dangerous” gene duplicates after SSD, a
significantly enhanced retention of “dangerous” duplicates is predicted after WGD. All in all,
this population genetics model supports the idea that the enhanced retention of “dangerous”
WGD duplicates prone to dominant deleterious mutations is an indirect consequence of the
initial speciation events triggered by WGD and the ensuing purifying selection in post-WGD
species.
On longer timescales, we expect that this initial retention bias of “dangerous” ohnologs
through WGD effectively promote a prolonged genetic drift and, thus, a progressive functional
divergence between ohnolog pairs. This eventually favors the subfunctionalization of ancestral
functions between ohnolog pairs, which ultimately warrants their long-term maintenance fol-
lowing WGD events. This subfunctionalization process requires, however, that the expression
of ohnologs is not rapidly suppressed by large-scale deletion or silencing mutations in regu-
latory regions. As ohnolog pairs are not arranged in tandem, large-scale deletions through
unequal crossing-over cannot typically remove entire ohnolog duplicates while preserving the
integrity of nearby genes. Furthermore, as the size of promoter or enhancer regions is typi-
cally much smaller than UTRs and coding regions, one expects that the rate of transcriptional
silencing does not exceed the rates of functional silencing and divergence in UTRs and coding
regions. In fact, early estimates [Nadeau and Sankoff, 1997] showed that gene loss and func-
tional divergence after genome duplications in early vertebrates occurred at comparable rates
in gene families including at least two ohnologs. This is also directly evidenced by pseudote-
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traploid species like the vertebrate Xenopus laevis, which still retains about ∼ 40% of its initial
ohnologs from a 30-million-year-old WGD [Sémon and Wolfe, 2008]. Theses observations sug-
gests that ohnologs prone to dominant deleterious mutations have at least a few million years
to diverge and become nonredundant genes before they have a chance to be deleted or tran-
scriptionally silenced.
Yet, we found that the retention of these dangerous ohnologs remains intrinsically stochas-
tic by nature as many of them have also been eliminated following WGD events. This pre-
sumably occurred through loss-of-function mutations, transcriptional silencing, or large-scale
deletion before ohnolog pairs could diverge and become nonredundant genes. More quanti-
tatively, a simple theoretical estimate, derived from the long-term retention statistics [Singh
et al., 2012] shows that only 6%–10% of the initial ohnolog duplicates have been retained on
average at each round of WGD. By comparison, ∼ 23%–30% of the initial ohnologs prone to
gain-of-function mutations have been retained on average at each WGD. This implies that
genes susceptible to deleterious mutations are two to five times more likely to retain ohnologs
on long evolutionary timescales. Moreover, genes combining several factors associated with
enhanced susceptibility to autosomal-dominant deleterious mutations have been found to be
more than ten times more likely to retain ohnologs than genes lacking gain-of-function muta-
tions, as illustrated on the examples of oncogenes with autoinhibitory folds (Figures 10.1 and
10.2).
A small number of genes susceptible to dominant deleterious mutations have also been
fixed by SSDs in the human genome. This might come about by positive selection as predicted
by our model [Malaguti et al., 2013], however, the possibility of beneficial gain-of-function
mutations is very low owing to their susceptibility to deleterious mutations. This is evidenced
by their very low retention after SSD in the human genome. In general, the fixation of SSDs
by subfunctionalization is also less likely in the absence of positive selection.
There are specific evidences for models of subfunctionalization such as Escape from Adap-
tive Conflict [Des Marais and Rausher, 2008] and Innovation-Amplification-Divergence [Näs-
vall et al., 2012] for limited cases. Yet, their role on a genome-wide scale is hard to explain. In
general, as the subfunctionalization model was developed before the SSD versus WGD bias was
reported, it does not explain the strong bias observed by us and many other studies. Indeed,
the suspicion that subfunctionalization alone is the major mechanism of duplicated gene re-
tention is growing [MacCarthy and Bergman, 2007; Freeling, 2008, 2009]. The ‘true’ instances
of neofunctionalization are rare. Nevertheless, neofunctionalization also fails to provide an
explanation of the biased retention of dominant disease genes by WGD.
The elimination of ohnologs has been shown to drive further speciation events within post-
WGD (sub)populations, due to the emergence of recombination barriers from the accumulation
of differences in ohnolog deletion patterns between post-WGD individuals [Lynch and Force,
2000b]. The resulting fragmentation of post-WGD subpopulations is then expected to sustain
negative selection pressure that favors the retention of the remaining ohnolog pairs prone to
deleterious mutations, as outlined in Figure 13.1. Hence, although most WGDs are unlikely to
bring much fitness benefit on short evolutionary timescales (if only due to the population bot-
tlenecks associated with WGD-induced speciations), they provide a unique evolutionary mech-
anism to experiment virtually unlimited combinations of regulation/deletion patterns from re-
dundant ohnolog genes. Over long timescales (>100–500 MY), such trial and error combina-
tions have visibly led to the evolutionary success and radiation of WGD species.
Some previous studies have alluded to the origin of Mendelian disease genes [Makino and
McLysaght, 2010; Dickerson and Robertson, 2011] by WGD. In addition to Mendelian disease
genes, we also wanted to characterize the genes implicated in cancers, and therefore, cancer
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genes and oncogenes contribute a significant fraction to our disease gene dataset. However,
the role of cancer mutations in evolution is considered to be insignificant because of the nature
of these mutations, which are mostly somatic and are believed to typically occur later in life
past the reproductive periods of the extant animals. Furthermore, as the occurrence of cancer
has certainly increased in the modern times due to a variety of factors, there is a debate on
antiquity of cancer as a disease [Capasso, 2005; David and Zimmerman, 2010a,b; Faltas, 2010;
Wang et al., 2010b]. In our analysis however, we observed that dominant cancer genes also
present very strong retention bias after WGD. Although, most cancers occur later in the lifes-
pan, cancer is one of the leading cause of death, even in young adults (see Table 6 in [Siegel
et al., 2013]). For example, cancer is the first leading cause of natural deaths in both males and
females of age 1-19 and 20-39 according to the cancer mortality statistics in Unites States of
America in 2009 [Siegel et al., 2013]. Although, such systematic analysis is difficult to obtain
for many countries in the world and for other organisms and specially for the ancestors the
vertebrates. Yet, even a relatively small rate of cancer instances in juvenile and young organ-
isms in the ancestor of vertebrates would be enough to strongly bias the evolution of genes
implicated in cancers on a time-scale of 100-500 MY. In addition, mutations in the germline
can also predispose subsequent generations to cancer.
A considerable part of our analysis concerns the accurate detection of ohnologs in the ver-
tebrate genomes. As shown by our results, the P-value based approach is indeed efficient in
removing possible false positive candidates. Most importantly, since our P-values depend on
the genomic context, orthologs and paralogs, it allows to bypass arbitrary criteria while detect-
ing ohnologs. However, there are many scopes of improvements in our approach.
We resort to a content based synteny as the conservation of gene collinearity is limited
owing to a very long time period of evolution since the 2R-WGD [Putnam et al., 2008]. Yet,
our approach could be improved to seek for such regions of conserved gene order and provide
more weight to the ohnologs residing on such regions. After WGD, since the ohnologs are
lost randomly from the duplicated sister region, each region in an outgroup genome should
alternatively correspond to multiple duplicated sister regions in the vertebrate genome. Such
alternative synteny correspondence has been used to prove WGD events in Saccharomyces
cerevisiae [Kellis et al., 2004] and Tetraodon [Jaillon et al., 2004]. Such alternation could be
difficult to find in the vertebrate genomes. Yet, if observed in some genomic regions, it would
be a tell-tail sign of ‘true’ ohnologs belonging to such regions.
There is unmistakable evidence now that vertebrates have descended from polyploid an-
cestors [Dehal and Boore, 2005; Putnam et al., 2008] and our aim in this study was to detect
the ohnologs in the vertebrate genomes with high confidence. Therefore, we did not attempt to
find an optimum number of ohnologs or the patterns reminiscent of WGD to prove that WGD
actually occurred. Yet, we observed that in the genome of organisms such as Drosophila and
C. elegans our approach could not identify many ohnologs. Therefore, with the identification
and optimization of minimum required ohnologs and ohnolog families and their genomic dis-
tribution, our approach can also be used to detect unknown WGD events in the sequenced (or
upcoming) genomes. These improvements would be specially useful to study relatively recent
genome duplications events.
We noticed that some of the limitations in detecting the ohnologs are sorting the candidates
with correct duplication time and the level of genome annotation. In future, we would like
to identify ohnologs in all the sequenced vertebrate and Teleost Fish genome in Ensembl to
systematically study the fraction of ohnologs not detected by our approach correspond to the
lineage specific loss of ohnologs in different vertebrates or the annotation anomalies. More
importantly, our work also opens avenues for a large number of possible analyses such as
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the relative impact of 2R- and 3R-WGDs in the fish genomes, attempting to distinguish the
genes retained from the 1st or the 2nd round of duplication based on syntenic patterns, and
identifying ohnologs in other classes of genes such as non-coding RNAs.
Another important aspect of our work is related to the use of advanced inference methods
such as the Mediation analysis which allowed us to study three-property causal relationships.
However, a desirable improvement would be to detect causal networks using genomic and func-
tional data on a larger number of variables.
In conclusion, we present evidence supporting an evolutionary link between the susceptibil-
ity of human genes to dominant deleterious mutations and the expansion of these “dangerous”
gene families by two WGD events at the onset of vertebrates. We propose that deleterious
mutations, responsible for many cancers and other severe genetic diseases have also underlain
purifying selection over long evolutionary time-scales, which effectively favored the retention
of vertebrate ohnologs prone to dominant deleterious mutations. From a population genetics
perspective, we argue that this counterintuitive retention of dangerous ohnologs hinges in fact
on WGD-induced speciation events, which are largely credited for the genetic complexity and
successful radiation of vertebrate species. These findings highlight the importance of purifying
selection from WGD events on the evolution of vertebrates and, beyond, exemplify the role of
non-adaptive forces on the emergence of eukaryote complexity.
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SUMMARY
The emergence and evolutionary expansion of gene
families implicated in cancers and other severe
genetic diseases is an evolutionary oddity from
a natural selection perspective. Here, we show that
gene families prone to deleterious mutations in the
human genome have been preferentially expanded
by the retention of ‘‘ohnolog’’ genes from two rounds
of whole-genome duplication (WGD) dating back
from the onset of jawed vertebrates. We further
demonstrate that the retention of many ohnologs
suspected to be dosage balanced is in fact indirectly
mediated by their susceptibility to deleterious muta-
tions. This enhanced retention of ‘‘dangerous’’ ohno-
logs, defined as prone to autosomal-dominant dele-
terious mutations, is shown to be a consequence of
WGD-induced speciation and the ensuing purifying
selection in post-WGD species. These findings high-
light the importance of WGD-induced nonadaptive
selection for the emergenceof vertebrate complexity,
while rationalizing, from an evolutionary perspective,
the expansion of gene families frequently implicated
in genetic disorders and cancers.
INTRODUCTION
Just as some genes happen to be more ‘‘essential,’’ owing to
their deleterious loss-of-function or null mutations, some genes
can be classified as more ‘‘dangerous,’’ due to their propensity
to acquire deleterious gain-of-function mutations. This is, in
particular, the case for oncogenes and genes with autoinhibitory
protein folds, whose mutations typically lead to constitutively
active mutants with dominant deleterious phenotypes (Pufall
and Graves, 2002).
Dominant deleterious mutations, that are lethal or drastically
reduce fitness over the lifespan of organisms, must have also
impacted their long term evolution on timescales relevant for
genome evolution (e.g., >10–100 million years [MY]). In fact,
dominant disease genes in humans have been shown to be
under strong purifying selection (Furney et al., 2006; Blekhman
et al., 2008; Cai et al., 2009). Yet, ‘‘dangerous’’ gene families
implicated in cancer and severe genetic diseases have also
been greatly expanded by duplication in the course of vertebrate
evolution. For example, the single orthologous locus, Ras85D in
flies and Let-60 in nematodes, has been duplicated into three
RAS loci in typical vertebrates, KRAS, HRAS, and NRAS, that
present permanently activating mutations in 20%–25% of all
human tumors, even though HRAS and NRAS have also been
shown to be dispensable for mouse growth and development
(Ise et al., 2000; Esteban et al., 2001).
While the maintenance of essential genes is ensured by
their lethal null mutations, the expansion of dangerous gene
families remains an evolutionary puzzle from a natural selection
perspective. Indeed, considering that many vertebrate disease
genes are phylogenetically ancient (Domazet-Loso and Tautz,
2008; Cai et al., 2009; Dickerson and Robertson, 2012), and
that their orthologs also cause severe genetic disorders in extant
invertebrates (Berry et al., 1997; Ciocan et al., 2006; Robert,
2010), it is surprising that dangerous gene families have been
duplicated more than other vertebrate genes without known
dominant deleterious mutations. While gene duplicates can
confer mutational robustness against loss-of-function muta-
tions, multiple copies of genes prone to gain-of-function muta-
tions are expected to lead to an overall aggravation of a species’
susceptibility to genetic diseases and thus be opposed by puri-
fying selection.
Two alternative hypotheses can be put forward to account for
the surprising expansion of dangerous gene families. Either, the
propensity of certain genes to acquire dominant deleterious
mutations could be a mere by-product of their presumed advan-
tageous functions. In that case, only the overall benefit of gene
family expansion should matter, irrespective of the mechanism
of gene duplication. Alternatively, gene susceptibility to domi-
nant deleterious mutations could have played a driving role in
the striking expansion of dangerous gene families. But what
could have been the selection mechanism?
In this article, we report converging evidences supporting the
latter hypothesis and propose a simple evolutionary model to
explain the expansion of such dangerous gene families. It is
based on the observation that the majority of human genes
prone to dominant deleterious mutations, such as oncogenes
and genes with autoinhibitory protein folds, have not been dupli-
cated through small scale duplication (SSD). Instead, the expan-
sion of these dangerous gene families can be traced back to two
rounds of whole-genome duplication (WGD), that occurred at the
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onset of jawed vertebrates, some 500 MY ago (Ohno, 1970; Put-
nam et al., 2008).
These two rounds of WGD in the early vertebrate lineage are
frequently credited with creating the conditions for the evolution
of vertebrate complexity. Indeed, WGD-duplicated genes, so-
called ‘‘ohnologs’’ in honor of Susumu Ohno (Ohno, 1970; Wolfe,
2000), have been preferentially retained in specific gene classes
associated with organismal complexity, such as signal transduc-
tion pathways, transcription networks, and developmental
genes (Maere et al., 2005; Blomme et al., 2006; Freeling and
Thomas, 2006; Sémon andWolfe, 2007;Makino andMcLysaght,
2010; Huminiecki and Heldin, 2010). By contrast, gene dupli-
cates coming from SSD are strongly biased toward different
functional categories, such as antigen processing, immune
response, and metabolism (Huminiecki and Heldin, 2010). SSD
paralogs and WGD ohnologs also differ in their gene expression
and protein network properties (Hakes et al., 2007; Guan et al.,
2007). Furthermore, recent genome-wide analysis have shown
that ohnologs in the human genome have experienced fewer
SSD than ‘‘nonohnolog’’ genes and tend to be refractory to
copy number variation (CNV) caused by polymorphism of small
segmental duplications in human populations (Makino and
McLysaght, 2010). These antagonist retention patterns of WGD
and SSD/CNV gene duplicates in the human genome have
been suggested to result from dosage balance constraints (Ma-
kino and McLysaght, 2010) on the relative expressions of
multiple protein partners (Veitia, 2002), as proposed earlier for
other organisms like yeast (Papp et al., 2003) and the parame-
cium (Aury et al., 2006).
In this article, we investigate the evolutionary causes respon-
sible for the expansion of gene families prone to deleterious
mutations in vertebrates and propose a simple evolutionary
model accounting for their antagonistic retention pattern after
WGD and SSD events. The retention of ohnologs in the human
genome is shown to be more strongly associated with their
susceptibility to deleterious mutations, than their functional
importance or ‘‘essentiality.’’ We also demonstrate using
a causal inference analysis, that the retention of many ohnologs
suspected to be dosage balanced is in fact an indirect effect of
their higher susceptibility to deleterious mutations. We argue
that the enhanced retention of dangerous ohnologs is a some-
what counterintuitive yet simple consequence of the speciation
event triggered by WGD and the ensuing purifying selection in
post-WGD species.
These findings rationalize, from an evolutionary perspective,
the WGD expansion of gene families frequently implicated in
genetic disorders, such as cancer, and highlight the importance
of nonadaptive selection on the emergence of vertebrate
complexity.
RESULTS
Genes Prone to Deleterious Mutations Retain More
Ohnologs
We first analyzed a possible association between the suscepti-
bility of human genes to deleteriousmutations and their retention
of ohnologs, as proposed in Gibson and Spring (1998) for multi-
domain proteins. To this end, we considered multiple classes of
genes susceptible to deleterious mutations from experimentally
verified databases and literature. These classes include cancer
genes (from multiple sources including COSMIC [Forbes et al.,
2011] and CancerGenes [Higgins et al., 2007]), genes mutated
in other genetic disorders, dominant negative genes from
OMIM, and genes with autoinhibitory protein folds (Experimental
Procedures). We looked at the relative contributions ofWGD and
SSD in the expansion of these ‘‘dangerous’’ gene classes.
The results, depicted in Figures 1 and S1, demonstrate indeed
a strong association between the retention of human ohnologs
from vertebrate WGD and their reported susceptibility to delete-
rious mutations, as compared to nonohnologs, whereas an
Autoinhibition
(461)
Autoinhibition
& cancer (369)
Autoinhibition
& oncogene (114)
Oncogenes
(813)
Dominant Neg.
39%
61%
(477)
1.5  (x2.9)
Susceptibility  to  Dosage Balance
54%
46%
1.2  (x2.2)
Haploinsufficient Permanent Complex
(239)
7%
0.08  (x0.15)
(330)
76%
24%
20%
9%
3.2  (x6.0) 4.0  (x7.6) 10.1 (x19)
80%
Susceptibility  to  Deleterious  MutationsB
Complex
41%
59%
(3,814)
0.7  (x1.3)
All  Genes
(20,506)
35%
65%
ReferenceA
Ratio:  0.53
52%
48%
Genes  (8,095)
Cancer or Disease
0.92  (x1.7)
61%
1.5  (x2.9)
39%41%
59%
Dom. Disease
Genes  (440)
1.4  (x2.7)
C
91% 93%
Figure 1. Prevalence of Retained Ohnologs in the Human Genome within Different Gene Classes
(A and B) Prevalence of retained ohnologs either ‘‘w/ SSD or CNV’’ or ‘‘w/o SSD & CNV’’ for all 20,506 human protein-coding genes (A), and gene classes
susceptible to deleterious mutations (B). Note that gene classes with higher susceptibility to deleterious mutations retained more ohnologs.
(C) Ohnolog retention in gene classes susceptible to dosage balance constraints. Fold changes in ohnolog/nonohnolog ratios are given relative to the reference
from all human genes in (A).
See also Figure S1.
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opposite pattern is found for SSD/CNV gene duplicates. Overall,
the 8,095 human genes associated with the occurrence of
cancer and other genetic diseases have retained significantly
more ohnologs than expected by chance, 48% versus 35%
(48%; 3,844/8,095; p = 1.33 10129, c2 test). Furthermore, these
associations, which do not take into account the actual severity
of the gene mutations, are clearly enhanced when the analysis is
restricted to genes with direct experimental evidence of domi-
nant deleterious mutations, such as dominant disease genes
(59%; 261/440; p = 1.7 3 1027, c2 test), dominant negative
mutants (61%; 292/477; p = 3.9 3 1034, c2 test), oncogenes
(61%; 493/813; p = 1.4 3 1054, c2 test), or genes exhibiting
autoinhibitory constraints (76%; 350/461; p = 2.7 3 1077, c2
test). The biased retention of ohnologs is even stronger for genes
combining several factors associated with an enhanced suscep-
tibility to deleterious mutations, such as cancer genes with auto-
inhibitory folds, (80%; 294/369; p = 1.0 3 1073, c2 test), or
oncogenes with autoinhibitory folds, (91%; 104/114; p = 6.9 3
1037, c2 test).
This retention of dangerous ohnologs is illustrated on Table 1
that presents an up-to-date list of 76 hand-curated gene families
of up to four ohnologs, exhibiting both autoinhibitory folds and
oncogenic properties (see Table S1 for oncogenic and autoinhi-
bitory details and references). These dangerous ohnologs are
typically found along signal transduction cascades, from
receptor tyrosine kinases and cytoplasmic or nuclear kinases
to guanine exchange factors (GEF), GTPase activating proteins
(GAP), and transcription factors (Table 1, gene classes A–E). In
addition, autoinhibited oncogenes are also found in other ohno-
log families with diverse functions (Table 1, gene class F). By
contrast, we obtained a hand-curated list of only ten nonohnolog
genes exhibiting both autoinhibitory and oncogenic properties,
Table 1, gene class G (see Table S2 for oncogenic and autoinhi-
bitory details and references). Interestingly, half of them (4/10)
can be traced back to SSD events, which occurred after or at
the same period of the two WGD in early vertebrate lineages
(Table S2). All in all, this implies that >90% of known oncogenes
with autoinhibitory folds have retained at least one ohnolog pair
in the human genome (as well as, possibly, a few additional
duplicates from more recent SSD events).
Ohnologs Are Conserved but More ‘‘Dangerous’’ than
‘‘Essential’’
We then investigated whether the susceptibility of ohnologs to
deleterious mutations could be directly quantified through
comparative sequence analysis. We used Ka/Ks ratio estimates,
which measure the proportion of nonsynonymous substitutions
(Ka) to the proportion of synonymous substitutions (Ks)
(Extended Results and Table S3). Ohnologs exhibit statistically
lower Ka/Ks ratios, Figures 2, S2, and S3, which provides direct
evidence of strong conservation, consistent with a higher
susceptibility of ohnologs to deleterious mutations. Similar
trends have also been reported for ohnologs specific to teleost
fishes (Brunet et al., 2006) or to themore recentWGD in Xenopus
laevis lineage (Sémon and Wolfe, 2008). Note, however, that the
functional consequences of such deleterious mutations, leading
either to a gain or a loss of function, cannot be directly inferred
from Ka/Ks distributions. Yet, as outlined below, we found
marked differences in the retention of ‘‘dangerous’’ ohnologs
prone to dominant gain-of-function mutations and ‘‘essential’’
ohnologs exhibiting lethal loss-of-function or null mutations.
While autosomal-dominant disease genes exhibit a strong
ohnolog retention bias (Figure 1B), 59% versus 35% (59%;
261/440; p = 1.73 1027, c2 test), autosomal-recessive disease
genes are not significantly enriched in ohnologs 37% versus
35% (37%; 221/598; p = 0.24, c2 test). Similarly, human ortho-
logs of mouse genes, reported as being ‘‘essential’’ genes
from large-scale null mutant studies in mouse, are not strongly
enriched in ohnologs 56% versus 54% (56%; 1,537/2,729; p =
3.8 3 103, c2 test), where 54% = 3,190/5,956 is the global
proportion of ohnologs among the 5,956 genes tested for null
mutation in mouse (Experimental Procedures). In fact, this small
enrichment becomes even nonsignificant once genes with domi-
nant allelic mutants are removed from the list of 5,956 genes
tested for essentiality in mouse, i.e., 50% versus 48% (50%;
760/1,525; p = 0.09, c2 test), where 48% = 1,782/3,739 is the
global proportion of ohnologs among the 3,739 genes tested
for essentiality in mouse, after removing dominant disease
genes, oncogenes, and genes with dominant negative mutations
or autoinhibitory folds.
All in all, this shows that the retention of ohnologs has been
most enhanced for genes prone to autosomal-dominant delete-
rious mutations and not autosomal-recessive deleterious muta-
tions. This suggests that the retention of ohnologs is more
strongly related to their ‘‘dangerousness,’’ as defined by their
high susceptibility to dominant deleterious mutations, than their
functional importance or ‘‘essentiality,’’ as identified through
large-scale null mutation studies in mouse.
Ultimately, we will argue that the ‘‘dangerousness’’ of ohno-
logs effectively controls their individual retention in the genomes
of post-WGD species, as will be shown below in the section
Model for the Retention of Dangerous Ohnologs.
Mixed Susceptibility of Human Ohnologs to Dosage
Balance
An alternative hypothesis, focusing instead on the collective
retention of interacting ohnologs, has been frequently invoked
to account for the biased retention of ohnologs in unicellular
organisms like yeast (Papp et al., 2003) or the paramecium
(Aury et al., 2006) and in higher eukaryotes (Birchler et al.,
2001; Makino and McLysaght, 2010).
This ‘‘dosage balance’’ hypothesis posits that interacting
protein partners tend to maintain balanced expression levels in
the course of evolution, in particular, for protein subunits of
conserved complexes (Birchler et al., 2001; Veitia, 2002; Papp
et al., 2003; Veitia, 2010; Makino and McLysaght, 2010). Thus,
SSD of dosage balanced genes are thought to be generally detri-
mental through the dosage imbalance they induce, thereby
raising the odds for their rapid nonfunctionalization (Papp
et al., 2003; Maere et al., 2005). By contrast, rapid nonfunction-
alization of ohnologs after WGD has been suggested to be
opposed by dosage effect, in particular, for highly expressed
genes and genes involved in protein complexes or metabolic
pathways (Aury et al., 2006; Evlampiev and Isambert, 2007;
Gout et al., 2010; Makino andMcLysaght, 2010). This is because
WGD initially preserves correct relative dosage between
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Table 1. Ohnolog Families with Both Autoinhibitory and Oncogenic Properties
A. Ohnolog Receptor Tyrosine Kinases and Other Receptor Kinases
ALK LTK KIT CSF1R FLT3
EGFR ERBB2 ERBB3 ERBB4 MET MST1R
FGFR1 FGFR2 FGFR3 FGFR4 NPRA NPRB
IGF1R INSR INSRR PDGFRA PDGFRB
B. Ohnolog Cytoplasmic and Nuclear Protein Kinases
ABL1 ABL2 PKN1 PKN2 PKN3
ARAF BRAF RAF1 PRKAA1 PRKAA2
AKT1 AKT2 AKT3 PRKCA PRKCB PRKCG
CAMK1 CAMK1D CAMK1G PNCK PRKCE PRKCH
CAMKK1 CAMKK2 PRKCI PRKCZ
CSNK1D CSNK1E PRKD1 PRKD2 PRKD3
GSK3A GSK3B PRKG1 PRKG2
GRK4 GRK5 GRK6 PTK2 PTK2B
JAK1 JAK2 JAK3 TYK2 RSK1 RSK2 RSK3 RSK4
SRC FGR FYN YES1 MSK1 MSK2
HCK LCK BLK LYN NDR1 NDR2
MKNK1 MKNK2 SYK ZAP70
NEK6 NEK7
C. Ohnolog GEF
ARHGEF3 NET1 RALGDS RGL1 RGL2 RGL3
ARHGEF6 COOL1 SOS1 SOS2
DBL DBS MCF2L2 TIAM1 TIAM2
FGD1 FGD2 FGD3 FGD4 TIM WGEF SGEF NGEF
PDZ-RHOGEF LSC LARG VAV1 VAV2 VAV3
P114-RHOGEF GEF-H1
D. Ohnolog GAP
ASAP1 ASAP2 ASAP3 PLXNA1 PLXNA2 PLXNA3 PLXNA4
IQGAP1 IQGAP2 IQGAP3 PLXNB1 PLXNB2 PLXNB3 PLXND1
E. Ohnolog DNA Binding and Transcription Factors
CEBPA CEBPB CEBPE IRF4 IRF8 IRF9
CUX1 CUX2 MEIS1 MEIS2 MEIS3
ELK1 ELK3 ELK4 p53 p63 p73
ETS1 ETS2 RUNX1 RUNX2 RUNX3
ETV1 ETV4 ETV5 SOX1 SOX2 SOX3
ETV6 ETV7
F. Other Ohnolog Genes with Both Autoinhibitory and Oncogenic Properties
ANP32A ANP32B ANP32E nNOS eNOS
ATP2B1 ATP2B2 ATP2B3 ATP2B4 NOTCH1 NOTCH2 NOTCH3
cIAP1j2 XIAP PLCB1 PLCB2 PLCB3
CCNT1 CCNT2 PLCD1 PLCD3 PLCD4
FLNA FLNB FLNC PLCG1 PLCG2
FURIN PCSK4 PTPN1 PTPN2
KPNA2 KPNA7 SMURF1 SMURF2
NEDD4 NEDD4L TRPV1j3 TRPV2 TRPV4 TRPV5j6
NOXA1 NOXA2
G. Nonohnolog Genes with Both Autoinhibitory and Oncogenic Properties
CAMK4 ELF3 MELK MOS PDPK1 BRK PTPN11 RET RPS6KB1 TTN
GEF, guanine exchange factors; GAP, GTPase activating proteins.
See also Tables S1 and S2.
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expressed genes, whereas subsequent random nonfunctionali-
zation of individual ohnologs disrupts this initial dosage balance.
For instance, yeast Saccharomyces cerevisiae has retained 76%
of its ribosomal gene ohnologs from a 150 MY old WGD (Kellis
et al., 2004; Lin et al., 2007), although the maintenance of these
ohnologs has been suggested to require frequent gene conver-
sion events (Kellis et al., 2004; Evangelisti and Conant, 2010)
aswell as fine-tuned dosage compensation to ensure a balanced
expression with the remaining 24% ribosomal genes having lost
their ohnologs (Zeevi et al., 2011).
Following on this dosage balance hypothesis, we performed
statistical analysis on multiprotein complexes from HPRD (Ke-
shava Prasad et al., 2009) and CORUM (Ruepp et al., 2010) data-
bases and a hand-curated list of permanent complexes (Zanivan
et al., 2007) (Experimental Procedures) to investigate for
a possible association between the retention of human ohnologs
and their susceptibility to dosage balance constraints.
The results depicted in Figure 1C demonstrate, in agreement
with (Makino and McLysaght, 2010), that genes implicated in
multiprotein complexes have retained significantly more ohno-
logs than expected by chance, 41% versus 35% (41%; 1,567/
3,814; p = 8.7 3 1017, c2 test). This trend is also enhanced
when focusing on haploinsufficient genes, that are known for
their actual sensitivity to dosage balance constraints (Qian and
Zhang, 2008) (54%; 179/330; p = 8.0 3 1014, c2 test).
Yet, surprisingly, an opposite trend corresponding to the elim-
ination of ohnologs is observed for genes implicated in perma-
nent complexes, that are presumably strongly sensitive to
dosage balance constraints (7.5%; 18/239; p = 1.2 3 1018, c2
test) (Figure 1C). In fact, looking more closely at the few human
ohnologs, that have not been eliminated from permanent
complexes (Table 2), we found that they are likely under less
stringent dosage balance constraints than most proteins in
permanent complexes, as they typically coassociate with mito-
chondrial proteins or form large multimeric subcomplexes with
intrinsic stoichiometry disequilibrium.
This suggests that the elimination of most ohnologs from
permanent complexes is, in fact, strongly favored under dosage
imbalance and becomes likely inevitable once a few of those oh-
nologs have been accidentally lost following WGD. Indeed, the
uneven elimination of ohnologs in permanent complexes is ex-
pected to lead to the assembly of nonfunctional, partially formed
complexes detrimental to the cell, unless dosage compensation
mechanisms effectively re-establish proper dosage balance at
the level of gene regulation (Birchler et al., 2001), as for yeast
ribosomal proteins (Zeevi et al., 2011). By contrast, transient
complexes, which are typically more modular than permanent
complexes, are expected to accommodate such dosage
changes more easily, as they do not usually require the same
strict balance in the expression levels of their protein partners.
These findings on the differences in retention of human ohno-
logs between permanent andmore transient complexes suggest
the relevance of different underlying causes. Although dosage
balance presumably remains the primary evolutionary constraint
in permanent complexes (<2% of human genes), which lead to
the elimination of ohnologs in permanent complexes in
Figure 2. Ka/Ks Distributions for WGD and SSD or CNV Duplicates in the Human Genome
(A–D) Ka/Ks distributions for human-human (Hs-Hs) ohnolog pairs (A) and human-amphioxus (Hs-Bf) ortholog pairs (B) with different confidence status (see
Extended Results). Ka/Ks distributions for human-amphioxus (Hs-Bf) ortholog pairs involving a human ohnolog (C) and for human-amphioxus (Hs-Bf) ortholog
pairs exhibiting either SSD or CNV (D).
See also the Extended Results, Figures S2 and S3, and Table S3 for statistical significance and comparison with other invertebrate outgroups.
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vertebrate genomes, gene susceptibility to deleterious muta-
tions may be more relevant for the retention of ohnologs within
the 17% of human genes participating in more transient
complexes. For instance, transient complexes involved in phos-
phorylation cascades or GTPase signaling pathways are known
to bemore sensitive to the level of activation of their protein part-
ners than to their total expression levels. Thus, although the
active forms of multistate proteins typically amount to a small
fraction of their total expression level, hence providing a large
dynamic range for signal transduction, it alsomakes thempartic-
ularly susceptible to gain-of-function mutations. Such mutations
can shift protein activation levels 10- to 100-fold without
changes in expression levels and likely underlie stronger evolu-
tionary constraints than the 2-fold dosage imbalance caused
by gene duplication.
Indirect Cause of Ohnolog Retention in Protein Complex
To further investigate the relative effects of dosage balance and
gene susceptibility to deleterious mutations, we analyzed
whether the overall enhanced retention of ohnologs within multi-
protein complexes (Figure 1C) could indirectly result from an
enhanced susceptibility to deleterious mutations. Indeed, as
outlined in Figure 3A, cancer and disease genes are more prev-
alent within complexes than expected by chance, 29% versus
19% (29%; 2,362/8,095; p = 3.73 10132, c2 test) and this trend
is enhanced for genes with stronger susceptibility to deleterious
mutations, such as oncogenes (39%; 320/813; p = 2.9 3 1052,
c2 test) or oncogenes with autoinhibitory folds (59%; 67/114; p =
2.9 3 1028, c2 test). By contrast, ohnologs are only slightly,
although significantly, more prevalent in complexes than
expected by chance, 22% versus 19% (22%; 1,567/7,110; p =
9.0 3 1014, c2 test), whereas the proportion implicated in
cancer or disease genes is clearly enhanced 54% versus 39%
(54%; 3,844/7,110; p = 9.5 3 10140, c2 test).
To go beyond these simple statistical associations and quan-
tify the direct versus indirect effects of deleterious mutations and
dosage balance constraints on the biased retention of human
ohnologs, we have performed a Mediation analysis following
the approach of Pearl (Pearl, 2001, 2011). The Mediation frame-
work, developed in the context of causal inference analysis, aims
at uncovering, beyond statistical correlations, causal pathways
along which changes in multivariate properties are transmitted
from a cause, X, to an effect, Y. More specifically, a Mediation
analysis assesses the importance of a mediator, M, in transmit-
ting the indirect effect of X on the response Y h Y(x,m(x))
(Figure 3B).
Mediation analyses have been typically used in social
sciences research (Baron and Kenny, 1986) as, for instance, in
the context of legal disputes over alleged discriminatory hiring.
In such cases, the problem is to establish that gender or race
(X) have directly influenced hiring (Y) and not simply indirectly
through differences in qualification or experience (M). Mediation
analyses have also been used in epidemiology, as in a formal
study (Robins and Greenland, 1992) that establishes the direct
effect of smoking (X) on the incidence of cardiovascular diseases
(Y), while taking into account the indirect effect of other aggra-
vating factors, such as hyperlipidemia (M).
In this report, we have applied the Mediation analysis to
genomic data to discriminate between direct effect (DE) and indi-
rect effect (IE) of deleterious mutations (X or M) and dosage
balance constraints (M or X) on the biased retention of human
ohnologs (Y). The results, derived in Extended Experimental
Procedures (Table S4) and summarized in Figure 3C and
Table S5, demonstrate that the retention of ohnologs in the
human genome is more directly caused by their susceptibility
to deleterious mutations than their interactions within multipro-
tein complexes.
Indeed, the direct causal effect of a change from ‘‘noncom-
plex’’ to ‘‘complex’’ proteins only accounts for 23% of a small
total effect (TE) of complex on the retention of ohnologs
(DE/TE = 23% with TE = 0.079), whereas 82% of this small total
effect is indirectly mediated by their susceptibility to deleterious
mutations (IE/TE = 82% with 5% nonlinear coupling between
direct and indirect effects) (Extended Results). By contrast, the
alternative hypothesis, assuming a direct effect of deleterious
mutations, accounts for 99% of a three times larger total effect
on ohnolog retention (DE/TE = 99% with TE = 0.23), whereas
the ‘‘complex’’ versus ‘‘noncomplex’’ status of human genes
Table 2. Low Retention of Ohnologs in Permanent Complexes
Permanent Complexesa Number of Ohnologs Intrinsic Stoichiometry Disequilibrium of Ohnologs in Permanent Complexes
ATP F0 3/12 the 3 ohnologs ATP5G1-3 form the 10-mer C-ring of the F-type ATP synthase
ATP F1 0/5
COX 2/11 the 2 ohnologs COX4I1,2 coassemble with 3 mitochondrial encoded genes
SRS 2/32 Ohnologs are X-linked RPS4X (with no X-inactivation) and Y-linked RPS4Y1
Mitochondrial SRS 0/30
LRS 2/50 RPL3 and RPL39 have ohnologs RPL3L and RPL39L with unknown functions
Mitochondrial LRS 0/48
Proteasome 2/31 ohnologs PSMA7 or PSMA7L are included in the 2 rings of 7 a subunits
Pyruvate dehydrogenase 0/5
RNA Pol II 0/12
RNA Pol III 0/9
COX, cytochrome c oxidase; LRS, large ribosomal subunit; SRS, small ribosomal subunit.
aZanivan et al., 2007.
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has a negligible indirect effect on ohnolog retention in this case
(IE/TE = 2%) (Extended Results). These trends are also further
enhanced when the analysis is restricted to the 40% of human
genes (8,215) without SSD and CNV duplicates (Figure 3D; Table
S5; Extended Results). In fact, the direct effect of multiprotein
complexes then tends to oppose the retention of ohnologs
(DE/TE = 33% with TE = 0.064), as in the case of permanent
complexes detailed above, but on an increased sample size of
8,215 genes without SSD or CNV duplicates (i.e., more than
a third of human genes) in place of 239 genes from permanent
complexes. By contrast, there is a five times larger total effect
due to the direct effect of deleterious mutations on the retention
of ohnologs (DE/TE = 101%with TE = 0.32), Figure 3D. This is an
instance of Simpson’s paradox, where two effects oppose each
other, thereby, revealing the existence of conflicting underlying
causes, namely, a strong positive effect of deleterious mutations
and a small negative effect of dosage balance constraints on the
retention of human ohnologs without SSD and CNV duplicates.
We have also examined the effects of other alternative proper-
ties on the retention of ohnologs (Extended Results; Table S5). In
particular, we have found that gene expression levels and Ka/Ks
ratios do not significantly mediate the effect of deleterious muta-
tions on the retention of ohnologs. In fact, gene expression levels
(Extended Experimental Procedures) have a negligible total
effect on the retention of human ohnologs (TE = 0.003), by
contrast to what has been reported for the paramecium (Gout
et al., 2009). The total effects of Ka/Ks on ohnolog retention
are also lower than the total effects of deleterious mutations,
as TEs from deleterious mutations are 2- to 3-fold stronger
than TEs from Ka/Ks and become >10-fold stronger for genes
without SSD and CNV (Extended Results).
In addition, we have performed a complementary systematic
study of all these genomics properties using partial correlation
analysis, which aims at ‘‘removing’’ the effect of a third property
(Z) on the standard pair correlations between two variables (X)
and (Y). The results detailed in Extended Results and Table S6
are entirely consistent with those obtained through mediation
analysis, although the two approaches are not equivalent.
Indeed, although mediation effects require partial correlation,
partial correlation does not imply mediation, in general
(Extended Results).
All in all, these results support the fact that the retention of
ohnologs in the human genome is more strongly associated
with their ‘‘dangerousness’’ (i.e., susceptibility to dominant dele-
terious mutations) than with their functional importance (‘‘essen-
tiality’’), sensitivity to dosage balance, absolute expression
levels or sequence conservation (i.e., Ka/Ks).
Model for the Retention of ‘‘Dangerous’’ Ohnologs
As demonstrated above, human genes with a documented
sensitivity to dominant deleterious mutations have retained
statistically more ohnologs from the two WGD events at the
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Figure 3. Mediation Analysis of the Indirect Effect of Deleterious Mutations on the Retention of Ohnologs in Multiprotein Complexes
(A) Enhanced susceptibility of complexes to deleterious mutations.
(B) Mediation diagram depicting the direct versus indirect (i.e., mediated) effects of the cause X on the outcome Y(x,m(x)) (Pearl, 2011). See also Extended
Experimental Procedures.
(C and D) Quantitative Mediation analysis of direct versus indirect effects of deleterious mutations and dosage balance on the retention of human ohnologs using
(C) all human genes (20,506) or (D) all human genes without SSD nor CNV (8,215). The thickness of the arrows outlines the relative importance of the corre-
sponding direct or indirect effects. These results are consistent with those obtained from partial correlation analysis.
See also the main text, Extended Results, and Tables S4, S5, and S6.
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onset of jawed vertebrates. This suggests that ohnologs have
been retained in vertebrate genomes, not because they initially
brought selective advantages following WGD, but because their
mutations were more likely detrimental or lethal than nonfunc-
tional, thereby preventing their rapid elimination from the
genomes of surviving individuals following WGD transitions, as
outlined in the evolutionary model depicted in Figure 4.
For completeness and clarity, Figure 4 examines all possible
evolutionary scenarios following either a SSD or a WGD duplica-
tion event in the genome of one or a few individuals in an initial
population. The first and critical difference between SSD and
WGD duplication events occurs at the population genetics level
with an obligate speciation following WGD event, owing to the
difference in ploidy between pre- and post-WGD individuals.
As a result, all individuals in the post-WGDpopulation carry twice
as many genes as their pre-WGD relatives, whereas only a few
individuals in the post-SSD population carry a single small dupli-
cated region. Figure 4 then outlines the three mutation/selection
scenarios focusing on a single gene duplicate in the genomes of
post-SSD or post-WGD populations: (A) Beneficial mutations
after SSD or WGD are expected to spread and become eventu-
ally fixed in the new populations, although the bottleneck in
population size following WGD limits in practice the efficacy of
adaptation in post-WGD species. (B) Neutral or nearly neutral
mutations mainly lead to the random nonfunctionalization of
one copy of most redundant gene duplicates and, therefore, to
their elimination following both SSD and WGD events. In post-
WGD populations, this results in the ‘‘reciprocal gene loss’’ of
most gene duplicates, which is also known to lead to further
speciations in post-WGD species, owing to the interbreeding
incompatibility between post-WGD individuals with different
‘‘reciprocal gene loss’’ pattern (Lynch and Force, 2000a). Alter-
natively, neutral or nearly neutral mutations can also result in
the eventual retention of both duplicate copies through subfunc-
tionalization (Hughes, 1994; Lynch and Force, 2000b), that is, by
rendering each duplicate copy unable to perform all the func-
tions of their ancestral gene (see Discussion). (C) Finally, domi-
nant deleteriousmutations favor the elimination of the individuals
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(A–C) Horizontal lines represent the genome of different individuals. Square blocks symbolize the genes, duplicated (SSD: blue; WGD: red) or not (black). Black
crosses highlight the loss of one gene (small crosses) or the elimination of an individual (larger crosses), whereas bordered square blocks emphasize retained
mutated copies. Evolutionary scenarios are depicted at the population genetics level following either a SSD (left panel) or a WGD (right panel) in one or a few
individuals of an initial population. Unlike SSD, WGD is invariably coupled to a speciation event, owing to the difference in ploidy between pre- and post-WGD
individuals. Three possible scenarios—beneficial (A), neutral or nearly neutral (B), or deleterious mutations (C) in one gene duplicate—are outlined in post-SSD
and post-WGD populations. The main difference concerns the mutation/selection process of ‘‘dangerous’’ genes, i.e. genes prone to autosomal-dominant
deleterious mutations (C). See main text for a detailed description.
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(or their descendants) harboring them through purifying selec-
tion. However, this typically leads to opposite outcomes in
post-SSD and post-WGD populations. In post-SSD populations,
dominant deleterious mutations will tend to eliminate SSD dupli-
cates before they have the time to reach fixation (see below). By
contrast, in post-WGD populations, where all ohnologs have
been initially fixed through WGD-induced speciation, purifying
selection will effectively favor the retention of dangerous ohno-
logs, as all surviving individuals still present (nondeleterious)
functional copies of these dangerous genes.
Note, in particular, that this somewhat counterintuitive evolu-
tionary model for the retention of ‘‘dangerous’’ ohnologs hinges
on two unique features:
(1) It requires an autosomal dominance of deleterious muta-
tions, in agreement with our observation, above, that re-
tained ohnologs are more ‘‘dangerous’’ than ‘‘essential.’’
(2) It relies on the fact that successful WGD events start with
a concomitant speciation event, which immediately fixes
all ohnolog duplicates in the initial post-WGD population
(Figure 4).
Note, also, that the same evolutionary trend is expected for
dangerous SSD duplicates that would have the time (t) to
become fixed through genetic drift in a population of size N
before deleterious mutations can arise at a rate K, i.e., t = 4N <
1/K. This corresponds to a population bottleneck effect with
N < 1/(4K) z5,000–10,000 for typical vertebrates.
DISCUSSION
Beyond human and vertebrate genomes, WGD events have
now been established in all major eukaryote kingdoms (Sémon
and Wolfe, 2007; Evlampiev and Isambert, 2007). Unlike
SSD events, WGD transitions provide a unique evolutionary
mechanism, enabling the simultaneous duplication of entire
genetic pathways and multiprotein complexes, followed by
long periods of functional divergence and extensive loss of oh-
nologs (Aury et al., 2006). Moreover, although both WGD and
SSD events have expanded the gene repertoires and resulting
protein networks (Evlampiev and Isambert, 2007; Evlampiev
and Isambert, 2008) of eukaryotes, it has become increasingly
clear that WGD and SSD events actually lead to the expansion
of different gene classes in the course of evolution, (Maere
et al., 2005; Aury et al., 2006; Sémon and Wolfe, 2007; Makino
and McLysaght, 2010; Huminiecki and Heldin, 2010; and this
study).
In this article, we report that WGD have effectively favored the
expansion of gene families prone to deleterious mutations in the
human genome, such as genes implicated in cancer and genes
with autoinhibitory interactions. In particular, we found that the
retention of many ohnologs suspected to be dosage balanced
is in fact indirectly mediated by their susceptibility to deleterious
mutations.
From a broader perspective, a number of studies have now
shown that many genomic properties, such as gene essentiality,
duplicability, functional ontology, network connectivity, expres-
sion level, mutational robustness, divergence rates, etc., all
appear to be correlated to some extent. In the light of the present
study, we expect that many of these statistically significant
correlations mainly result from indirect rather than direct associ-
ations, which may even frequently oppose each other. This high-
lights the need to rely on more advanced inference methods to
analyze the multiple, direct, and indirect causes underlying the
evolution of specific gene repertoires.
In the present study, we have quantitatively analyzed the direct
versus indirect effects of the susceptibility of human genes to
deleterious mutation and dosage balance constraints on the
retention of ohnologs and proposed a simple evolutionary mech-
anism to account for the initial retention of ‘‘dangerous’’ ohno-
logs after WGD (Figure 4). On longer timescales, we expect
that this initial retention bias of ‘‘dangerous’’ ohnologs effectively
promote a prolonged genetic drift and, thus, a progressive func-
tional divergence between ohnolog pairs. This eventually favors
the subfunctionalization (Hughes, 1994; Lynch and Force,
2000b) of ancestral functions between ohnolog pairs, which ulti-
mately warrants their long-term maintenance following WGD
events.
Note, however, that this subfunctionalization process requires
that the expression of ohnologs is not rapidly suppressed by
large-scale deletion or silencing mutations in regulatory regions.
As ohnolog pairs are not arranged in tandem, large-scale dele-
tions through unequal crossing-over cannot typically remove
entire ohnolog duplicates while preserving the integrity of nearby
genes. Furthermore, as the size of promoter or enhancer regions
is typically much smaller than UTRs and coding regions, one
expects that the rate of transcriptional silencing does not exceed
the rates of functional silencing and divergence in UTRs and
coding regions. In fact, early estimates (Nadeau and Sankoff,
1997) showed that gene loss and functional divergence after
genome duplications in early vertebrates occurred at compa-
rable rates in gene families including at least two ohnologs.
This is also directly evidenced by pseudotetraploid species like
the vertebrate Xenopus laevis, which still retains 40% of its
initial ohnologs from a 30-million-year-old WGD (Sémon and
Wolfe, 2008). All in all, this suggests that ohnologs prone to
dominant deleterious mutations have at least a few million years
to diverge and become nonredundant genes before they have
a chance to be deleted or transcriptionally silenced.
Yet, we found that the retention of these dangerous ohnologs
remains intrinsically stochastic by nature as many of them have
also been eliminated following WGD events. This presumably
occurred through loss-of-function mutations, transcriptional
silencing, or large-scale deletion before ohnolog pairs could
diverge and become nonredundant genes. More quantitatively,
a simple theoretical estimate, derived from the long-term reten-
tion statistics of Figure 1, shows that only 6%–10% of the initial
ohnolog duplicates have been retained on average at each round
of WGD, Figure 5 (see Extended Results for details). By compar-
ison, 23%–30% of the initial ohnologs prone to gain-of-func-
tion mutations have been retained on average at each WGD.
This implies that genes susceptible to deleterious mutations
are two to five timesmore likely to retain ohnologs on long evolu-
tionary timescales. Moreover, genes combining several factors
associated with enhanced susceptibility to autosomal-dominant
deleterious mutations are shown to be more than ten times more
Cell Reports 2, 1387–1398, November 29, 2012 ª2012 The Authors 1395
likely to retain ohnologs than genes lacking gain-of-function
mutations (Figure 5), as illustrated on the examples of oncogenes
with autoinhibitory folds (Table 1).
In turn, the elimination of ohnologs has been shown to drive
further speciation events within post-WGD (sub)populations,
due to the emergence of recombination barriers from the accu-
mulation of differences in ohnolog deletion patterns between
post-WGD individuals (Lynch and Force, 2000a). The resulting
fragmentation of post-WGD subpopulations is then expected
to sustain negative selection pressure that favors the retention
of the remaining ohnolog pairs prone to deleterious mutations,
as outlined in Figure 4. Hence, although most WGDs are unlikely
to bring much fitness benefit on short evolutionary timescales (if
only due to the population bottlenecks associated with WGD-
induced speciations; Figure 4), they provide a unique evolu-
tionary mechanism to experiment virtually unlimited combina-
tions of regulation/deletion patterns from redundant ohnolog
genes. Over long timescales (>100–500 MY), such trial and error
combinations have visibly led to the evolutionary success and
radiation of WGD species.
In summary, we present evidence supporting an evolutionary
link between the susceptibility of human genes to dominant dele-
terious mutations and the documented expansion of these
‘‘dangerous’’ gene families by two WGD events at the onset of
jawed vertebrates. We propose that deleterious mutations,
responsible for many cancers and other severe genetic diseases
on the lifespan of human individuals, have also underlain puri-
fying selection over long evolutionary timescales, which effec-
tively favored the retention of vertebrate ohnologs prone to
dominant deleterious mutations, as outlined in Figure 4. From
a population genetics perspective, we argue that this counterin-
tuitive retention of dangerous ohnologs hinges in fact on WGD-
induced speciation events, which are largely credited for the
genetic complexity and successful radiation of vertebrate
species.
These findings highlight the importance of purifying selection
from WGD events on the evolution of vertebrates and, beyond,
exemplify the role of nonadaptive forces on the emergence of
eukaryote complexity (Fernández and Lynch, 2011).
EXPERIMENTAL PROCEDURES
WGD Duplicated Genes or ‘‘Ohnologs’’
Human ohnolog genes were obtained from (Makino and McLysaght, 2010).
Makino and McLysaght compared different vertebrate and six nonvertebrate
outgroup genomes to identify ohnologs in the human genome. The final data
set consists of 8,653 ohnolog pairs and 7,110 unique ohnologs. We further
divided ohnologs into well supported (3,963), plausible (894), and more uncer-
tain (2,253) ohnologs (see Extended Experimental Procedures).
SSD Duplicated Genes
We identified paralogous genes within the human genome from sequence
similarity search. We obtained a total of 11,185 SSD genes. In particular,
paralogs that were not annotated as ohnologs were taken to be SSD genes
(see Extended Experimental Procedures).
Genes with CNV
CNV regions were obtained from Database of Genomic Variants (Zhang et al.,
2006). A total of 5,709 genes were identified to be CNV genes as their entire
coding sequence fell within one of the CNV regions.
Cancer and Disease Genes
We obtained cancer genes from multiple databases, including COSMIC (For-
bes et al., 2011) and CancerGenes (Higgins et al., 2007), listed in Table S7. The
detailed list of 6,917 cancer genes is given in Table S8 with a hand-curated list
of 813 verified or predicted (Bozic et al., 2010) oncogenes (see Extended
Experimental Procedures). We obtained 2,580 disease genes from the ‘‘Mor-
bidmap’’ database of OMIM and hand curated subsets of 440 autosomal-
dominant and 598 autosomal-recessive disease genes from Blekhman et al.
(2008).
Genes with Autoinhibitory Folds
To obtain genes coding for proteins with autoinhibitory folds we searched
PubMed with keyword ‘‘autoinhibitory domain’’ and retrieved relevant autoin-
hibitory genes and domains manually. Further gene candidates with autoinhi-
bitory folds were obtained from databases, OMIM, SwissProt, NCBI Gene, and
GeneCards using the parsing terms: auto/self-inhibit*. Careful manual curation
of this list of gene candidates with the available literature finally yielded a total
of 461 genes with autoinhibitory folds (94% of initial candidates).
Essential Genes
Mouse essential genes were obtained from Mouse Genome Informatics data-
base. Essential genes were defined as genes having lethal or infertility pheno-
types on loss-of-function or knockout mutations (2,729 genes) (see Extended
Experimental Procedures).
Genes in Complexes and Permanent Complexes
Protein complexes were obtained from Human Protein Reference Database
(HPRD) (Keshava Prasad et al., 2009) and CORUM database (Ruepp et al.,
2010). In addition, a manually curated data set of permanent complexes
(239 genes) was obtained from Zanivan et al. (2007). The final data set consists
of 3,814 protein complex genes (see Extended Experimental Procedures).
Haploinsufficient and Dominant Negative Genes
Haploinsufficient and dominant negative candidate genes were obtained from
parsing OMIM text files with Perl regular expressions. The resulting gene lists
were manually curated with the available literature, yielding a total of
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Figure 5. Estimates of Ohnolog Retention Rates
Estimates of ohnolog retention rates ps in early vertebrates from the observed
fraction fs of ohnologs in the human genome for gene classes, s, with
increasing susceptibility to deleterious mutations. The theoretical estimate
(red curve) is obtained assuming that the retentions of ohnologs were
comparable for each of the two WGD at the onset of vertebrates, and reads
Ps =2=fs  1
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð2=fs  1Þ2  1
q
as detailed in the Extended Results and
Tables S7 and S8.
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330 haploinsufficient genes (80% of initial candidates) and 477 dominant-
negative genes (63% of initial candidates).
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la sensibilité des techniques d’imagerie, 
permettront de continuer à développer 
de nouveaux rapporteurs. En outre, les 
outils de détection et de suivi des cel-
lules, ainsi que l’analyse des oscillations 
permettront de développer le même type 
d’approche chez d’autres vertébrés. ‡
A technical breakthrough 
for understanding segmentation clock 
dynamics and synchrony
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> Si la conservation des gènes essentiels 
à la vie des organismes se conçoit intui-
tivement bien, à l’inverse, l’étonnante 
expansion des familles de gènes à l’ori-
gine des cancers ou d’autres maladies 
génétiques chez les vertébrés pose ques-
tion. Alors qu’on pourrait supposer que 
la multiplication de ces gènes « dan-
gereux » confère malgré tout un avan-
tage sélectif, nos travaux récents [1] 
suggèrent en fait que ces gènes ont été 
multipliés et conservés en raison de leur 
dangerosité à la suite de deux accidents 
génétiques majeurs correspondant à des 
duplications globales de génome.
De l’expansion des familles de gènes 
dangereux chez les vertébrés
Pour comprendre l’origine de l’expan-
sion des familles de gènes dangereux 
chez les vertébrés, il faut remonter à 
l’ancêtre commun de tous les vertébrés, 
il y a quelque 500 millions d’années. Par 
un mécanisme presque toujours létal, 
mais qui a joué un rôle essentiel au 
cours de l’évolution, notre lignée encore 
invertébrée a entièrement dupliqué son 
génome deux fois de suite et a sur-
vécu à ces deux accidents génétiques 
majeurs. Ces deux duplications globales 
du génome ont conduit à l’émergence et 
à la complexification des vertébrés dont 
certains gènes ont conservés jusqu’à 
quatre copies. Au total, un quart à un 
tiers de nos gènes serait directement 
issu de ces deux duplications de génome 
à l’origine des vertébrés [2]. Ces gènes 
sont appelés gènes ohnologues en l’hon-
neur du généticien Susumu Ohno qui fut 
le premier à avancer l’hypothèse de ces 
duplications globales du génome chez les 
vertébrés [3].
Après une duplication globale du 
génome, les organismes perdent géné-
ralement près de 80 à 90 % des gènes 
dupliqués, ce qui entraîne une expansion 
hétérogène de leurs voies de signali-
sation (Figure 1) et de leurs réseaux 
de gènes [4-6]. Cependant, de façon 
surprenante, on constate que les copies 
ohnologues retenues dans le génome 
humain comportent un nombre élevé de 
gènes dangereux, c’est-à-dire présen-
tant une forte susceptibilité aux muta-
tions délétères dominantes comme les 
oncogènes notamment. Certains de ces 
gènes dangereux ont même gardé leurs 
quatre copies depuis l’origine des ver-
tébrés ! C’est le cas par exemple des 
gènes RalGEF (Ral guanine-nucleotide 
exchange factor) (Figure 1) qui activent 
les voies Ras-Ral impliquées dans la 
migration et la prolifération cellulaires 
dans des tumeurs [7]. De même, le gène 
Ras, qu’on retrouve en un seul exemplaire 
chez les invertébrés comme la drosophile 
(Figure 1), a conservé chez la plupart des 
vertébrés trois ohnologues proto-onco-
géniques (KRas, HRas et NRas) (Figure 1) 
qui présentent des mutations constituti-
vement actives dans plus de 25 % des cas 
de cancer chez l’homme.
m/s n° 4, vol. 29, avril 2013
DOI : 10.1051/medsci/2013294008
NouvellesAvril2013.indd   358 12/04/2013   10:24:47
m/s n° 4, vol. 29, avril 2013
NO
UV
EL
LE
S
M
AG
AZ
IN
E
 359
Le mécanisme de conservation 
des ohnologues
Pourquoi les multiples copies ohnologues 
de ces gènes dangereux, à l’origine de 
nombreux cancers et maladies géné-
tiques sévères, n’ont-elles pas été éli-
minées chez les vertébrés ? Pour le com-
prendre, il faut avoir en tête deux points 
essentiels (Figure 2) : (1) la duplication 
globale du génome, lorsqu’elle n’est pas 
létale, implique nécessairement l’appa-
rition d’une nouvelle espèce composée 
d’individus possèdant tous initialement 
leurs gènes en double ; et (2) l’inégalité 
des gènes face aux mutations. Alors que 
la plupart des gènes tendent à perdre 
leur fonction par mutation, les gènes 
dangereux se caractérisent par le fait 
que leurs mutations entraînent fréquem-
ment une suractivation, c’est-à-dire un 
gain de fonction, plutôt qu’une perte de 
fonction. En général, la perte de fonction 
d’un ohnologue ne pose pas de problème 
tant qu’il reste une copie fonctionnelle 
de ce gène, ce qui conduit à l’élimina-
tion progressive d’une des copies de la 
plupart des ohnologues non dangereux. 
En revanche, la survenue de mutations 
conduisant à des gains de fonction ou, 
plus généralement, à des phénotypes 
dominants délétères qui caractérisent 
les ohnologues dangereux, va entraîner 
des pathologies du développement ou 
test 2) ou des gènes dont la protéine 
est auto-inhibée (76 % ; 350/461 ; 
p = 2,7 x 10-77, test 2). De même, 
lorsque l’on considère des classes de 
gènes combinant plusieurs facteurs de 
dangerosité, telles que la classe des 
oncogènes dont la protéine est auto-
inhibée, ces biais de rétention dépassent 
les 90 % (91 % ; 104/114 ; p = 6,9 x 
10-37, test 2). À l’inverse, nous avons 
montré que les gènes associés à des 
mutations délétères récessives chez 
l’homme, ainsi que la plupart des gènes 
essentiels connus chez la souris, n’ont 
pas conservé un excès d’ohnologues. 
Il apparaît donc que la rétention des 
gènes ohnologues serait directement 
liée à leur susceptibilité aux mutations 
délétères dominantes et non pas à leur 
nature fondamentale pour l’organisme. 
Nous avons en fait démontré [1], au 
moyen d’analyses statistiques d’infé-
rences bayésiennes, telles que l’analyse 
de Médiation [10], que la dangero-
sité est bien la cause principale de la 
rétention des gènes ohnologues chez 
l’homme. En particulier, les équilibres 
entre les niveaux d’expression géné-
tique, fréquemment proposés comme la 
principale cause des biais de rétention 
des ohnologues, semblent en fait résul-
ter indirectement des effets des muta-
tions délétères dominantes [1].
Au delà de ces exemples, nous avons 
effectué une étude d’exploration de 
données à grande échelle sur l’en-
semble des gènes humains, à partir des 
bases de données accessibles en ligne 
(comme COSMIC [8], CancerGenes [9]) 
et de publications. Ceci nous a per-
mis de mettre en évidence une forte 
association entre la dangerosité des 
ohnologues et leur rétention dans le 
génome humain. Dans ces analyses, nous 
avons considéré différentes classes de 
gènes susceptibles d’être affectés par 
des mutations délétères. Ces classes 
comprennent notamment des gènes 
dont l’implication dans les cancers est 
connue et des gènes dont les mutations 
induisent typiquement des phénotypes 
délétères dominants, par exemple via 
une perte d’interaction d’auto-inhibition 
entraînant un gain de fonction perma-
nent pour le gène mutant.
Les résultats obtenus [1] indiquent 
que les 8 095 gènes impliqués dans des 
cancers ou dans des maladies géné-
tiques comportent significativement 
plus d’ohnologues que l’ensemble des 
20 506 gènes codant pour les protéines 
humaines, soit 48 % contre 35 % (48 % ; 
3 844/8 095 ; p = 1,3 x 10-129, test 2). 
En outre, ce biais de rétention aug-
mente fortement dans le cas des onco-
gènes (61 % ; 493/813 ; p = 1,4 x 10-54, 
Figure 1. Expansion des voies de signalisation Ras-Ral. Voies de signalisation Ras-Ral chez la drosophile (A) et chez l’homme (B). Après les deux 
duplications globales de génomes chez l’ancêtre des vertébrés, chez l’homme, le gène RGL a conservé ses quatre copies ohnologues (RalGDS, RGL1, 
RGL2, RGL3), le gène Ras a conservé trois copies ohnologues (Kras, Hras, Nras) et le gène Ral a conservé deux copies ohnologues (RalA, RalB) [7]. 
Cet exemple illustre la nécessaire réorganisation des voies de signalisation et des réseaux d’interactions protéine-protéine après un évènement de 
duplication globale du génome, et l’élimination par divergence d’une partie des gènes dupliqués [4-6].
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se passe comme si les individus de ces 
populations n’avaient pas pu se débar-
rasser de nombreux gènes dangereux 
redondants, directement fixés par spé-
ciation dans leur génome dupliqué et 
non pas fixés progressivement grâce à un 
avantage sélectif comme pour la plupart 
des gènes dupliqués individuellement. 
Ensuite, les gènes ohnologues conservés 
se différencient et deviennent souvent 
des acteurs majeurs du développement, 
de la signalisation et de la régulation 
cellulaires. Par exemple, les cadhérines, 
sorte de colle qui lient les cellules entre 
elles, ont conservé de multiples ohno-
logues exprimés dans différents tissus, 
comme la E-cadhérine qui lie les cellules 
épithéliales entre elles, ou la N-cadhérine 
exprimée dans le tube neural et les neu-
rones. Mais les mutations des cadhérines 
qui entraînent la décohésion des cellules 
entre elles sont aussi impliquées dans la 
migration des cellules tumorales et leur 
dissémination vers d’autres organes.
Conclusions
Ces accidents génétiques majeurs de 
doublement du génome survenus il y a 
500 millions d’années dans l’évolution 
des vertébrés ont donc permis l’émer-
gence d’organismes plus complexes, 
mais aussi la multiplication des gènes 
dangereux chez les vertébrés. Ces résul-
tats éclairent d’un point de vue évolu-
tif nouveau l’expansion des familles de 
gènes fréquemment impliquées dans des 
maladies génétiques et de nombreux 
cancers. ‡
Evolution and cancer: 
expansion of dangerous gene repertoire 
by whole genome duplications
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distingue du concept d’avantage sélec-
tif généralement associé à l’évolution 
(sélection naturelle ou adaptative).
La multiplication des gènes dangereux 
chez les vertébrés est donc liée à ce 
phénomène spécifique et très rare de 
duplication globale du génome qui existe 
en fait dans la plupart des branches 
eucaryotes. Sa compréhension doit se 
faire au niveau de la génétique des popu-
lations au sein des nouvelles espèces 
issues d’une duplication de génome. Tout 
des tumeurs. Celles-ci pénalisent les 
organismes atteints et, plus ou moins 
directement, leur descendance qui finira 
par s’interrompre. Pour autant, les gènes 
dangereux impliqués ne sont pas élimi-
nés mais au contraire conservés dans 
la population, puisqu’ils sont encore 
présents sous une forme non délétère 
dans le reste de la population issue de 
la duplication du génome (Figure 2). Ce 
processus évolutif par élimination de 
mutants (sélection de purification) se 
Figure 2. Évolution des gènes dupliqués après duplicaton globale du génome. A-C. Les lignes 
horizontales représentent le génome de différents individus. Les carrés symbolisent les gènes 
dupliqués (rouges) ou non dupliqués (noirs). Les croix noires représentent la perte d’un seul gène 
(petites croix) ou l’élimination d’un individu (grande croix), tandis que les carrés avec bordures 
indiquent les copies mutées. Les scénarios d’évolution sont décrits comme il se doit au niveau 
d’une population d’individus. Lorsqu’elle n’est pas létale, une duplication globale de génome 
chez un ou plusieurs individus de la population initiale (deux lignes horizontales rouges pour un 
individu avec duplication complète) implique nécessairement l’émergence d’une nouvelle espèce 
dont tous les gènes ont été dupliqués. La sélection de purification favorise alors indirectement 
la conservation des ohnologues dangereux non mutés dans le génome des individus qui survivent. 
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> La survie d’un organisme multicellu-
laire est étroitement liée au maintien 
de l’homéostasie dans l’ensemble des 
tissus constituant cet organisme. Cette 
capacité à maintenir cet équilibre vital 
est assurée par des populations de cel-
lules souches, via trois caractéristiques 
principales : (1) la possibilité de se divi-
ser et de renouveler ce compartiment en 
générant de nouvelles cellules souches ; 
(2) l’absence de fonctions tissulaires 
spécifiques ; et (3) la capacité de se 
différencier en cellules spécialisées. La 
moelle osseuse, où résident les cellules 
souches hématopoïétiques (CSH) res-
ponsables de la production des cellules 
du sang, constitue un tissu modèle pour 
l’étude des cellules souches somatiques. 
En effet, l’identification de multiples 
marqueurs de surface et le dévelop-
pement d’anticorps dirigés contre ces 
marqueurs et utilisables en cytométrie 
de flux (FACS, fluorescent activated cell 
sorter), permettent de discriminer et 
d’isoler les divers précurseurs des cel-
lules sanguines.
Les cellules souches sont sensibles, 
comme toute cellule, aux conditions 
de stress, en particulier aux dommages 
de l’ADN. Ainsi, au cours du temps, 
l’accumulation de mutations contribue 
au déclin des capacités des cellules 
souches. L’existence de mécanismes de 
réparation de l’ADN est donc essentielle 
au maintien des populations de cellules 
souches [1]. Une étude récente de notre 
groupe décrit le rôle d’un système de 
réparation de l’ADN et la nature géno-
toxique de métabolites endogènes dans 
les CSH de souris [2].
L’anémie de Fanconi, une pathologie 
s’accompagnant d’un défaut 
de réparation de l’ADN
La thématique de recherche principale 
de notre équipe concerne l’étude des 
mécanismes de réparation de l’ADN et, 
en particulier, celle des gènes impli-
qués dans l’anémie de Fanconi. Notre 
approche est essentiellement génétique 
et se base sur des modèles cellulaires et 
murins (souris génétiquement modifiées 
ou knockout [KO]). Du nom du pédiatre 
suisse Guido Fanconi qui décrivit cette 
maladie génétique rare au début du 
XXe siècle [3], l’anémie de Fanconi se 
manifeste dès l’enfance par des malfor-
mations squelettiques, une forte prédis-
position à certains types de cancers (en 
particulier des leucémies myéloïdes) et 
une aplasie médullaire progressive. Les 
cellules de ces patients sont très sen-
sibles à des drogues anticancéreuses, 
telles que la cisplatine ou la mitomy-
cine C. Cette sensibilité constitue la base 
du test de diagnostic dit de « cassures 
chromosomiques » [4]. En effet, en liant 
de façon covalente deux bases oppo-
sées (interbrins d’ADN) ou adjacentes 
(intrabrin d’ADN), ces drogues induisent 
des lésions (ponts inter- ou intrabrins, 
DNA crosslinks) de l’ADN qui bloquent 
la réplication et la transcription. Ces 
ponts interbrins ont pour conséquence 
une augmentation des cassures chromo-
somiques. Dans les cellules de patients 
atteints d’anémie de Fanconi, ceci est 
dû à un défaut de réparation de l’ADN. 
À ce jour, une quinzaine de gènes ont 
été identifiés, codant pour des protéines 
impliquées dans cette voie de réparation 
des lésions pontantes de l’ADN.
Les aldéhydes, source de dommages 
à l’ADN
Les cassures chromosomiques se mani-
festent spontanément dans les cellules 
de patients, en dehors de la présence de 
drogues comme la cisplatine, ce qui sug-
gère l’existence d’agents génotoxiques 
présents de façon naturelle dans les 
cellules de ces patients. Notre groupe a 
confirmé cette hypothèse en montrant 
en 2011 que les aldéhydes produits par 
le métabolisme cellulaire (en particu-
lier l’acétaldéhyde) étaient à l’origine 
de dommages à l’ADN dans les cellules 
de patients atteints d’anémie de Fan-
coni [5]. Des souris double KO pour les 
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PLoS Computational Biology recently published an article by Chen, Zhao, van Noort and Bork [1] 
reporting that human monogenic disease (MD) genes are 1) enriched in duplicates and 2) more 
functionally similar to their closest paralogs, in contrast to duplicated non-disease genes, based on 
sequence conservation and expression profile similarity. Chen et al. then proposed that human MD 
genes have frequently functionally redundant paralogs that can mask the phenotypic effects of 
deleterious mutations. 
We would like to point out here two lines of evidence which appear more relevant to explain this 
surprising enrichment in duplicates of human disease genes. The first evidence is that human gene 
duplicates should be distinguished depending whether they originate from small scale duplication 
(SSD) or from the two rounds of whole genome duplication (WGD) that occurred in early vertebrates 
some 500 million years ago. In fact, as shown quantitatively below using Chen et al.'s dataset, 
human MD genes are actually depleted, not enriched, in SSD duplicates, whereas they are clearly 
enriched in WGD duplicates, when compared to non-disease genes. This opposite retention pattern 
cannot be explained by a selection mechanism independent of the SSD or WGD origin of MD gene 
duplicates. The second line of evidence concerns the mode of inheritance of human MDs, which 
provides a more stringent criterion than sequence conservation or co-expression profile to assess 
the likelihood of functional compensation by paralogs of MD genes. In particular, the recessiveness 
of a human disease is expected to be a prerequisite for functional compensation by a paralog gene. 
Indeed, autosomal dominant MDs are unlikely to experience significant functional compensation 
from a different locus, since even a perfectly functional allele is unable to mask the deleterious 
phenotypic effects of a dominant allelic mutant on the same heterozygote locus. 
We first address the difference between SSD duplicates and WGD duplicates,  also called “ohnologs” 
after Susumu Ohno's early “2R hypothesis” [2] which has now been firmly established [3]. The 
importance of distinguishing between SSD and WGD duplicates in the human genome has already 
been reported in a number of papers [4, 5, 6] including our own [7]. As shown in Figure 1A, human 
genes tend to partition into three main gene categories with respect to duplicates: those with WGD 
but no SSD duplicates (about 28%), those with SSD but no WGD duplicates (about 41%) and 
singletons without WGD nor SSD duplicates (about 24%), while human genes with both WGD and 
SSD duplicates are relatively rare (about 7%). Gene families enriched either in WGD or SSD 
duplicates also correspond to distinct functional classes [4, 5], with WGD genes frequently involved 
in signaling, regulation and development, whereas SSD genes are typically implicated in different 
functions such as antigen processing, immune response and metabolism. 
In addition, human diseases have been shown to be enriched in WGD duplicates, while being 
significantly depleted in SSD duplicates [4, 7]. This could not be seen with Chen et al.'s dataset which 
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lumps together all gene duplicates irrespective of their WGD or SSD origin. In fact, using the same 
monogenic disease (MD) dataset readily confirms and extends these earlier results, as depicted in 
Figure 1B. MD genes are significantly enriched in ohnologs, 38.7% vs 28% (p = 1.78 x 10-64; 2 test), 
while showing at the same time a significant depletion in both SSD, 36.1% vs 41.2% (p = 2.24 x 10-13; 
2 test) and singletons, 16.8% vs 24.1% (p = 5.69 x 10-34; 2 test). These results demonstrate that, 
although MD genes retain significantly more duplicates than singletons (Figure 1B), these duplicates 
are primarily enriched in ohnologs and not SSD copies, as compared to the relative WGD and SSD 
content of the entire human genome, Figure 1A. 
To explain the global enrichment in MD gene duplicates, Chen et al. proposed that “functional 
compensation by duplication of genes masks the phenotypic effects of deleterious mutations and 
reduces the probability of purging the defective genes from the human population”. However, we 
note that, while recent gene duplicates might be able to mask the phenotypic effect of recessive 
(e.g. loss-of-function) mutations, dominant (e.g. gain-of-function) mutations should typically lead to 
deleterious phenotypic effects regardless of the presence of any functionally redundant paralog at a 
different locus on the human genome.  
In order to assess the extent of possible functional compensation on the retention of MD gene 
duplicates, we have used the mode of inheritance of human MDs rather than the less specific criteria 
of sequence conservation and expression profile similarity of MD genes. To this end, we retrieved 
the available information on the dominance and recessiveness of MDs from OMIM [8] and Blekhman 
et al. [9]. Manual curation yielded 621 autosomal dominant and 839 autosomal recessive MD genes 
after excluding sex linked genes and MD genes documented as both dominant and recessive. We 
then analyzed the duplication biases of recessive MDs (with possible functional compensation) and 
dominant MDs (with unlikely functional compensation). Figure 1C shows that recessive MDs do not 
present any biased retention of ohnologs, 28.7% vs 28% (p = 0.49; 2 test), SSD duplicates, 38.9% vs 
41.2% (p = 0.16; 2 test) nor singletons,  24.1% vs 25.4% (p = 0.38; 2 test), as compared to their 
respective prevalence in the entire human genome, Figure 1A. These observations clearly show that 
the maintenance of recessive MD genes is in fact independent of their WGD, SSD or singleton status, 
suggesting limited effects of functional compensation by paralogs on the retention of gene 
duplicates associated to recessive MDs in human. By contrast, we observed, Figure 1D, that 
dominant MDs exhibit a strong enrichment in ohnologs, 45.6% vs 28% (p = 1.87 x 10-22; 2 test) with 
concomitant depletions in both SSD, 29.6% vs 41.2% (p =4.51 x 10-9; 2 test), and singletons, 13.8% vs 
24.1% (p =2.22 x 10-9; 2 test). This is unlikely to result from a functional compensation by paralogs 
due to the molecular genetics of dominant MDs, as discussed above. 
So, what could be the evolutionary mechanism behind the enhanced retention of WGD duplicates 
and depletion of SSD duplicates and singletons associated to MDs in human? In [7], we proposed a 
population genetics model based on the observation that a major difference between SSD and WGD 
scenarios concerns the timing of fixation of gene duplicates. It is well known that the SSD scenario 
starts with a gene duplication in the genome of a single individual, which subsequently needs to 
spread through the entire population to reach fixation. By contrast, the WGD scenario entails an 
initial fixation of duplicated gene pairs in the genome of all individuals in the small population arising 
through WGD. This is because WGD typically induces a speciation event due to the ploidy 
incompatibility of the post-WGD individuals with the rest of the pre-WGD population. This 
population genetics model for the fixation of SSD versus WGD duplicates then predicts that the 
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enhanced retention of “dangerous” ohnologs prone to dominant deleterious mutations is a direct 
consequence of purifying selection in post-WGD population, as most surviving individuals retain 
(non-deleterious) functional copies of their ohnologs prone to dominant deleterious mutations, 
while ohnologs prone to recessive deleterious mutations are more readily eliminated through loss-
of-function mutations (see [7] for further details). 
All in all, it appears that MD genes have preferentially retained WGD rather than SSD duplicates, as 
compared to non-disease genes. Yet, only dominant MD genes exhibit a clear enrichment in WGD 
duplicates, while the retention of recessive MD genes, which might in principle experience 
functional compensation from paralogs, is in fact independent of their WGD, SSD or singleton status. 
These results cannot be explained by the functional compensation hypothesis proposed in [1]. They 
are, however, consistent with a population genetics model taking into account the initial fixation of 
ohnologs through WGD-induced speciation and the ensuing purifying selection in post-WGD 
populations [7]. 
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Expansion des familles de gènes impliquées dans des maladies par duplication du génome 
chez les premiers vertébrés 
L'expansion  au  cours  de  l'évolution  de  familles  de  gènes  impliquées  dans  les  cancers  et  d'autres 
maladies génétiques graves est  surprenante du point de vue de  la  sélection naturelle. Dans  cette 
thèse,  nous  avons montré  que  des  familles  de  gènes  sujettes  à  des mutations  délétères  dans  le 
génome  humain  se  sont  principalement  agrandies  par  rétention  de  gènes  "ohnologues"  issus  de 
deux  duplications  globales  du  génome  (GGD)  datant  de  l'origine  des  vertébrés  à mâchoires.  En 
utilisant  une  méthode  d'inférence  avancée,  nous  avons  aussi  démontré  que  la  rétention  de 
nombreux ohnologues soupçonnés d'être susceptibles aux équilibres de dosage d'expression était en 
fait  plus  directement  liée  à  leur  sensibilité  aux  mutations  délétères.  Cette  rétention  priviligiée 
d'ohnologues "dangereux", définis comme sujets à des mutations délétères dominantes, semble être 
une  conséquence  des  évênements  de  spéciation  provoqués  par  ces  GGD  et  la  sélection  de 
purification qui a suivi dans  les espèces post‐GGD. Nous avons également développé une approche 
quantitative  pour  identifier  les  ohnologues  dans  le  génome  des  vertébrés.  Ces  ohnologues  sont 
facilement  accessibles  à  partir  d'un  serveur  Web.  Nos  résultats  soulignent  l'  importance  de  la 
sélection non adaptative induite par GGD dans l'émergence de la complexité des vertébrés, tout en 
rationalisant, d'un point de vue évolutif, l'extension des familles de gènes fréquemment impliquées 
dans  les maladies génétiques et  les cancers. Les ohnologues  identifiés par notre approche ouvrent 
également  la  voie  à  de  nouvelles  analyses  de  génomique  fonctionnelle  distinguant  l'origine  des 
gènes dupliqués. 
 
 
Expansion of disease gene families by whole genome duplication in early vertebrates 
The emergence and evolutionary expansion of gene families implicated in cancers and other severe 
genetic diseases  is  an evolutionary oddity  from  a natural  selection perspective.  In  this  thesis, we 
have  shown  that  gene  families prone  to deleterious mutations  in  the human  genome have been 
preferentially  expanded  by  the  retention  of  "ohnolog"  genes  from  two  rounds  of whole‐genome 
duplication  (WGD)  dating  back  from  the  onset  of  jawed  vertebrates.  Using  advanced  inference 
analysis, we have further demonstrated that the retention of many ohnologs suspected to be dosage 
balanced is in fact indirectly mediated by their susceptibility to deleterious mutations. This enhanced 
retention of "dangerous" ohnologs, defined as prone to autosomal‐dominant deleterious mutations, 
is  shown  to be  a  consequence of WGD‐induced  speciation  and  the ensuing purifying  selection  in 
post‐WGD species. We have also developed a statistical approach to identify ohnologs in vertebrate 
genomes with  high  confidence.  These  ohnologs  can  be  easily  accessed  from  a web  server.  Our 
findings  highlight  the  importance  of WGD‐induced  non‐adaptive  selection  for  the  emergence  of 
vertebrate complexity, while rationalizing, from an evolutionary perspective, the expansion of gene 
families  frequently  implicated  in  genetic  disorders  and  cancers.  The  high  confidence  ohnologs 
identified  by  our  approach  will  also  pave  the  way  for  novel  functional  genomic  analyses 
distinguishing gene duplicates according to their origin. 
